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ABSTRACT
The purpose of this study was to investigate cardiovascular disease risk in Black and 
Caucasian urban working females of the Makana region of the Eastern Cape. One- 
hundred and sixty six age-matched urban-working individuals (Black n = 88; 
Caucasian n = 78) voluntarily participated in this cross-sectional study. Cardiovascular 
disease risk was assessed in four categories: 1) obesity, classified as ‘morphological 
risk’, 2) blood pressure, classified as ‘cardiovascular risk’, 3) diet, physical activity, 
smoking, and alcohol consumption, classified as ‘lifestyle risk’, and 4) education and 
income, classified as ‘socioeconomic factors’. Results showed that Black females 
were significantly (p<0.01) heavier than Caucasian females and categorized as 
‘obese’ according to BMI classifications (31.19 ± 8.09 kg.m2 and 25.90 ±4.67 kg.m2, 
respectively). Black females also presented with significantly (p<0.01) higher waist 
circumferences and waist-to-stature ratios, further confirming the obesity prevalence 
in this group. When accounting for those who were on anti-hypertensive mediation, 
Black females additionally presented with significantly (p<0.05) higher blood pressure, 
categorizing them as ‘pre-hypertensive’ (MAP = 98 ± 16 mmHg and 85 ± 11 mmHg, 
respectively). These results therefore placed Black females at increased 
cardiovascular disease risk compared to Caucasian females. With respect to lifestyle 
factors, Black females consumed significantly (p<0.05) more kilojoules carbohydrates, 
and total sugar than Caucasian females, and expended more physical activity MET- 
minutes per week (2688.86 ± 1486.56 MET-minutes and 1828.27 ± 2238.10 MET- 
minutes, respectively). However, reduced validity of physical activity data as well as 
poor dietary recall limited the interpretations of these findings. In addition, despite 
significant differences between smoking and alcohol consumption between groups, 
the majority of both Black and Caucasian females reported being non-smokers and 
consumed alcohol minimally. Thus, these were concluded to be unlikely contributors 
to cardiovascular disease risk in these samples. Socioeconomic results nevertheless 
expectedly showed that Black females were significantly (p<0.05) less educated, and 
subsequently earned lower incomes. It was thus concluded that this may be a likely 
contributor to higher cardiovascular risk in Black females. Future recommendations 
include the incorporation of exercise intensity measures as well as objective measures 
of habitual diet. This is in order to get a clearer understanding of the impact of these 
lifestyle factors on cardiovascular disease risk.
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CHAPTER I -  INTRODUCTION
1.1 BACKGROUND
South Africa is comprised of a vast mix of people and cultures including not only a 
number of different racial groups, but also large socioeconomic disparities (Steyn et 
al., 2006). This ranges from those few at the top end of the socio-economic scale, to 
the majority of South Africans who live below the poverty line (evidenced by a Gini 
coefficient of 63.4 in 2015, which is the highest among the BRICS countries) (The 
World Bank, 2016). As all of the BRICS countries (Brazil, Russia, India, China, and 
South Africa) are grouped together as countries in a similar stage of newly advanced 
economic development, the fact that the economic disparity is highest within South 
Africa highlights the unique context of the country, and emphasizes the need for 
individualized attention (The World Bank, 2016). Due to these unique set of 
circumstances, South Africans face a broad spectrum of diseases, comprising of 
communicable (infectious) diseases; non-communicable (lifestyle-related) diseases; 
and HIV/AIDS (Bradshaw & Steyn, 2001; Econoex, 2009). In addition, due to the high 
violent crime rate, South Africans are also vulnerable to violence-related injuries and 
trauma, which places them at an even greater health risk (Bradshaw et al., 2006). Due 
to the combination of these four factors, the country suffers from what is termed the 
‘quadruple burden of disease’ (Econex, 2009; Moodley et al., 2013). Research has 
shown that the heaviest burden of disease falls on poor communities in urban areas, 
and this is often due to poor access to state health care and education (Mayosi et al., 
2009; Walter and Durandt, 2011). As the majority of those people living in these poor 
urban areas are black South Africans (Mayosi et al., 2009), it is therefore black South 
Africans who bear the brunt of the quadruple burden of disease in the country (Mayosi 
et al., 2009).
Historically, non-communicable diseases received little attention in developing 
countries; these diseases predominantly affected white urban males and were typically 
associated with ‘affluence’ characterized by sedentary lifestyles and poor eating habits 
(Ezzati et al., 2005; Taubes, 2008). Evidence from almost fourty years ago indeed 
shows that white males were one of the most, if not the most, obese and at risk 
population for non-communicable diseases in the world (Ezzati et al., 2005). However,
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the health status of the world, and particularly in the developing countries within Africa, 
is rapidly changing (WHO, 2016).
Within most African countries, non-communicable diseases have emerged to become 
the second highest cause of death (Econex, 2009). This is second to HIV/AIDS which 
remains the primary cause of death in most African countries (WHO, 2007; WHO, 
2011). Nevertheless, non-communicable diseases have risen rapidly in Africa.
Within South Africa, more people died due to non-communicable diseases (specifically 
cardiovascular disease) than due to HIV/AIDS or other infectious diseases in 2014, 
and the vast majority of these were Black South Africans (Econex, 2009; Zatu et al., 
2015). More specifically, Black South African women have emerged as the most at 
risk population for cardiovascular disease in the country, comprising of more than half 
of the cardiovascular disease deaths in South Africa in 2014 (Goedecke et al., 2009). 
This recent and rapid change in the South African disease profile highlights the 
urgency with which cardiovascular disease risk requires attention, particularly in Black 
female South Africans.
A proposed explanation for the emergence of cardiovascular disease lies in the impact 
of rapid urbanization and industrialisation, which is initiated by the geographical 
transition from more traditional rural environments, to urban environments (Steyn et 
al., 2006). What accompanies this geographical transition is an epidemiological and 
nutritional transition characterized by a change in cultural lifestyle behaviours such as 
changes in dietary and physical activity habits (Steyn et al., 2006; Walter and Durandt, 
2011). Some of these changes are attributed to inherent aspects of urbanized living 
such as readily accessible fast-food and public transport, making it easier for people 
to make poorer dietary choices and reducing their physical activity levels as they are 
using more public transport (Steyn et al., 2006). However, many of these behavioural 
changes are also due to social factors such as the perceived ‘higher status’ associated 
with being able to afford fast-food, as well as the stigma towards being ‘slim’ in many 
African cultures, which is often associated with ‘disease’ or ‘weakness’ (Walter and 
Durandt, 2011). Subsequently, being overweight or obese is considered more socially 
acceptable, thus typically contributing to the growing rates of obesity and 
cardiovascular disease (Walter and Durandt, 2011). It therefore becomes important
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to assess both lifestyle changes and socio-cultural practises and norms when 
assessing the health status of any population.
Nevertheless, some pressing questions still persists: what is causing and accelerating 
the incidence of cardiovascular disease in Black South African women? And more 
specifically, does cardiovascular disease affect Xhosa women of the Eastern Cape in 
a similar way to other racial groups? Many studies globally have looked at 
cardiovascular risk factors in Caucasian populations of all countries, but only a few 
have looked at Black South African populations (Alberti et al., 2005). This is evidenced 
by the fact that population-specific cardiovascular risk factor ‘cut-off’ norms exist for 
Caucasian populations, but not for Black South Africans (Alberti et al., 2005). Of those 
studies who have looked at Black South Africans, the majority of them have been 
conducted in the North West Province, the Western Cape, and Gauteng (Vorster et 
al., 2002; Senekal et al., 2003; Jennings et al., 2008; Goedecke et al., 2009), and 
these studies compared their findings to Caucasian cut-off norms. Not only does this 
question their validity, but it also highlights the large gap in the literature for the other 
provinces, including the Eastern Cape. It is useful to assess cardiovascular disease 
risk in other provinces in order to gain a deeper understanding of cardiovascular health 
in South Africa. In addition, gaining data that is representative of the entire country is 
beneficial in order to assess the relevance and reliability of ‘cut-off’ norms. 
Furthermore, there is a plethora of health-related research conducted on Caucasian 
women, and Caucasian women represent another urban population in South Africa. 
Therefore they represent an appropriate comparison group to Black urban South 
African women for any research into cardiovascular disease risk in urban female 
populations.
1.2 STATEMENT OF THE PROBLEM
As cardiovascular disease is rapidly increasing in South Africa, knowledge of the 
populations’ disease risk profiles is required. Due to poverty and recent urbanisation, 
Black South African populations are vulnerable to developing cardiovascular disease. 
In particular, Black South African women have shown increased risk of cardiovascular 
disease in recent years. To date however, there is a paucity in the literature assessing 
cardiovascular disease risk in individuals residing in the Eastern Cape; one of the 
poorest and most poverty-stricken provinces in the country. In addition, most of the
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research worldwide is conducted on Caucasian populations. Accordingly, the aim of 
this research is twofold: the first aim is to add new data to the body of literature on 
cardiovascular disease risk in black females within the Eastern Cape. Secondly, this 
research aims to assess and compare cardiovascular disease risk in urban black 
women and Caucasian women, thereby exploring the interaction between race, 
culture, and lifestyle factors, and their impact on cardiovascular disease risk.
1.3 RESEARCH HYPOTHESES
It is expected that cardiovascular disease risk will be different between Black females 
and Caucasian females. More specifically, it is expected that a higher prevalence of 
cardiovascular risk factors will be present in Black females compared to Caucasian 
females.
1.4 STATISTICAL HYPOTHESES 
Null hypothesis 1:
There will be no difference in morphological characteristics between the two 
samples, as defined by a) Mass, b) BMI, c) waist circumference, d) waist-to-stature 
ratio e) body composition.
H0: ^Black morph (a,b,c,d, e) = ^Caucasians morph (a,b,c,d, e)
Ha: ^Black MORPH (a,b,c,d, e) + ^Caucasians MORPH (a,b,c,d, e)
Null hypothesis 2:
There will be no difference in cardiovascular risk parameters (CV) between the two 
samples, as defined by f) blood pressure, g) fasting glucose levels, h) fasting insulin 
levles
H0: |jBlack cv (f,g,h) = ^Caucasians cv (f,g,h)
Ha: ^Black cv (f,g,h) + ^Caucasians cv (f,g,h)
4
Null hypothesis 3:
The lifestyle-related factors will be similar between the two samples, as defined by 
i) dietary intake, j) physical activity levels, k) tobacco use, and l) alcohol 
consumption
H0: ^Black lifestyle (i,j,k,l) = ^Caucasians lifestyle (i,j,k,l)
Ha: ^Black lifestyle (i,j,k,l) + ^Caucasians lifestyle (i,j,k,l)
Null hypothesis 4:
There will be no difference in the socio-economic status of the two samples, as 
defined by m) annual income, and n) education level
H0: ^Black socio-economic status (m,n) = ^Caucasians socio-economic status (m,n)
Ha: ^Black socio-economic status (m,n) + ^Caucasians socio-economic status (m,n)
5
CHAPTER II -  LITERATURE REVIEW
2.1 GLOBAL HEALTH PROFILE
Non-communicable diseases, also known as chronic diseases, are the leading cause 
of death worldwide (WHO, 2011). Twenty nine million deaths alone were attributed to 
non-communicable diseases in 2002 (Econex, 2009; Yach et al., 2011) and they 
currently account for over 60% of deaths worldwide (WHO, 2011). Despite initially 
being associated with high income countries, the prevalence of non-communicable 
diseases is increasing rapidly in developing countries. This increase is to such an 
extent that currently, 80% of global chronic disease deaths occur in low and middle 
income countries (WHO, 2011). This is of particular relevance to a South African 
context as South Africa is classified as a middle income, or developing country.
There are four main diseases that are listed as non-communicable: cardiovascular 
disease, certain cancers, chronic obstructive respiratory disease, and type ll diabetes, 
and typically occur as a result of lifestyle factors (Beaglehole et al., 2011). These 
factors include physical inactivity, excessive alcohol and tobacco consumption, and 
unhealthy eating habits (WHO, 2011). In most cases, it is a combination of these 
lifestyle factors over a prolonged period of time that contribute to the development of 
these conditions (Crush et al., 2011). Unlike communicable diseases, non­
communicable diseases cannot be passed from one person to another- highlighting 
the profound impact that individual lifestyle factors have on the aetiology of these 
diseases (Yach et al., 2011). Nevertheless, the risk of developing a non-communicable 
disease is amplified by certain non-modifiable risk factors such as age, sex, race, and 
family history. These factors will be discussed in detail at a later point in this chapter.
Cardiovascular disease led to the greatest number of deaths worldwide in 2002, 
followed by cancer, chronic obstructive respiratory disease, and type ll diabetes 
(WHO, 2011). Since then, prevalence of all above listed diseases has increased, with 
a particularly large increase in prevalence of type ll diabetes from 2% of the global 
population in 2002, to an estimated 9% in 2009 (Yach et al., 2004; Bertram et al., 
2013). Although non-communicable diseases currently lead to 60% of deaths 
worldwide, it is predicted that if the present trend is maintained, non-communicable
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diseases will account for 80% of the global burden of disease in 2020 (Boutayeb, 
2006). It is therefore urgent and imperative to explore and develop efficient 
preventative strategies to halt the growing trend of non-communicable diseases 
through the control of risk factors. Specifically, this needs to be aimed at adjusting 
lifestyle behaviours which impact risk conditions, and thus affects overall health. This 
focus area will be discussed in greater detail at a later point in this chapter.
2.1.1 WHAT IS CARDIOVASCULAR DISEASE?
Cardiovascular disease is a general term that describes diseases of the heart or blood 
vessels (Naranjan et al., 2012). More specifically, cardiovascular disease occurs when 
blood flow to the heart, brain, or rest of the body is reduced due to a blood clot 
(thrombosis), or a hardening and narrowing of the arteries (atherosclerosis) (Libby et 
al., 2009). Four main types of cardiovascular disease exist and they are: coronary 
heart disease, aortic disease, stroke, and peripheral arterial disease (Libby and 
Theroux, 2005; Coffman and Eberhardt, 2003; Libby et al., 2009; Naranjan et al., 
2012).
2.1.1.1 Coronary Heart disease and Aortic disease
Coronary heart disease and occurs when the flow of oxygen-rich blood to the heart is 
blocked or reduced by a build-up of plaque (cholesterol) in the coronary arteries (Libby 
& Theroux, 2005). As the coronary arteries are the two major blood vessels that supply 
the heart with blood, a narrowing of these arteries therefore restricts this blood flow 
substantially. If the arteries are partially blocked or hardened due to the plaque, this 
can lead to mild chest pain (angina) (Libby & Theroux, 2005). However, if the arteries 
become completely blocked however, the heart becomes starved of oxygen and an 
acute myocardial infarction (heart attack) occurs (Libby and Theroux, 2005). Coronary 
heart disease is the most prevalent form of cardiovascular disease and accounts for 
25% of global deaths annually (WHO, 2011). A less common form of heart disease, 
aortic disease, occurs through the same mechanism as coronary heart disease only 
that the aorta is affected instead of the coronary arteries (Naranjan et al., 2012).
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2.1.1.2 Stroke and peripheral arterial disease
A stroke can occur when blood supply to the brain is obstructed and reduced (Wolf et 
al., 1991). This deprives the brain of oxygen and nutrients, and subsequently causes 
brain cells to die. In 80% of cases, strokes are caused by a build-up of plaque which 
blocks the artery (ischemic stroke) while the remaining 20% occur as a result of 
leaking or bursting of a blood vessel (haemorrhagic stroke) (Wolf et al., 1991). 
Peripheral arterial disease occurs through the same mechanics as a stroke, only that 
blood supply is obstructed to arteries in the limbs, usually the legs (Coffman & 
Eberhardt, 2003). As with a stroke, if the artery is completely blocked, nerve and 
muscles cells of the affected limb begin to die (Coffman & Eberhardt, 2003).
2.2 SOUTH AFRICAN HEALTH PROFILE
The South African health profile is unique as its people suffer a ‘quadruple burden of 
disease’ comprising acquired immune deficiency syndrome (AIDS), non­
communicable diseases, communicable diseases, and death due to injury and 
violence (Bourne et al., 2002; Bradshaw et al., 2003; Econex, 2009; Tathiah et al., 
2013). Although it is common for developing countries to experience a double burden 
of disease resulting from the simultaneous occurrence of communicable diseases and 
non-communicable diseases, South Africa has the added burden of HIV/AIDS and 
injury due to violence (Econex, 2009). This places an increased demand on the 
already under-resourced public health services which are accessed by 80% of the 
population (Bradshaw et al., 2005).
Despite the high prevalence of HIV/AIDS in South Africa, in 2014, more premature 
deaths resulted directly from non-communicable diseases than from HIV/AIDS (Figure 
1) (WHO, 2016). In accordance with global trends, cardiovascular disease led to the 
greatest number of deaths in South Africa in 2014, and the majority of these were 
Black South Africans (Zatu et al., 2014; WHO, 2016).
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Figure 1 Estimated causes of death in South Africa, 2014 (WHO, 2016).
2.2.1 SOCIOECONOMIC STATUS AND CARDIOVASCULAR DISEASE RISK
Despite the dissolution of the Apartheid regime in 1994, the effects thereof are still 
echoed throughout South Africa (Talip et al., 2003; Steyn et al., 2005). This is 
evidenced by pervasive socioeconomic disparities- particularly affecting Black 
populations who are typically poorer and less educated than all other race groups 
(Bradshaw et al., 2000). Subsequently, it is these poor Black populations that bear the 
brunt of the quadruple burden of disease (Bradshaw et al., 2000; Vorster et al., 2002).
Perhaps more pertinent, however, is the impact of socioeconomic status on 
cardiovascular disease risk in South Africa. There is a strong body of evidence 
highlighting the link between low socioeconomic status and increased cardiovascular 
disease risk, and this is attributed to three main factors: poor education, lack of access 
to sufficient healthcare, and socioeconomic stress (DHS, 2003; Steptoe et al., 2003; 
Brydon et al., 2006; Clark et al., 2009).
Lack of education contributes to high cardiovascular disease risk through limited 
exposure to the dangers of unhealthy eating, lack of physical activity, smoking, and 
alcohol use from a young age1 (DHS, 2003; WHO, 2016). This is supported by a vast 
body of research highlighting the protective effect of adequate education on the 
development of chronic diseases (DHS, 2003; Senekal et al., 2003; Ehrlich et al., 
2004; Ehrlich et al., 2005; Kruger et al., 2005). This is of particular importance in a
1 The impact of these lifestyle factors will be discussed in more detail later in this chapter, under ‘modifiable risk factors for 
cardiovascular disease’, pp. x.
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South African context which is currently undergoing a nationwide ‘education crisis’- 
invariably contributing to the high incidences of cardiovascular disease (Fleisch, 2008; 
Spaull, 2013).
In addition to poor education, those of low socioeconomic status are reliant on public 
healthcare; a vastly under-resourced and heavily burdened sector in South Africa, 
resulting in the lack adequate healthcare for the majority of poor populations 
(Bradshaw et al., 2007). These health services are required to cater to a plethora of 
diseases, including infectious diseases, violence and trauma-related injuries, and 
HIV/AIDS- all of which are highly prevalent countrywide (Woolard, 2002). Thus, 
resource allocation is prioritized for these more immediate and urgent conditions, 
further limiting the care available to those with cardiovascular disease (Woolard,
2002) . This therefore highlights the difficulties associated with relying on health 
statistics in South Africa, particularly where clinical care and subsequent diagnoses 
are limited.
Socioeconomic stress refers to the concomitant stress that occurs as a result low 
socioeconomic status (Steptoe et al., 2003). This stress is attributed to poor living 
conditions, increased financial strain, as well as the above mentioned difficulties 
associated with lack of quality education and access to healthcare (Steptoe et al.,
2003) . A plethora of research highlights the impact of socioeconomic stress on 
cardiovascular disease risk, further highlighting the association between low 
socioeconomic status and cardiovascular disease risk (Steptoe et al., 2003; Brydon et 
al., 2006; Clark et al., 2009).
Therefore, in addition to both non-modifiable and modifiable risk factors which will 
discussed in detail below, it is imperative to also address socioeconomic status when 
assessing cardiovascular disease risk in certain populations.
2.3 NON-MODIFIABLE RISK FACTORS FOR CARDIOVASCULAR DISEASE
There are a number of non-modifiable risk factors that are associated with increased 
risk of developing cardiovascular disease. These include race, family history, age, and 
sex (DHS, 2003; Fodor & Tzerovska, 2004; WHO, 2007).
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2.3.1 RACE AND FAM ILY HISTORY
Globally, it is well documented that disproportionately higher rates of cardiovascular 
disease are evident in Black populations compared to Caucasian counterparts (Kurian 
and Cardarelli, 1995; WHO, 2007; Gebreab et al., 2012). In addition, Hispanics and 
Native American Indians are also considered to be at greater risk than Caucasians 
(WHO, 2007). In 2009, overall death rate due to cardiovascular disease in the USA 
was 236.1 per 1000, however when looking at just African Americans, it was 387.0 for 
males and 267.9 for females (American Heart Association, 2016). Despite this statistic, 
it remains unclear whether this difference in prevalence is due to race alone, or to a 
combination of race and cultural specific lifestyle factors. This is an important 
consideration as lifestyle factors are considered as ‘modifiable’, therefore there needs 
to be a clear distinction between racial (genetic) and habitual factors (lifestyle) that 
contribute to cardiovascular disease risk. For example, 65% of Indian people living in 
India rely on rice as their staple food (WHO, 2011). This is due in part to availability, 
but also largely to cultural dietary practices that incorporate rice into almost every dish 
(WHO, 2011). If this is then considered in conjunction with the high prevalence of type 
II diabetes in Indian populations, it becomes premature to associate the disease 
prevalence purely with racial factors (genetics), while not considering the unique 
dietary practises (lifestyle) as a potential contributor. To the author’s knowledge, no 
studies have attempted to unpack this relationship, and thus the interaction between 
race and cultural practices is largely underreported. Therefore in order to accept that 
certain races are more likely to develop cardiovascular disease than others, culturally 
specific lifestyle factors need to be assessed first.
Research has however demonstrated that certain cardiovascular disease risk factors 
have a genetic predisposition (Fodor and Tzerovska, 2004). In other words, if a genetic 
predisposition is inherited, cardiovascular disease is more likely to develop regardless 
of dietary habits and other lifestyle factors (Fodor and Tzerovska, 2004). In particular, 
this is evident with hypertension and hypercholesterolemia that runs in families (WHO, 
2011). Despite genetic predispositions however, lifestyle factors can still reduce or 
exacerbate overall risk, and thus shouldn’t be ignored (WHO, 2011).
In South Africa however, the prevalence of cardiovascular disease among different 
races is less clear. On one end, it has been suggested that Black South African males
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and females are at less risk for developing cardiovascular disease than their 
Caucasian counterparts (Vorster et al., 2005; Jennings et al., 2008). One study 
highlighted that Black South Africans had lower levels of the hormone homocysteine 
compared to Caucasians, and this exerted a protective effect as high levels of 
homocysteine are associated with cardiovascular disease risk (Vorster et al., 2005). 
Because baseline homocysteine levels are genetically determined, it was concluded 
that Black South Africans may have a genetic advantage over other populations with 
respect to cardiovascular disease risk (Vorster et al., 2005). However, contradictory 
evidence states that the highest prevalence of stroke mortalities is evident among 
Black South Africans, in addition to Black South African women being the most obese 
population in the country (Tibazarwa et al., 2009; Kandala et al., 2014; Goedecke et 
al., 2015). As a result, this evidence suggests that Black South Africans are at the 
highest risk for certain types of cardiovascular disease (Cappuccio, 1997). It is 
therefore imperative that more research on the general health of Black South African 
populations is conducted in order to gain deeper insight into the confounding findings 
to date.
Nevertheless, despite uncertainties regarding racial prevalence of disease risk, the 
health status of South Africa is changing (Bourne et al., 2002; Econex, 2009). Due to 
rapid urbanization and the subsequent accessibility of commodities such as fast food, 
more Black South Africans are presenting with cardiovascular disease today than 
before (Bradshaw et al., 2007; Econex, 2009; WHO, 2016). Additionally, insulin 
resistance and type II diabetes rates in South Africa have nearly doubled from 5.5% 
in 2000 to 9% in 2009, which highlights the ever increasing prevalence of chronic 
disease, which is reason for concern (WHO, 2011). Therefore, despite suggested 
genetic benefits, many Black South Africans are living with chronic diseases, and this 
places the impetus on exploring lifestyle factors for effective management and 
prevention.
2.3.2 AGE AND SEX
It is widely accepted that risk for cardiovascular disease increases with age (Dubnov 
et al., 2003; Bray and Champagne, 2005). In particular, males over the age of 45 and 
females over the age of 55 are at high risk, with post-menopausal females posing the 
greatest risk (Carr, 2003). In females, it is suggested that the increase in risk after 55
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years is associated with menopause which is characterized by the reduction in 
oestrogen concentrations and subsequent cessation of menses (Dubnov et al., 2003). 
In normal concentrations, oestrogen plays a cardio-protective role in the body by 
promoting the growth of healthy vascular endothelium cells in blood vessels, as well 
as assisting in vasodilation and fluid regulation (Dubnov et al., 2003). Additionally, the 
effects of reduced oestrogen concentrations result in redistribution of subcutaneous 
fat to the visceral area. As oestrogen levels drop, testosterone levels rise, which 
promotes central storage of fat. This places women at an even greater risk as visceral 
adiposity is one of the greatest risk factors for cardiovascular disease (Reckelhoff, 
2001; Carr, 2003; Dubnov et al., 2003). Therefore females in their productive years 
are largely protected from developing cardiovascular disease by this mechanism, 
whereas post-menopausal females whose oestrogen levels drop, are not (Wellman et 
al., 1996). It is due to these risk factors that many women are prescribed exogenous 
hormone replacement therapy (HRT) in attempt to counteract the natural decline in 
oestrogen concentrations at menopause (Dubnov et al., 2003).
For males, cardiovascular disease risk is attributed to firstly the absence of the cardio­
protective effects of oestrogen, and secondly, to greater visceral adiposity (Dubnov et 
al., 2003). As the male sex hormone testosterone promotes the storage of fat centrally, 
men < 45 years are at greater risk compared to females of the same age, as central 
adiposity is an independent risk factor the development of cardiovascular diseases 
(Reckelhoff, 2001). This explanation is supported by the fact that by the time females 
reach menopause, their risk of cardiovascular disease increases dramatically as their 
fat distribution becomes more centrally located (Reckelhoff, 2001; Dubnov et al., 
2003). It is however less clear why risk increases after the age of 45 years in males. 
The National Heart, Lung, and Blood Institute (2016) postulate that this is simply due 
to the ageing effect; however there is still a paucity in literature reporting on this.
2.4 MODIFIABLE RISK FACTORS FOR CARDIOVASCULAR DISEASE
As with the non-modifiable risk factors, there are also a number of modifiable-risk 
factors for cardiovascular disease. In order to effectively explore and develop 
management and preventative strategies, modifiable risk factors require particular 
focus as they are the ones that can be changed.
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Apart from being modifiable, these factors also differ from non-modifiable risk factors 
as they consist of both modifiable ‘conditions’ as well as modifiable ‘behaviours’. The 
conditions include hypertension, central obesity, insulin resistance/hyperglycaemia 
and dyslipidaemia, while the behaviours include physical activity levels, dietary habits, 
alcohol consumption, and smoking (Bazzano et al., 2003; Pischon et al., 2008). The 
key point however is that while ‘conditions’ and ‘behaviours’ are both modifiable 
factors, it is the behaviours that typically affect the conditions. In turn, the conditions 
affect the overall disease risk through the categorization of ‘cardio-metabolic risk’. 
Figure 2 depicts this relationship below:
Figure 2: Diagram depicting the impact of modifiable behaviours on conditions and 
disease.
Research should therefore intervene at the behavioural level in order to effectively 
impact overall health (King et al., 2007; Noakes et al., 2013). In order to do so 
however, a detailed understanding of the modifiable health conditions associated with 
cardiovascular disease risk and how behaviour affects them, is required.
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2.4.1 M O DIFIABLE CONDITIO NS
The following section unpacks the cardiovascular risk conditions in detail; however, 
due to the inherent relationship between risk behaviours and risk conditions, the 
mechanisms behind the development of these conditions will only be addressed later 
under ‘modifiable behaviours’.
2.4.1.1 Hypertension
Hypertension is defined as the pathological elevation of blood pressure to a level 
>140/90 mm Hg, and is a major contributor to the development of cardiovascular 
disease (Galobardes et al., 2003; Kemp et al., 2011). In the majority of cases, 
hypertension contributes to mortality in the form of strokes, heart attacks, and kidney 
failure (WHO, 2011). More specifically, data from observational studies involving more 
than one million participants aged 40-89 years, indicated that death from both ischemic 
heart disease and strokes increased progressively and linearly as blood pressure 
increased (Kokkinos and Myers 2012). The authors stated in particular that for every 
20 mm Hg systolic increase or 10 mm Hg diastolic increase in blood pressure, mortality 
from heart disease doubled. In addition, longitudinal data obtained from the 
Framingham Heart Study indicated that blood pressure levels between 130-139/85-89 
mm Hg are associated with a more than twofold increase in risk of cardiovascular 
disease as compared with blood pressure levels below 120/80 mmHg (Simonneau et 
al., 2013). However, the damage associated with hypertension can be mostly reversed 
if blood pressure is reduced back to normal levels (WHO, 2011). It is therefore 
imperative that hypertension management strategies are communicated and 
implemented in order to reduce cardiovascular disease risk.
Due to its prevalence, risk, and difficulty in management, hypertension is a global 
public health concern (Gasperin et al., 2009). It affects approximately one billion 
people worldwide, and is expected to increase to 1.5 billion by 2025 (WHO, 2011). 
Kearney et al. (2005) indicated that the estimated number of hypertensive individuals 
in developing countries outweighed those in developed countries by almost twofold. 
However, contradictory global statistics indicate that one in three adults in American 
have hypertension, and the same is seen in South Africa and other developing 
countries (Kemp et al., 2011). Nevertheless, despite the high prevalence worldwide, 
hypertension disproportionately affects black Africans, or those of black African
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descent (Cappuccio, 1997). This is of particular importance in a South African context 
as hypertension is listed as the primary risk factor for cardiovascular disease in the 
local black populations- a finding likely linked to the high incidence of stroke within this 
group (Cappuccio, 1997; Kearney et al., 2005; Kemp et al., 2011).
In addition to being more prevalent in Black populations, hypertension is also more 
prevalent in females than in males (DHS, 2003; WHO, 2011). In the year 2000, 47000 
premature deaths were attributed to hypertension in South Africa, and 66% of these 
were women (Maseko et al., 2006; Norman et al., 2007). The reason behind this 
disproportionate prevalence in females can only be speculated; but it has been 
suggested to be influenced by rural cultural norms whereby women are considered to 
be more attractive if they are overweight, and they are encouraged to adopt sedentary 
lifestyles (Walter and Durandt, 2011). This will be discussed in further detail under the 
‘modifiable behaviours’ section.
Research has indicated that hypertension within Black populations may have a genetic 
link (Norman et al., 2007), however country-wide statistics from the 1940s indicate that 
hypertension was largely non-existent within black South Africans at the time 
(Tibazarwa et al., 2009). As a result, this draws attention to the impact of lifestyle 
factors as potential contributors to hypertension. Both the above mentioned cultural 
norms and the impact of lifestyle factors will be discussed in more detail under the 
‘modifiable behaviours’ sections.
Interestingly, and likely influenced by the high prevalence of hypertension among black 
South Africans, the South African standardised blood pressure norms differ from 
norms indicated by the American Heart Association (2016). American norms state that 
a blood pressure between 120/80 mm Hg -  139/89 mm Hg is considered ‘high-normal’ 
or ‘pre-hypertensive (WHO, 2011; American Heart Association, 2016). South African 
norms however indicate that blood pressure between 120/80 mm Hg - 129/84 mm Hg 
is still considered normal, while blood pressure between 130/85 mm Hg -139/89 mm 
Hg is considered ‘pre-hypertensive’ (South African Heart and Stroke Foundation, 
2014). The distinction between the two norms is therefore in what is considered 
‘normal’ versus ‘pre-hypertensive’, as they both indicate that a person is hypertensive 
from 140/90 mm Hg upwards. This is important when assessing an ethnically
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homogenous sample of people as they require representative health norms for 
accurate representation of health status.
2.4.1.2 Obesity
Obesity is defined as a chronic condition where abnormal or excessive amounts of fat 
are accumulated and stored around the body (Rippe et al., 1998). This condition leads 
to a plethora of health risks and implications, and is one of the greatest risk factors for 
cardiovascular disease and all-cause mortality (Despres et al., 2008; Goodpaster et 
al., 2010; Tsatsoulis et al., 2013). According to Goodpaster et al. (2010): "the high and 
sustained prevalence of obesity is among the most significant public health problems 
for the 21st century” pp. 9. As a result, it requires immediate and urgent attention.
The most widely used tool to classify overweight and obesity is body mass index (BMI); 
a ratio calculated between weight (kg) and height (m) which is then compared to 
established norms (James et al., 2001). According to the World Health Organization 
criteria, obesity is diagnosed when BMI > 30 kg.m-2. Thereafter ‘stages’ of obesity, and 
associated level of risk, increases as BMI increases (Table 1).
Table 1: WHO classification of weight (WHO, 2004).
BMI (kg.m-2) Classification Risk
< 18.5 Underweight Low
18.5-24.9 Normal Average
25.0-29.9 Overweight Increased
30.0-34.9 Obese class 1 High
35.0-39.9 Obese class II Severe
> 40.0 Obese class III Very severe
Despite the popularity of the BMI index, it is a crude measure as it cannot determine 
body composition; it can only determine total weight in relation to height (Nevill et al., 
2006; Despres et al., 2008). This becomes problematic when muscle mass cannot be 
accounted for, as a heavy muscle mass can translate into an ‘overweight’ or ‘obese’ 
BMI category, despite a low fat percentage. However, in the majority of individuals, it
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can provide a basic insight into possible weight problems, and thus is commonly used 
as the first screening tool for obesity (Nevill et al., 2006; Despres et al., 2008).
Despite the health risks associated with obesity in general, central obesity has been 
shown to have more adverse consequences than peripheral obesity (Despres et al., 
2008; Tsatsoulis et al., 2013). Central obesity is defined as the accumulation of fat 
around the abdomen, and is associated with high risk of hypertension, type II diabetes, 
and cardiovascular disease (Alberti et al., 2005; Tsatsoulis et al., 2013). It is primarily 
measured as waist-circumference (WC), but waist-to-stature ration (WSR) is an 
additional measure (Shields et al., 2012). Waist circumference classifications do vary 
among different population groups, however the guidelines put forth by WHO based 
on several global studies provide a useful initial screen for risk profiles of individuals 
(Table 2).
Table 2: WHO classification of waist circumference (WHO, 2011).
Waist circumference (cm)
Risk High Risk
Men >94 >102
Women <80 <88
The aetiology of obesity is multifactorial, consisting of a combination of genetic, 
metabolic, environmental, and behavioural factors contributing to its development and 
progression (Bray and Champagne, 2005). Nevertheless, it is more commonly thought 
that obesity occurs as a result of an energy imbalance, whereby energy consumed 
and stored exceeds energy expended (Potischman, and Freudenheim, 2003; King et 
al., 2007; Taubes, 2008). In other words, it is widely accepted that obesity is strongly 
associated with poor diet and physical inactivity (Henderson, 2005). When looking at 
global statistics, this is supported by the fact that 75% of obesity is attributed to lifestyle 
factors, and only 25% is attributed to genetic and metabolic factors (Despres et al., 
2008; Tsatsoulis et al., 2013).
In South Africa, a noticeable prevalence of obesity can be seen in Black females; so 
much so that Black South African females are the most obese population in the country 
(Goedecke et al., 2009; Tibazarwa et al., 2009; Jackson, 2010). Country wide statistics
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on overweight and obesity were first presented in the Department of Health Survey 
(DHS) carried out in 1998, and these indicated that 56% of females were overweight 
(across all races). Within the Eastern Cape however, it was shown that 25.7% of 
females were overweight; and a further 29.7% of females were obese. In a follow up 
survey carried out in 2003, notable increases in obesity rates were evident in the 
Eastern Cape when compare to the 1998 data. With 31.9% of females being classified 
as obese in 2003, the Eastern Cape presented with the highest obesity rates in the 
country (DHS, 2003). As these findings encompassed all races however, specific 
conclusions about Black South African females cannot be drawn. Nevertheless, these 
findings do highlight the prevalence of obesity in females and as the majority of the 
province is comprised of Black South Africans, it is likely that the majority of females 
making up this statistic would have been Black South African women (Stats SA, 
2013).To support this conclusion, research from 2006 and 2010 indicate that Black 
South African women were not only significantly more obese than other populations, 
but that obesity prevalence in this group was increasing over time (van der Merwe and 
Pepper 2006; Jackson et al., 2010).
2.4.1.2.1 ‘Metabolically healthy obese’ South African women
Perhaps the most interesting and challenging factor coming to the forefront of research 
on South African populations is the observation of the ‘metabolically health obese’ 
phenotype evident in a number of Black South African women (Walker et al., 2001; 
Weinsier et al., 2001; Jennings et al., 2008).
Jennings et al. (2008) highlight that while Black South African females were the most 
obese sub-population in the country, many of them expressed characteristics of 
metabolically healthy individuals, and thus were deemed the ‘metabolically healthy 
obese’. Particularly when compared to their Caucasian counter parts, this study 
demonstrated that obesity in itself did not always correlate with metabolic distress in 
Black Africans; a direct contradiction of the commonly accepted association between 
obesity and cardiovascular disease risk (Alberti et al., 2005; Tsatsoulis et al., 2013). 
This study attributed the ‘healthy obese’ status of these black women to lower levels 
of visceral adiposity, which resulted in better glucose metabolism (Jennings et al., 
2008). Additionally, Weinsier et al. (2001) stated that the prevalence 
hypercholesterolemia, hypertension, and type II diabetes were low in many obese
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Black South African women, and thus they exhibited a ‘healthy obese’ profile. 
However, this classification of ‘metabolically healthy obese’ Black South Africans 
needs to be interpreted with caution. All these studies have compared African data to 
European norms for cardiovascular risk, as African norms do not exist. As a result, it 
is possible that if the norms are adjusted specifically for African populations, the 
prevalence of cardiovascular disease risk would be different. Therefore further 
research assessing metabolic health profiles of Black South Africans is paramount to 
understanding the complexity associated race-specific disease risk.
2.4.1.3 Insulin Resistance and Type II Diabetes
In order to understand the mechanisms behind insulin resistance and type II diabetes, 
the role of insulin in the body needs to first be understood.
2.4.1.3.1 The role of insulin
Insulin is a peptide hormone produced by cells in the pancreas and it serves to regulate 
glucose metabolism in the body (Reaven, 1993; Ball et al., 2004). Once broken down 
in the stomach, foods containing carbohydrates, as well as pure sugars, convert into 
glucose and are transported to the body’s cells through the bloodstream (Ludwig, 
2002). The cells however require the presence of insulin as they cannot receive the 
glucose and use it as energy without the presence of insulin (Ludwig, 2002). Thus 
shortly after food is ingested and blood glucose levels begin to elevate, the brain sends 
a message to the pancreas to release insulin into the blood stream in order to 
effectively transport the glucose in the blood to the body cells to be used as energy 
(Tsatsoulis et al., 2013). Insulin achieves this by binding to the individual cells and 
generating a gateway for glucose to be diffused into the cell (Reaven, 1993; Noakes 
et al., 2013; Despres et al., 2008).
A second role of insulin is to maintain adequate and safe blood glucose levels 
(Reaven, 1993). If more glucose is in the blood than is needed to provide cells with 
sufficient energy, insulin acts to remove the excess glucose and stores it in fat cells 
(Reaven, 1993). Without this action, excess blood glucose that is not transported into 
working cells for energy will remain in the blood stream which could lead to 
hyperglycaemia; a state in which blood glucose levels are elevated above normal 
levels (< 7 mmol.l-1) (American Diabetes Association, 2014). If this state is prolonged,
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damage to nerves, blood vessels, impaired vision and kidney failure can occur as 
blood flow to these organs is compromised due to the viscosity of the blood, and this 
can lead to cell death (Ball et al., 2004). Thus insulin not only acts to transport energy 
in the form of glucose into the cells, but also acts as a protective mechanism against 
hyperglycaemia (Tsatsoulis et al., 2013). The body therefore relies on sufficient and 
timely release of insulin from the pancreas in order to effectively manage energy 
transportation and homeostasis in the body (Ludwig, 2002; Ball et al., 2004; Noakes 
et al., 2013).
2.4.1.3.2 Insulin resistance
Insulin resistance occurs when insulin levels are excessively high (>10 mmol.l-1) over 
a prolonged period of time, causing the body’s sensitivity to the hormone to be reduced 
(Reaven, 1988; Ludwig, 2002; Despres et al., 2008; Noakes et al., 2013; Tsatsoulis et 
al., 2013). Insulin resistance is thus synonymous to reduced insulin sensitivity 
(Reaven, 1988). An insulin-resistant response occurs when the pancreas 
overproduces insulin in response to a rise in blood glucose (Tsatsoulis et al., 2013). 
In most cases, the insulin production at this high level can continue to maintain blood 
glucose levels for a period of time, thus it is not classified as type II diabetes (Reaven, 
1988; Ludwig, 2002). However, prolonged increased output of insulin can desensitize 
the cells to the effects of insulin over time, thus reducing the amount of glucose able 
to diffuse into the cells, and thereby increasing levels of circulating glucose in the blood 
(hyperglycaemia) (Reaven, 1988). In conjunction, over time, the pancreas becomes 
unable to keep up with the body’s increased need for insulin thus further elevating 
concentrations of glucose in the blood (Ludwig, 2002). Consequently, insulin 
resistance is often referred to as ‘pre-diabetes’ as people who have insulin resistance 
often develop type ll diabetes at a later stage (Reaven, 1988). Thus, effective 
management of insulin resistance is essential to preventing the development of type ll 
diabetes (Reaven, 1988; Despres et al., 2008). Furthermore, insulin resistance is 
associated with a number of other health implications including elevated triglyceride 
levels, increased visceral adiposity, and elevated blood pressure, which further 
emphasizes the urgent need to explore effective management strategies (Despres et 
al., 2008).
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2.4.1.3.3 Diabetes
Two forms of diabetes exist: type l diabetes and type ll diabetes (Ludwig, 2002; 
Tsatsoulis et al., 2013). Type l diabetes, also known as insulin-dependent diabetes, is 
commonly a hereditary condition in which the pancreas is incapable of producing 
adequate amounts of insulin (American Diabetes Association, 2014). However, 
individuals may develop type I diabetes later on in life due to exposure to certain 
viruses that permanently damage the pancreatic cells or pancreatic cancer (WHO, 
2011). Nevertheless, as this is primarily a genetic disease that presents early on in 
life, there is a natural paucity in the literature with respect to its impact on 
cardiovascular disease. The majority of literature explores the impact of type II 
diabetes, an acquired type of diabetes, on cardiovascular health.
Type ll diabetes, also referred to as ‘diabetes mellitus’ or ‘non-insulin dependent 
diabetes’, is the most common form of diabetes worldwide (Reaven, 2005; Noakes et 
al., 2013). Unlike type I diabetes, type II diabetes is lifestyle-related whereby it 
develops over time due to overstimulation of the pancreas which initially causes insulin 
resistance (Noakes et al., 2013). If the body adopts an insulin resistant state for a 
prolonged period of time, this typically causes the pancreas to fail to secrete necessary 
insulin levels, which causes a lack of energy to the cells and blood glucose levels rise 
(Ludwig, 2002; WHO, 2011; Tsatsoulis et al., 2013). This represents the physiological 
state of a person with type II diabetes. Therefore in direct contrast to type I diabetes, 
type II diabetes is classified by excessive insulin levels, where type I is characterized 
by insufficient levels (American Diabetes Association, 2014). This is of importance as 
it is precisely this distinction that makes type II diabetes a huge risk for cardiovascular 
disease, as it is associated with the damaging effects of high insulin levels (Reaven, 
1988; Reaven, 2005).
Among type II diabetic individuals, coronary heart disease and strokes account for 
90% of all premature deaths (National Diabetes Data Group, 1995). As a result, type 
II diabetes was recognized as a coronary artery ‘disease risk-equivalent’ by the 
National Institute of Health in 1995. This classification suggests that the risk of heart 
disease in a person with type II diabetes is equal to that of a person without type II 
diabetes who has previously experienced a coronary event (Eckel et al., 2005). Further 
statistics indicate that individuals with type II diabetes have a two-to-fourfold increase
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in risk of developing coronary artery disease (WHO, 2011). Interestingly however, the 
risk is much greater in women than in men.
Results from the WHO MONICA Project (1988) assessed mortality rates in men and 
women with type II diabetes aged 25-64 and found that mortality was 38% higher for 
diabetic men and 86% higher for diabetic women one year after diagnosis (Evans et 
al., 2001). More recent research shows similar findings as it is well documented that 
women with type II diabetes are at a greater risk for developing cardiovascular disease 
than their male counterparts (WHO, 2011; American Heart Association, 2015; National 
Heart, Lung, and Blood Institute, 2016). Although the exact mechanism by which type 
II diabetes places women at greater risk is not well understood, Tsatsoulis et al. (2009) 
state that: "The disparity between the incidence of coronary heart disease in age- 
matched premenopausal women and men suggests that endogenous sex hormones 
such as oestrogen and progesterone or both have a significant influence on 
vasculature... type II diabetes therefore abrogates the protective effects of oestrogens 
in premenopausal women” (pp. 36-37). Therefore, as oestrogen can no longer play a 
cardio-protective role in women with type II diabetes, they inevitably succumb to 
greater risk for cardiovascular disease (Tsatsoulis et al., 2009).
2.4.1.4 Dyslipidaemia
When addressing the health implications associated with elevated cholesterol levels, 
the two most common conditions that are referred to are ‘hypercholesterolemia’ and 
‘dyslipidaemia’ (Nelson et al., 2014). In order to understand these conditions however, 
‘cholesterol’, and the role it plays in the body, needs to first be defined.
Cholesterol is the broad name given to a form of steroidal-lipid that is responsible for 
a number of functions in the human body (American Heart Association, 2016). These 
functions include maintaining the permeability and fluidity of cell membranes, as well 
as being a precursor to synthesis of steroid-base hormones such as oestradiol and 
testosterone, and fat-soluble Vitamin D (WHO, 2011). The word itself is derived from 
the ancient Greek words ‘chole’- (bile) and ‘steros’ (solid), to which the suffix - ‘ol’ 
(alcohol) is added (Google dictionary).
Cholesterol itself is located within lipoproteins, which serve as transport molecules for 
cholesterol throughout the body (Grundy et al., 1999). All lipoproteins comprise of
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apolipoproteins, phospholipids, triglycerides, and cholesterol, however there are three 
distinct types of lipoproteins which vary according to the density (Superko & Krauss 
2000; Sharma et al., 2009). These types are: very low density lipoprotein (VLDL), low 
density lipoprotein (LDL) and high-density lipoprotein (HDL) (Sharma et al., 2009). 
Although triglycerides exist within lipoproteins, they can also exist outside of them as 
‘serum triglycerides’, which circulate in the blood and aid in fuelling the cells with 
energy (Superko & Krauss 2000; Sharma et al., 2009). In normal quantities, all 
lipoproteins and triglycerides serve a fundamental role in maintaining homeostasis in 
the body; however it becomes detrimental to health when normal concentrations are 
disrupted (Superko and Krauss, 2000). In particular, high levels of total cholesterol, 
otherwise referred to as ‘hypercholesterolemia’, associated with increased risk of 
cardiovascular disease (Grundy et al., 1999; Adiels et al., 2008; Sharma et al., 2009; 
Peer et al., 2013; Goedecke et al., 2015).
It is important to note however that when referring to cholesterol levels or more 
specifically, hypercholesteromemia, it is in fact the lipoprotein content (within which 
the cholesterol resides) that is being measured (Brunzell et al., 2008). In other words, 
any elevation in VLDL, LDL, HDL, or triglyceride concentrations will contribute to an 
elevated ‘total cholesterol’ level (Brunzell et al., 2008). However, a key limitation of 
measuring hypercholesterolemia is that it doesn’t distinguish between which types of 
lipoproteins that are elevated, only that ‘total cholesterol’ (a crude and imprecise term), 
is elevated (Superko & Krauss, 2000). For example, normative values for total 
cholesterol are accepted as <5.2 mmol/l-1; any values higher than this would exhibit a 
hypercholesteraemic state (Eckel et al., 2005; Adiels et al., 2008). This is inherently 
problematic however as not all types of lipoproteins are harmful when elevated; one 
is in fact protective (Castelli, 1996; Webber et al., 2014).
It is well established throughout literature that high concentrations of both LDL 
cholesterol and triglycerides are positively correlated with increased risk for 
cardiovascular disease (Castelli, 1996; Grundy, 1998; Eckel et al., 2005; Adiels et al., 
2008; Sharma et al., 2009; Goedecke et al., 2015). This is due to the small size and 
density of LDL particles which enables them to filter more rapidly into arterial wall. As 
a result, they often get lodged within the lining which develops into plaque build-up 
over time (Grundy, 1999). As the plaque builds, it can eventually cause a blockage in 
the artery which can lead to myocardial infarction (Libby and Theroux, 2005).
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Alternatively, the blockages harden the lining of the artery which can lead to 
atherosclerosis (Grundy, 1999; Adiels et al., 2008).
With respect to triglycerides, these are purely fat molecules that the body uses as fuel 
(Nordestgaard and Varbo, 2014). However, excess triglycerides lead to the synthesis 
of smaller, and denser LDL particles which increases their likelihood of getting lodged 
into the artery wall (Grundy, 1998; Nordestgaard and Varbo, 2014). It is therefore well 
accepted that in order to maintain cardiovascular health, LDL and serum triglyceride 
concentrations need to remain within safe levels (< 2.59 mmol/l-1 and < 1.7 mmol/l-1 
respectively) (Castelli, 1996; Grundy, 1998; Eckel et al., 2005; Adiels et al., 2008; 
Sharma et al., 2009; Kontush, 2014; Webber et al., 2014).
In contrast to LDL and triglycerides, high concentrations of HDL serves a protective 
role from developing cardiovascular disease (Castelli, 1996; Tran-Dinh et al., 2013; 
Kontush, 2014; Webber et al., 2014). In a study conducted by Castelli (1996), the ratio 
of HDL to total cholesterol was found to be a greater indicator of heart disease than 
total cholesterol alone. In other words, this study showed that sex and age-matched 
individuals with a total cholesterol of 5.2 mmol/l-1, and an HDL level of <1.04 mmol/l-1, 
were found to be at the same risk as individuals with a higher total cholesterol of 6.7 
mmol/l-1, who also had higher HDL concentrations (Castelli, 1996). More recent 
studies have shown similar results, strengthening the finding of the protective effects 
of HDL on cardiovascular health (Tran-Dinh et al., 2013; Kontush et al., 2014; Webber 
et al., 2014). Therefore, the use of total cholesterol as an indicator of health presents 
an unclear picture; it cannot ascertain the ratio of HDL, LDL and triglycerides and thus 
any conclusions drawn from it are innately limiting. Because of this, a more detailed 
assessment of cholesterol ascertaining the precise ratio of HDL, LDL, and triglycerides 
is typically used (Supoerko & Krauss, 2000). When this ratio is suboptimal, a state of 
‘dyslipidaemia’ is reached (Adiels et al., 2008; Sharma et al., 2009).
Dyslipidaemia is determined using the ‘atherogenic lipoprotein phenotype’ (more 
commonly referred to as the ‘lipid triad’ or ‘dyslipidaemic triad’) which is characterized 
by the combination of high serum triglyceride levels (> 2 mmol/l-1), high LDL levels (> 
3.37 mmol/M) and low HDL levels (< 1.04 mmol/M) (Sharma et al., 2009; Tran-Dihn et 
al., 2013; Kontush, 2014; Webber et al., 2014). Despite the former popularity of using 
hypercholesterolemia as an indicator of cardiovascular disease risk, the association
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between dyslipidaemia and cardiovascular disease risk is undeniable, hence its 
inclusion in the metabolic syndrome criteria (Eckel et al., 2005; Alberti et al., 2005; 
Despres et al., 2008).
Worldwide, dyslipidaemia disproportionately affects Caucasians in comparison to 
those of black African ancestry (Goedecke et al., 2015). Studies conducted in both the 
USA and South Africa have shown that Black women specifically exhibit lower total 
cholesterol, triglycerides, and LDL than Caucasian counterparts (Despres et al., 2000; 
Punyadeera et al., 2001; Peer et al., 2013; Goedecke et al., 2015). Nevertheless, HDL 
concentrations are comparable between the two groups. These findings could explain 
why Black South African women have a lower lipid-attributed mortality rate compared 
to Caucasian counter parts (47 in 100 000 and 152 in 100 000 respectively) (Lambert 
et al., 2007). One explanation is that black women have lower levels of visceral 
adiposity, which can therefore have a positive impact on cholesterol levels (Weinsier 
et al., 2001; Jennings et al., 2008). Nevertheless, it has also stated that black women 
present with more insulin resistance than white women (Eckel et al., 2005). This begs 
the question of whether or not genetic polymorphisms may play a role in the more 
favourable lipid profiles in black females (Eckel et al., 2005). Alternatively, cultural- 
specific lifestyle factors which may contribute to this dichotomy requires exploration.
2.4.2 THE METABOLIC SYNDROME AND CARDIO-METABOLIC RISK
Despite the increased risk of cardiovascular disease associated with any of the above 
modifiable conditions, what is more pertinent is the noticeable clustering of these 
conditions that often occur in a number of individuals (Reaven, 1999; Alberti et al., 
2005; Grundy et al., 2005; Kahn et al., 2005; Miranda et al., 2005). This clustering of 
conditions is most commonly referred to as ‘the metabolic syndrome’, although a 
number of names such as syndrome X, dysmetabolic syndrome, and insulin resistant 
syndrome have been used (Reaven, 1988; Kahn et al., 2005; Miranda et al., 2005).
In his Banting Award Lecture in 1988, Gerald Reaven first described a syndrome 
characterized by the co-occurrence of a number of metabolic disturbances or 
conditions such as hypertension, insulin resistance, and dyslipidaemia (Reaven, 
1988). He postulated that this syndrome was not only frighteningly common, but was 
paramount to identifying individuals at high risk of developing type II diabetes and 
cardiovascular disease (Reaven, 1988; Despres et al., 2008). In other words, he
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hypothesized that the presence of this syndrome drastically increased a person’s 
cardio-metabolic risk; a term used to predict the lifetime risk for developing 
cardiovascular disease2 (Klein et al., 2007). Reaven termed this syndrome ‘syndrome 
X’, although it was soon more commonly referred to as ‘metabolic syndrome’ as the 
diagnostic criteria evolved (Alberti et al., 2005). Since then, there has been 
considerable evidence signifying an association between metabolic syndrome, type II 
diabetes and cardiovascular disease, and this led to attempts to produce standardised 
diagnostic criteria (Isomaa et al., 2001; Alberti et al., 2005; Eckel et al., 2005; Kahn et 
al., 2005; Miranda et al., 2005; Despres et al 2008).
In its infancy, the metabolic syndrome (or syndrome X as it was known then), was 
described by Reavan as a clustering of the following conditions: insulin resistance 
and/or hyperglycaemia; hypertension; and dyslipidaemia (particularly low HDL 
cholesterol and high VLDL triglycerides) (Reaven, 1988). In 1999 however, the World 
Health Organization revised these criteria to include obesity (particularly central 
obesity), as there was considerable evidence highlighting the intrinsic link between 
central obesity and metabolic disturbances; a finding that Reavan missed (Isomaa et 
al., 2001; Alberti et al., 2005; Kahn et al., 2005). They additionally added that insulin 
resistance or its surrogates (impaired glucose tolerance or type II diabetes), required 
the presence of two additional conditions to be classified as metabolic syndrome, 
rather than all five conditions being present (Alberti et al., 2005). The key however 
being that insulin resistance was the cornerstone of metabolic syndrome; a concept 
that Reaven himself initiated (Reaven, 1988; Alberti et al., 2005; Reaven, 2005). In 
2002 however, the US National Cholesterol Education Program: Adult Treatment 
Panel III took a less glucocentric approach: there was evidence to suggest that 
metabolic syndrome could be diagnosed without the presence of impaired glucose 
tolerance (Despres et al., 2008). Thus, they altered the diagnostic criteria accordingly 
and stated that any three of the five conditions need to be present to be diagnosed 
with metabolic syndrome; even in the absence of glucose-related conditions (Alberti 
et al., 2005). These five conditions were: central obesity (WC of > 94 cm men, > 80
2 ‘Cardio-metabolic risk is determined the presence of a single condition, or a combination of the conditions including obesity, insulin resistance or 
type II diabetes, hypertension, and dyslipidaemia (Klein et al., 2007; Despres et al., 2008). For example, a person presenting with hypertension 
alone has a higher cardio-metabolic risk than a healthy person without hypertension. Similarly, a person presenting with hypertension and insulin 
resistance has a higher cardiometabolic risk than a person with only hypertension (Despres et al., 2008). Cardio-metabolic is most severe in people 
with metabolic syndrome, although cardio-metabolic risk can still be evident in those without metabolic syndrome (Klein et al., 2007).
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cm females); hypertension (BP > 130/85 mm Hg); high triglycerides (> 1.7 mmol.l-1); 
low HDL cholesterol (> 1.03 mmol.l-1 men, < 1.29 mmol.l-1 women) and fasting 
hyperglycaemia (fasting plasma glucose >5.6 mmol.l-1) (National Cholesterol 
Education program, 2002).
Due to the number of different definitions and diagnostic criteria however, this led to 
considerable confusion and lack of comparability and reproducibility between studies 
assessing prevalence of the metabolic syndrome (Alberti et al., 2005). In particular, 
two critical problems have been identified: 1) the range of metabolic profiles evident in 
those with metabolic syndrome, and 2), the absence of racial consideration with 
respect to generalised norms (Alberti et al., 2005; Eckel et al., 2005; Despres et al 
2008)
2.4.2.1 Metabolic profiles
Using the ‘three of five’ framework, it is commonly accepted that if an individual 
presents with three or more of the above health conditions, they are diagnosed with 
metabolic syndrome (Balkau et al., 2007). However, as there are a mosaic of 
combinations of three of the five criteria for metabolic syndrome, this makes it difficult 
to compare level of risk from person to person (Despres et al., 2008). For example, 
person ‘A’ might present with hypertension, insulin resistance, and low HDL- 
cholesterol concentrations, while person ‘B’ presents with central obesity, elevated 
triglyceride levels and hypertension. Both individuals can be classified as having 
metabolic syndrome, but their metabolic profiles are considerably different (Despres 
et al., 2008). How can one then compare their level of risk for cardiovascular disease 
or type II diabetes? Is one at a greater risk than the other? This is difficult to determine 
as the impact of each individual condition, and the interaction of all conditions, is not 
quantifiable. Therefore both individuals can be classified as ‘high’ risk candidates, but 
their levels of risk cannot be directly compared to one another (Despres et al., 2008).
This leads into the next limitation; the quantification of risk. The notion of quantifying 
‘risk’ is inherently problematic as it lies on a continuum and is not absolute (Marquis 
et al., 2005; Despres et al., 2008). Therefore, the fact that the five variables are not 
used as continuous variables but rather counted as ‘present’ or absent, compromises 
the quality of diagnosis of the metabolic syndrome by virtue of overlooking the ‘degree’
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of classification (Despres et al., 2008). In other words, person ‘C’, with the same 
‘present’ conditions as person ‘A’ mentioned above, may have a higher blood pressure 
than person A (less favourable) but also a higher concentration of HDL-cholesterol 
(more favourable). Both patients have the same present conditions, but the degree 
and progression of the individual conditions vary, adding further complexity to the 
classification.
As a result, it is imperative that researchers understand the limitations of the current 
diagnostic tools for metabolic syndrome. The diagnostic tools can offer insight into 
metabolic health, but the inherent complexity associated with ‘level of risk’ must be 
approached with caution.
2.4.2.2 Racial consideration
Secondly, there is evidence to suggest that the cut-off values for the five conditions 
(central obesity, hypertension, fasting hyperglycaemia, HDL and triglyceride 
concentrations) are not representative to all ethnicities (Wang et al., 1994; Gurrici et 
al., 1998; Deurenberg-Yap et al., 2002; Tan et al., 2004). A study by Tan et al. (2004) 
assessed the metabolic health of 4723 Asian males and females of varying ages using 
the Adult Treatment Panel III criteria. Results showed that risk for type II diabetes was 
apparent at much lower levels of central obesity in Asians than in Europeans (Tan et 
al., 2004). This was explained by the fact that Asians had a higher percentage body 
fat at a lower BMI compared to Caucasians (Deurenberg-Yap et al., 2002). In light of 
this, the study concluded that the metabolic syndrome was largely underestimated in 
many Asian populations (Tan et al., 2004). Further studies conducted in Singapore 
and China support the findings by Tan et al. (2004); they found that cardiovascular 
disease and type II diabetes incidences occurred at lower BMI values than in 
Caucasian counter parts (Gurrici et al., 1998; Wang et al., 1994). In addition, Gurrici 
et al. (1998) identified that for any given percentage of body fat, BMI was 3 kg/m2 lower 
in Singaporeans. These studies are but a few that highlight the short-comings 
associated with applying ‘blanket’ cut-off values for metabolic syndrome to different 
ethnicities. Future studies should aim to ascertain level of risk within specific 
populations by taking into account their genetic differences and susceptibilities, in 
order to obtain more accurate diagnoses.
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Within a South African context, this problem is just as prevalent. A number of studies 
have emphasized the need for cut-off values specific to Black African populations, as 
there is considerable evidence to suggest that metabolic profiles differ between races 
(Schutte and Olckers, 2007; Despres et al., 2008; Jennings et al., 2008; Schutte et al., 
2014). Schutte and Olckers (2007) assessed and compared metabolic syndrome risk 
factors in 102 Black women and 115 Caucasian women (mean age of 31.3 ± 8.64 
years). They found that 30.4% of Caucasian women had metabolic syndrome, 
compared to a 24.8% prevalence in Black women. However, when individual risk 
factors were assessed, the Black women were found to have higher odds ratios for 
having metabolic syndrome for HDL cholesterol, blood pressure, and fasting glucose 
levels than Caucasians. Therefore despite not meeting the ‘three of five’ criteria for 
metabolic syndrome as frequently as Caucasian women, these Black women were at 
similar risk of cardiovascular disease and all-cause mortality. In light of this, it was 
suggested that the waist-circumference cut-off values were inappropriately high for 
African women, and needed to be downwardly adjusted. This study therefore 
concluded that the percentage of Black women with metabolic syndrome is likely 
underrepresented in South Africa (Schutte and Olckers, 2007).
Despres et al. (2008) similarly stated that the 88 cm cut-off value for waist- 
circumference in women was not applicable to all women across age and race. Here, 
the authors firstly stated that although pre-menopausal women stored fat differently to 
men (peripheral compared to central), post-menopausal women stored fat similarly to 
men (both central) (Reckelhoff, 2001; Carr, 2003; Dubnov et al., 2003) As a result it 
was concluded that the waist-circumference cut-off value of > 88 cm cannot be 
accurately applied to women of all ages, but is rather more applicable for pre­
menopausal (Despres et al., 2008). Secondly, this study emphasized the need for 
different cut-off values for different races. This is due to the difference in fat distribution 
patterns among women of different races; for example, pre-menopausal Black African 
women tend to store fat more peripherally than age-matched Caucasian women 
(Despres et al., 2008). Therefore, it was concluded that this difference in fat storage 
likely makes their sensitivity to central adiposity, and thus its impact on health, different 
(Despres et al., 2008). Jennings et al. (2008) conducted a study assessing the 
prevalence of metabolic disturbances associated with obesity in Black South African 
women. It was found that a higher percentage of these women were termed
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‘metabolically health obese’ as compared to Caucasian counterparts. This was largely 
attributed to differences in fat distribution between Black South African women and 
Caucasians, whereby more peripherally located fat stores in African women made 
them less susceptible to the dangers associated with centrally located fat. However, 
although this study highlighted the different metabolic profiles between Black South 
African and Caucasian women, it didn’t question the need for race-specific norms 
which may lead to more accurate representation of risk in these sub-groups. It 
therefore becomes premature to state that obesity in Black South African women is 
less associated with metabolic distress as in Caucasian women, as this is only the 
case when looking at ‘general’, non-race specific norms. Further research in South 
African therefore needs to delve into the complexities associated with race specific 
norms, and endeavour to establish these prior to comparing disease prevalence 
between races.
2.5 MODIFIABLE BEHAVIOURS
2.5.1 Dietary habits
In addition to the quadruple burden of disease, South Africa suffers from another 
health epidemic known as the ‘double burden of malnutrition’ (Abuya et al., 2012). This 
refers to a state in which a population experiences increasing levels of obesity, 
juxtaposed with a persistence of ‘under-nutrition’ (Abuya et al., 2012). Under-nutrition 
or ‘malnutrition’ is typically a concern to those living in rural areas of South African, 
while over-nutrition has begun to increase rapidly in more urbanized areas (Steyn et 
al., 2002; Stupar et al., 2012). This increase has been so rapid in recent decades that 
over-nutrition has been termed ‘the silent emergency’ of the developing world (Crush 
et al., 2011). This is attributed primarily to the nutrition transition. It is therefore 
essential to assess the nutritional habits of South Africans in order to gain a deeper 
understanding of their overall health profile.
2.5.1.1 The nutrition transition and a ‘Westernized diet’.
The ‘nutrition transition’ is a term that describes the changes in habitual dietary 
patterns of a population as they transition from a predominantly rural lifestyle, to an 
urban industrialized one (Vorster et al., 2002). Intrinsically linked to this is an 
‘epidemiological transition’, which describes a shift from largely infectious diseases, to
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chronic diseases associated with urbanization (Omran, 1998; Popkin and Gordon- 
Larsen, 2004). In South Africa, the traditional rural diet consisting of grains, starchy 
roots, legumes, vegetables, and fruit, has been abandoned in many urbanized areas 
for a diet high in energy-dense foods such as processed foods, animal-based foods, 
and foods with added fat and sugar (Popkin, 1994). As the ‘traditional’ diet is 
associated with a low prevalence of degenerative diseases, the adoption of the 
‘Westernized diet’ has subsequently been suggested to have a negative impact on the 
health status of these South Africans (Popkin and Gordon-Larsen, 2004). In order to 
understand the influence of a Westernized diet on health, it is first necessary to 
understand what constitutes this diet.
Interestingly, despite the common use of the term, the definition and description of a 
Westernized diet is often incomplete or inaccurate. Typically, such a diet is described 
as one high in saturated fat, and low in carbohydrates and fibre (Steyn et al., 2002; 
Vorster, 2002; Popkin and Gordon-Larsen, 2004). However, upon careful analysis, it 
appears that this is misleading. Firstly, one of the main components of a Westernized 
diet is fast food, where ‘fast food’ is defined as: "easily prepared and processed food 
such as burgers, pizzas, and fried chicken that are served at restaurants or fast food 
chains” (American Heart Association, 2016). Typically, this type of food is low in 
nutrients and low in fibre, while usually high in ‘trans fats’, rather than saturated fats 
(Mayo Clinic, 2016). Additionally, these foods have added sugars.
‘Trans fats’, otherwise known as trans-unsaturated fatty acids, are commonly 
produced industrially from vegetable fats through a chemical process of hydrogenation 
of oils, and is the most common form of fat used for deep-frying in fast food restaurants 
(Mayo clinic, 2016). As a result, the regular consumption of fast food normally leads 
to increased consumption ‘’trans fats’. Although saturated fat is a component of f ast 
food, ‘trans fats’ often exceed the saturated fat percentage substantially (Mayo Clinic, 
2016).
Secondly, a Westernized diet is described as one in which carbohydrates and fibre 
are generally replaced with foods derived from animals, such as meats, eggs, and 
diary (WHO, 2008; FBDG-SA, 2013). More specifically, it is widely accepted that over 
the past 100 years, the shift toward consumption of food derived from animals 
corresponds with the rapid increase in cardiovascular disease mortality globally (Norat
32
et al., 2005; Noakes et al., 2013). Despite this, there is evidence to suggest that these 
perceived global dietary trends are based on incomplete and inaccurate data from the 
United States Department of Agriculture statistics (USDA) in the 1940s-1980s 
(Taubes, 2008). These statistics in fact show that from the end of World War II, the 
consumption of whole milk, cream, and meat in America was half of what it was in the 
years prior to the war (Taubes, 2008). Additionally, the consumption of vegetable fat 
during this time (1947-1976) nearly doubled (Taubes, 2008). Since then, global 
industrialization and urbanization has increased the consumption of fast food, and thus 
the ‘Westernized diet’ has in fact transformed into one high in trans fats, and refined 
sugars, rather than one high in animal fat and protein (Taubes, 2008). In a South 
African context, this is evidenced by the common shift from ‘traditional foods’ 
consisting of pap (porridge made from ground maize), amasi (sour milk), imifino (wild 
spinach and other wild leaves), and trotters (pigs feet), to a more ‘Westernized diet’ 
comprising of processed foods high in trans fats and sugar such as fried chicken, 
hamburgers, potato chips, pies, sweets, and cake (Stupar et al., 2012).
The nutrition transition is generated by various aspects of economic globalization, 
urbanization with more sedentary lifestyles, changes in income, and influences of the 
modern food industry (Stupar et al., 2012). In particular, there is an apparent 
association between economic status and dietary habits. Stupar et al., (2012) 
interviewed a number of focus groups in urbanized Black South African schools, and 
found that there is a superior social status attached to being able to eat at fast food 
places, particularly fried chicken outlets. In a school setting, this notion of ‘status’ 
extends to being able to afford ‘junk’ food from a tuckshop, rather than having to rely 
on packed food from home which is perceived as ‘poor’ (Stupar et al., 2012).
2.5.2 Physical inactivity
The association between physical inactivity and cardiovascular disease has been 
widely researched and acknowledged as a growing global concern (Blair, 2009; Walter 
and Durandt, 2011). Blair (2009) specifically states that physical inactivity is not only 
a concern, but is the biggest public health concern of the 21st century. In 2014, physical 
inactivity was identified as the fourth leading risk factor for developing chronic 
diseases, preceded only by tobacco use, hypertension, and high blood glucose levels 
(Bull and Bauman, 2011; WHO, 2011). Despite being fourth on the list however, the
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actual impact of physical inactivity cannot be directly compared to hypertension and 
high blood glucose levels as physical inactivity is a behaviour, while hypertension and 
high blood glucose levels are conditions. Since behaviours typically impact conditions, 
it can therefore be argued that it is due to behaviours such as physical inactivity and 
tobacco use that conditions such as hypertension and high blood glucose levels arise 
in the first place, which then lead to increased risk of all-cause mortality. Additionally, 
physical inactivity is an intangible factor with respect to mortality; it is not possible to 
determine death directly due to physical inactivity. Rather, physical inactivity could 
lead to a number of health conditions which give rise to disease, which then results in 
premature death. Therefore statements such as ‘3.2 million premature deaths were 
attributed to physical inactivity alone in 2014’ by the World Health Organization (2016) 
are equally misguided as they are presumptuous since a), the deaths cannot be 
tangibly attributed to physical activity alone, and b), the causes of death in this 
particular statistic negate other external factors that could have contributed to ill health 
such as poor diet and/or genetic factors. It therefore remains pertinent to distinguish 
behaviours from conditions in order to assess and compare risk. Nevertheless, what 
is clear, is that physical inactivity is a worldwide problem, contributing to many health 
complications; thus attempts to increase levels of physical activity worldwide is 
pertinent to improving overall health (Blair et al., 2004; Bradshaw et al., 2007; Garber 
et al., 2011).
The 1995 American College of Sports Medicine (ACSM) guidelines recommended that 
adults should accumulate at least 30-minutes of moderate-intensity cardiorespiratory 
exercise on most, but preferably all days of the week to reap the health benefits 
associated with exercise (Blair et al., 2004; Garber et al., 2011). These health benefits 
include, but are not limited to, improved glucose sensitivity, lowered blood pressure, 
improved lipid profile, reduced risk of colon and breast cancer, reduced levels of 
depression, and weight loss (Bradshaw et al., 2007). However, in 2008, data showed 
that 34% of women and 28% of men worldwide did not meet these recommendations 
(WHO, 2010). Since then, prevalence of physical inactivity or ‘sedentariness’ has only 
increased, predominantly in low to middle-income countries (WHO, 2010).
As with the nutrition transition, the decrease in physical activity levels is equally 
attributed to rapid urbanization and industrialization, as this has led to the 
mechanisation of many previously manual jobs, and an increase in sedentary
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behaviour during many other occupational and domestic activities (Bradshaw et al., 
2007; WHO, 2010). Additionally, ‘passive’ modes of transport have also been 
associated with declining activity levels, although this is more prevalent in first world 
countries (Bradshaw et al., 2007).
However, one pressing question is evident. As there is considerable evidence 
highlighting the association between increased physical activity, improved over-all 
health, and weight-control, it becomes somewhat perplexing that obesity has become 
a global epidemic. In other words, if increased physical activity is the solution to 
combating obesity, why are people not engaging in physical activity? On possible 
answer to this question lies in the critical analysis of the ‘energy-in, energy-out’ model 
of weight-management.
2.5.2.1 Energy-in, energy-out model
The ‘energy-in, energy-out’, which is the most commonly accepted model for 
explaining the aetiology of obesity, works on the premise that obesity occurs as a 
result of a surplus of energy-in over time. This is due to the intake of more energy 
(calories) than are expended through exercise or activities of daily living (ADL) (King 
et al., 2007; Taubes 2008). As a result, the body has no means of ‘using up’ the 
surplus of energy that is taken in, and thus stores it body fat (Tsatsoulis et al., 2013). 
The solution to obesity is therefore to expend more energy than is taken in for weight 
loss to occur. Alternatively, if weight is to be maintained, one must simply expend as 
much energy as is consumed (Taubes, 2008). Based on this model, the worldwide 
epidemic of obesity would be easily rectified if people ate less and exercised more. 
Nevertheless, despite physical activity promotion and education, obesity rates are 
increasing, and there are 700 million obese people in the world (van Zyl et al., 2012). 
King et al. (2007) provide one possible explanation to this.
In their paper, King et al. (2007) explore the traditional ‘energy-in, energy-out’ model 
in greater detail and conclude that this mechanism of understanding is outdated. They 
highlight the metabolic and behavioural compensatory responses associated with an 
increase in energy expenditure, in response to an energy imbalance (King et al., 
2007). Due to this imbalance, and the fact that the human body is always looking to 
achieve and maintain homeostasis, this energy imbalance is usually compensated for 
by an increase in energy intake, and/or an increase in sedentary time (King et al.,
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2007). This points to a much more nuanced and intricate understanding of obesity 
development, and highlights the need to address many different lifestyle factors and 
their interactions with each other in order to gain a deeper understanding into the 
aetiology of this disease.
2.5.2.2 Physical inactivity in South Africa
Within South Africa, black women are identified as the most physically inactive, as well 
as the most obese (Walter and Durandt, 2011). Despite controversy around whether 
these women are typically more metabolically healthy than Caucasians, there is still a 
plethora of evidence suggesting that they are still a high risk group for chronic 
diseases, particularly cardiovascular disease and type II diabetes (Vorster et al., 2002; 
Bradshaw et al., 2007; Walter and Durandt, 2011). Although there is evidence to 
suggest that the high obesity rates within this population group may be attributed to 
genetics in part (Jennings et al., 2008), other evidence highlights cultural beliefs and 
norms as the primary contributor to the epidemic (Vorster et al., 2002; Steyn et al., 
2004; Bradshaw et al., 2007; Walter and Durandt, 2011).
Walter and Durandt (2011) assessed the socio-cultural barriers to physical activity 
among black isiXhosa speaking urban professional women, and found that the biggest 
barrier towards physical activity was the perceived ‘unattractiveness’ attached to 
weight loss by both the women themselves, and their partners. In this study, the 
participants who were interviewed stated that being overweight or ‘fat’ symbolized 
beauty, affluence, good health, and a negative HIV status in the isiXhosa culture 
(Jennings, 2004; Walter and Durandt, 2011). As a result, many women felt that 
engaging in exercise would lead to inevitable weight loss, and thus preferred to remain 
sedentary (Walter and Durandt, 2011). Another study by Jackson (2010) that 
assessed cardiovascular risk in urban, Black working males and females, found that 
perceived prevalence of obesity in females was significantly lower than actual rates of 
obesity. In this sample, 93.2% of the females were classified as obese, while only 
44.9% perceived this to be the case (Jackson, 2010).
In addition to cultural beliefs, research highlights the low rates of physical activity in 
populations of lower socioeconomic status; a finding attributed to the financial costs 
associated with partaking in formalized sports such as membership fees, equipment, 
and gear (Clark et al., 2009). However, Black males are considerably more active than
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Black females on average, suggesting that it is more likely cultural beliefs that 
influence the prevalence of sedentariness in Black female populations than low 
socioeconomic status (Walter & Durandt, 2011).
2.5.3 SMOKING
Smoking of tobacco products is a well-established risk factor for the development of 
cardiovascular disease, and is the leading cause of premature mortality globally 
(Fodor & Tzerovska, 2004, WHO, 2016). Specifically, it is associated with 71% of all 
lung cancers, 42% of chronic respiratory disease, and nearly 10% of cardiovascular 
disease (Shisana et al., 2014). Presently, it is estimated that tobacco accounts for six 
million deaths per year, and this is expected to increase to 10 million deaths in 2050 
(Groenewald et al., 2007; Shisana et al., 2014).
Of particular relevance is that one of the major lifestyle changes associated with 
urbanization is smoking- the prevalence of which is increasing in low and middle- 
income countries, particularly in urban areas (Pearson, 1999; Boutayehb, 2006). 
Research shows a smoking prevalence of nearly 50% in developing countries- a figure 
also expected to increase by 3.4% per year (Boutayeb, 2006). This trend is evident in 
South Africa and contributes to the increasing burden of chronic diseases, especially 
among the Black populations (John et al., 2004).
In 1992, the first national statistics became available, which reported that 32% of all 
South Africans smoked (Groenewald et al., 2007). It further stated that smoking was 
more prevalent in males of all population groups (52% of males smoked versus 17% 
of females) but that smoking rates among Black individuals were higher than those 
among Caucasians (Sitas et al., 2004). However, notably lower smoking rates were 
reported for Black females, only 10% of whom reportedly smoked, in comparison to 
27% of Caucasian and 59% of Coloured females (Sitas et al., 2004).
In 1998, smoking prevalence across the country was assessed in the national DHS- 
which provided the first available data for the Eastern Cape (DHS, 1998). Although 
this data was neither race nor sex specific, it reported that 50% of men within the 
Eastern Cape smoked, compared to 11% of women. For males, this represented the 
third highest prevalence rate in the country, while for females, this was the third lowest 
prevalence rate countrywide (DHS, 1998).
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In 2003 however, national statistics reported that smoking prevalence had decreased 
across the board (DHS, 2003; Groenwald et al., 2007). This was attributed to tobacco 
control legislation and rapidly increasing taxes making cigarettes simultaneously less 
desirable, and more expensive (DHS, 2003; van Walbeek, 2005). Between 1998 and 
2003, aggregate cigarette consumption decreased by more than a third, with a per 
capita cigarette consumption reduction off nearly 50% (van Walbeek, 2005). The 
highest decrease was evident in poorer Black populations, while decreases among 
wealthier Caucasian populations were less (van Walbeek, 2005). Nevertheless, the 
majority of this decrease was evident in male populations; females among different 
race groups showed little change. This is evidenced by the fact that between 1998 and 
2003, smoking prevalence in Black and Caucasian female populations remained at 
5.1% and 26.7%, respectively (DHS, 2003).
2.5.4 Alcohol consumption
Regular consumption of alcohol can have positive psychosocial and health effects 
(Cushman 2001; Bradshaw et al., 2007). Several studies have shown that the regular 
consumption of moderate amounts of alcohol is associated with reduced blood 
pressure and decreased overall mortality (Castelnuovo et al., 2002; Yusuf et al., 2004). 
However, excessive alcohol consumption has many adverse effects and is associated 
with liver cirrhosis and certain cancers, as well as hypertension (WHO, 2000; 
Bradshaw et al., 2007).
Historically, different patterns of alcohol consumption have been evident in different 
population groups (Bradshaw et al., 2007). Traditionally, rural Black individuals were 
known to consume alcoholic drinks made from plants, fruits, and grains, while drinks 
such as wine and beer were typically consumed by Caucasian individuals (Bradshaw 
et al., 2007). Due to recent urbanization however, traditional plant-based alcoholic 
drinks have been replaced with western alcoholic drinks; a transition believed to be 
partly attributed to the prominence of viticulture in South Africa.
Viticulture has become an integral part of the South African way of life, and is thought 
to have had a notable impact on drinking behaviours (Walker et al., 2002). The supply 
of crude wine as part of Black farm workers’ wages is thought to have contributed to 
the culture of heavy drinking that currently exists within the country. This heavy
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drinking culture is so prominent that alcohol consumption has been termed ‘the 
country’s most abused drug’ (Walker et al., 2002).
In 1998, nationwide results on alcohol consumption indicated that 28% of South 
Africans, accounting for 8.3 million individuals consumed alcohol (DHS, 1998). Within 
this percentage, prevalence rates were reported to be highest in Caucasian men 
(71%) and women (51%) and lowest in Black women (12%). Eastern Cape specific 
findings showed that 47.4% of males and 16.2% of females consumed alcohol (DHS, 
1998). In 2003, follow-up results indicated that alcohol consumption had decreased; 
findings mirrored across all provinces including the Eastern Cape. Interestingly 
however, reasons behind this decrease were not explored. These findings showed 
that of women in the Eastern Cape, 89.5% reported abstaining from alcohol within the 
last 12 months, and only 1.1 % reported being harmful or hazardous drinkers; a finding 
markedly lower than that of males, where 57.6% reported abstaining from alcohol 
within the last 12 months, and 4.8% reported being harmful or hazardous consumers 
(DHS, 2003). When comparing results across different race groups, of the women who 
reported abstaining from alcohol within the last 12 months, 61.3% of these were Black 
females, and 30.1% were Caucasian (DHS, 2003). These findings are mirrored across 
other studies, indicating that lifetime abstinence from alcohol use was most common 
in Black female populations, although the reasons behind this are not thoroughly 
explored (WHO, 2000; Martinez et al., 2011). However, due to the fact that these 
statistics are based on self-reports, it is likely that these were underestimated 
(Schneider et al., 2007).
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CHAPTER III - METHODOLODY AND PROTOCOL
3.1 RESEARCH AIM
The aim of this research was twofold: the first aim was to add new data to the body of 
literature on cardiovascular disease risk in Black and Caucasian females within the 
Eastern Cape. Secondly, this research aimed to compare the cardiovascular disease 
risk in urban Black and Caucasian women, by exploring the interaction between race, 
socioeconomic, and lifestyle factors.
3.2 RESEARCH DESIGN
This research was conducted as a ‘cross-sectional design’, otherwise referred to as a 
‘comparative descriptive design’. Herein, the study populations were assessed at one 
point in time with the aim of determining the prevalence of the outcome of interest 
(cardiovascular disease risk). The key to this type of design was that the environment 
within which the population exists remained the same; the researcher merely 
observed, measured, described, and reported on the prevalence of pre-selected 
variables naturally existing in the group. Thereafter, inferences on health status and 
subsequent proposed intervention-areas were further explored if/where necessary.
3.2.1 DEPENDANT AND INDEPENDENT VARIABLES
Various factors such as morphological characteristics, cardiovascular-risk parameters 
(CV), lifestyle-related factors, and socioeconomic status were assessed in order to 
provide an indication of the risk for cardiovascular disease. Each of these categories 
represented a dependant variable of interest for this study: obesity- representing 
morphological risk; hypertension and blood glucose and insulin concentrations- 
representing cardiovascular risk parameters (CV); diet, physical activity levels, 
smoking, and alcohol use- representing lifestyle-related factors; and education and net 
income- representing socio-economic status. According to these criteria, 
cardiovascular disease risk profiles of Black and Caucasian women forming an urban 
working population were compared; thus race and demographic location (urban) 
represented the independent variables of interest. Both dependent and independent 
variables are represented below (Table 3).
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Table 3: Dependent and independent variables.
RISK
URBAN
W ORKING
POPULATION
MORPHOLOGICAL CARDIOVASCULAR LIFESTYLE
SO CIO ­
ECONOMIC
STATUS
Black MASS, BMI, WC, WSR, BLOOD PRESSURE DIET, PA,
SMOKING,
ALCOHOL
EDUCATION,
NET MONTHLY 
INCOMECaucasian
Where: BMI = Body Mass Index; WC = waist-circumference; WSR: waist-to-stature ratio; PA = physical activity
3.3 WORLD HEALTH ORGANIZATION (WHO) STEP-WISE APPROACH
To assess the cardiovascular risk of these population groups, the WHO STEP-wise 
approach (STEPS) was used. This is a methodological tool which has been 
recommended for the assessment and surveillance of chronic disease risk, and is 
more specifically acclaimed as the gold standard entry level assessment tool for low 
and middle income countries (Strong and Bonita, 2004; Riley et al., 2016). The key 
objectives of STEPS are to gather comprehensive information on chronic disease risk 
factors thereby enabling appropriate implementation of programmes and 
interventions, and to collect standardised risk factor data to enable comparisons 
between populations/countries (Riley et al., 2016). As a result, the use of this tool was 
particularly advantageous as it allowed for comparisons between different racial 
groups. Additionally, this approach takes into account financial and logistical 
constraints that often hinder the implementation of objective measures, which was a 
further benefit within the context of this research. Therefore STEPS was chosen as 
the most comprehensive, accessible, and valid tool to use in order to achieve the aims 
of this research.
According to Bonita et al. (2001), a risk factor (within the context of chronic disease) 
is defined as any attribute, characteristic, or exposure of an individual, which increases 
the likelihood of developing a chronic disease. Using this definition, the STEP-wise 
approach proposes that risk be assessed according to the following three steps: Step 
1, questionnaire-based information; Step 2, standardized physical measurements
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(objective measures); and Step 3, blood samples for biochemical analyses (Bonita et 
al., 2004).
3.3.1 THE USE OF STEPS IN THE CURRENT STUDY
Within the current study, Steps 1,2  and 3 was utilized in the assessment of each risk 
factor. However, step 3 was adjusted slightly in accordance with the research aims. 
These changes, and the justifications behind them, are addressed below. A summary 
of the techniques used within the STEPS framework is presented:
42
Table 4: STEPs framework for the assessment of selected cardiovascular disease
R IS K S T E P  1: Q u e s tio n n a ire s S T E P  2: P h ys ica l 
m e a s u re m e n ts
S T E P  3: B lood  
s a m p le s
D iet • Three-day dietary recall.
• Selected questions on habitual 
intake (Adapted from Adult 
Health Questionnaire, 2003)
P h ys ica l a c tiv ity • Adapted Global Physical 
Activity Questionnaire 
(GPAQv2).
T o b a c c o  use • Adapted WHO STEP-wise 
surveillance questionnaire
A lc o h o l use  and  
d e p e n d e n c y
• Standard questionnaire for the 
monitoring of alcohol 
consumption and related hard 
(WHO STEP-wise)
O b e s ity • Stature, mass and 
waist circumference 
(from which BMI and 
waist-to-stature ratio 
will be calculated).
• Bioelectrical 
impedance analysis 
(BIA)
H y p e rte n s io n • Self-reporting of hypertension • Measured blood 
pressure
T y p e  II D iab e te s • Self-reporting of type II 
diabetes
• Fasting 
glucose and 
fasting insulin 
concentrations 
(HOMA-1)
H y p e rc h o le s te ro le m ia • N/A • NA • NA
S o c io -e c o n o m ic  s ta tu s • WHO STEP-wise questionnaire 
on 'expanded demographic 
information'.
43
The two sub-sections that were altered for the purpose of this study were the 
replacement of fasting glucose concentrations alone for fasting glucose and insulin 
concentrations, and the absence of hypercholesterolemia measures.
3.3.1.1 Blood glucose concentrations
Recent literature suggests that Black African populations do not typically present with 
elevated blood glucose levels as frequently as in other populations (Goedecke et al., 
2009). The proposed explanation for this lies in a genetic predisposition to 
hyperinsulinemia within Black African populations, whereby excessive levels of insulin 
are secreted for a prolonged period of time in order to maintain safe blood glucose 
levels (Goedecke et al., 2009). As a result, blood glucose measures alone often depict 
an inaccurate picture of glucose metabolism in these populations, thereby 
compromising the validity of the measure. For this reason, it was therefore decided 
that the relationship between fasting glucose and fasting insulin levels would be a 
more valid measure to take when assessing the biochemical health of Black Africa 
populations. Therefore both fasting glucose and fasting insulin concentrations were 
chosen to be measured in this study.
3.3.1.2 Hypercholesterolemia
Evidence exits to show that hypercholesterolemia is becoming an outdated and 
inaccurate indicator of cardiovascular disease risk (Brunzell et al., 2008). Despite its 
popularity in the past, recent evidence suggests that a more accurate measure is one 
that includes the ratio of HDL, LDL and triglyceride concentrations to total cholesterol 
concentrations (Sharma et al., 2009; Goedecke et al., 2015). Because of this, 
measures of total cholesterol only (which indicates the presence or absence or 
hypercholesterolemia) were excluded from this study as it is unethical to subject 
participants to a test which is shown to be inconclusive (Brunzell et al., 2008). 
Although it would be beneficial to measures HDL, LDL and triglyceride concentrations 
within the context of this study, it is an expensive test to administer and thus was not 
used due to financial constraints.
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3.4 ETHICS
Ethical clearance was obtained from Rhodes University Human Kinetics and 
Ergonomics Department Ethical Standards Committee for research involving human 
participants (Appendix 1).
3.5 MORPHOLOGICAL RISK
3.5.1 OBESITY
Various measurements exist pertaining to the assessment of obesity. Most commonly, 
these include stature, body mass (from which body mass index is calculated), and 
waist circumference (which in conjunction with stature, is used to calculate waist-to- 
stature ratio). Despite the ease of use of the above measures, alone, they often 
provide an incomplete and rather crude account of obesity risk (Neville et al., 2006; 
Daniels, 2009). Therefore, a more comprehensive assessment requires measures of 
body composition in addition. These include bioelectrical impedance analyses, 
skinfolds analysis, and hydrostatic weighing.
3.5.1.1 Body Mass Index (BMI)
The use of BMI is a well-known measurement is assessment of fatness in relation to 
stature (Daniels, 2009). Despite its biggest limitation of not being able to distinguish 
between fat mass and lean body mass, it is still accepted as one of the standard 
measures of obesity, particularly when used to assess sedentary populations (Flegal 
et al., 2013). One of the main benefits of using BMI is that it provides a quick and easy 
indication of body fat percentage, which is particularly applicable in field based 
research. By using both body mass and stature values, BMI therefore provides some 
indication of the linearity of ‘fatness’ in relation to height (Baumgartner and Jackson, 
1998).
The BMI classification system proposed by WHO (2004) provide guidelines for 
identifying and classifying overweight and obese individuals (Table 5).
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Table 5: WHO classification of body mass index (WHO, 2004).
BMI (kg.m-2) Classification CVD Risk
< 18.5 Underweight Low
18.5-24.9 Normal Average
25.0-29.9 Overweight Increased
30.0-34.9 Obese class I High
35.0-39.9 Obese class II Severe
> 40.0 Obese class III Very severe
3.5.1.2 Waist Circumference (WC)
Despite the health risks associated with obesity in general, central obesity has been 
shown to have more adverse consequences than peripheral obesity (Despres et al., 
2008; Tsatsoulis et al., 2013). Central obesity is defined as the accumulation of fat 
around the abdomen, and is associated with high risk of hypertension, type II diabetes, 
and cardiovascular disease (Alberti et al., 2005; Tsatsoulis et al., 2013). It is primarily 
measured as waist-circumference (WC), but additional measures include waist-to-hip 
ratio (WHR) and waist-to-stature ratio (WSR) (Shields et al., 2012). Waist 
circumference classifications do vary among different population groups, however the 
guidelines put forth by WHO based on several global studies provide a useful initial 
screen for risk profiles of individuals (Table 6).
Table 6: WHO classification of waist circumference (WHO, 2004).
Waist circumference (cm)
Risk High Risk
Males >94 >102
Females <80 <88
Due to the controversy in the literature with respect to race-specific waist 
circumference norms, and more specifically, the lack thereof, the above classifications 
serve as mere guidelines. Nevertheless, as waist circumference is accepted as a 
primary indicator of cardiovascular disease risk, it is an important measure to take in
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the context of this study. In order to account for possible misrepresentation of obesity 
within the Black female population however, an additional measure of waist-to-stature 
ratio was done.
3.5.1.3 Waist-to-Stature Ratio (WSR)
Waist-to-stature ratio, otherwise known as ‘waist-to-height ratio’, is a particularly useful 
measurement when looking at populations who are typically shorter or taller than the 
standard height averages worldwide (Goedecke et al., 2009). In the case of Black 
African women, the average height is 8 -10 cm shorter than the average height of 
Caucasian females (Goedecke et al., 2009). This is one of the reasons that the use of 
standardised waist circumference norms may not accurately reflect obesity in certain 
populations, as the differences in average height are not accounted for. For example, 
a blanket waist-circumference norm of >88 cm (indicative of high risk for 
cardiovascular disease in a woman) may be of greater risk to a Black African woman 
who is typically shorter than an age-matched Caucasian woman. In other words, the 
shorter woman would have a higher waist circumference proportionately to the taller 
woman, therefore putting her at a higher risk. It is for this reason that waist-to-stature 
ratio was a particularly useful and applicable ratio to use in the context of this study.
3.5.1.4 Body Composition: Bioelectrical impedance analysis
There are three widely accepted and commonly used methods for determining body 
composition, namely bioelectrical impedance analysis, skinfolds analysis, and 
hydrostatic weighing (Pecoraro et al., 2003). For the purpose of this study, bioelectrical 
impedance analysis was chosen for reasons discussed below.
Bioelectrical impedance analysis (BIA) is defined as the opposition of a conductor to 
the flow of an alternating current and involves the application of a 50kHz current 
through the body via electrodes which are place on the hands and feet (Dehghan and 
Merchant, 2008). This technique introduces a painless current (800^A) into the body 
at a frequency of 50 kHz in order to determine the electrical impedance of body tissues. 
As lean body tissue is rich in water and electrolytes, it poses minimal impedance. In 
contrast, adipose tissue high in fat poses high impedance and therefore increases 
impedance to a maximum (Dehghan and Merchant, 2008). Due to this, lean body
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mass and fat mass can be calculated from the difference in conductivity though the 
use of the following formula:
V = p x S2/R 
Where:
V = conductive volume (assumed to represent total body water or fat free mass)
P = specific resistivity of the conductor
S = stature (an estimate of length of the conductor)
R = whole body resistance (measured with four surface electrodes placed on the 
wrist and ankle)
(Taken from Saladino, 2014)
Bioelectrical impedance analysis is a non-invasive and relatively inexpensive 
technique for the measurements of body composition. Additionally, due to its 
portability, it is ideal for field based research (Kyle et al., 2004). Although skinfolds 
analysis is also portable measure and is considered more accurate in normal to 
overweight populations, this technique is invasive and provides inaccurate results in 
obese populations (Goedecke et al., 2009). This is due to the fact that skinfold callipers 
can only open to a set wideness that is often too narrow to grip the largest areas of fat 
at certain sites in obese populations (Amaral et al., 2011). As the prevalence of obesity 
in Black African female populations, it is likely that a large proportion of the participants 
will be obese, and thus the use of this technique was rejected.
Nevertheless, despite the practical benefits, bioelectrical impedance analysis is not 
without short-comings, as it is still considered the least accurate method of the above 
mentioned three (Savastano et al., 2010). The compromised accuracy here is typically 
due to the effects that body water content have on the measurements, whereby body 
composition before and after water ingestion can often produce different values of lean 
and fat body mass (Savastano et al., 2010). However, by ensuring that all participants 
are measured after having not eaten or drunk for 10 hours prior, the possible 
interaction effect of this confounding variable is largely diminished. Bioelectrical
48
impedance analysis is also a widely used and established method for determining 
body composition, and was therefore an acceptable selection for use in this study.
3.6 CARDIOVASCULAR RISKS
3.6.1 HYPERTENSION
Accurate and precise measurement of blood pressure is paramount in classifying and 
identifying hypertension-related cardiovascular disease risk (Pickering et al., 2005). 
The auscultatory technique, which involves a trained observer using a mercury 
sphygmomanometer and the Korotkoff sound technique, represents an accurate ‘gold- 
standard’ blood pressure measurement technique (Ogedegbe and Pickering, 2010). 
Although this is a manual technique which is subject to human error, it is still 
considered accurate and precise in comparison to automated blood pressure 
machines, providing that the user is properly trained and experienced in using the 
equipment (Ogedegbe and Pickering, 2010). In addition, the use of manual blood 
pressure measurement also considerably reduces the risk of equipment malfunction 
or error; an inherent limitation of automated blood pressure machines.
South African blood pressure norms differ from American standardized norms in that 
a blood pressure <129/84 mm Hg is still considered ‘normal’, whereby this is 
considered as ‘pre-hypertensive’ according to American norms (South African Heart 
and Stroke Foundation, 2014). Nevertheless, the globally-accepted cut-off value for 
Stage 1 hypertension is >140/90 mm Hg, and will thus be used as the basis of 
classification for hypertension. Any pre-hypertensive readings will be classified 
according to the South African norms due to the demographic of the sample groups in 
this study.
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Table 7: Hypertension classification (South Africa Heart and Stroke Foundation, 
2016).
SYSTOLIC BP (mmHg) DIASTOLIC BP (mmHg) CLASSIFICATION
120-129 80-84 Normal
130-139 85-89 Pre-hypertensive
140-159 90-99 Stage 1 hypertension
>160 >100 Stage 2 hypertension
BP indicates ‘blood pressure’; (mmHg) indicates millilitres of Mercury.
3.6.2 INSULIN SENSITIVITY
Insulin resistance (characterized by impaired insulin sensitivity and hyperinsulinemia) 
is a key factor contributing to type II diabetes in Black African populations (Goedecke 
et al., 2010).
The standard technique for the assessment of insulin sensitivity is the 
hyperinsulinemic euglycemic clamp (Keskin et al., 2005). This technique, often used 
in combination with the hyperglyceric clamp, determines the adequacy of 
compensatory p-cell hypersensitivity by periodically introducing small concentrations 
of glucose and insulin into the blood at regular pre-determined intervals over a set time 
duration (Keskin et al., 2005). Although typically considered the gold-standard 
technique, it is also complex and laborious technique that is too invasive for general 
epidemiological studies, as well as for any field study evaluating a large number of 
participants (Keskin et al., 2005; Minamino et al., 2009). In light of this, an established 
and widely used surrogate measure of insulin resistance, the Homeostasis Model 
Assessment Index (HOMA-I) will be used for this study.
The HOMA-I approach has been widely used in clinical research to assess insulin 
sensitivity, and works by applying a set formula to fasting glucose and insulin levels in 
order to determine and index indicating level of insulin sensitivity (or resistance) 
(Keskin et al., 2005; Minamino et al., 2009). Rather than looking purely at fasting 
insulin and fasting glucose levels in isolation, the HOMA-I approach uses the product 
of the two and then divides it by a constant (40.5 if mg/dL or 22.5 if mmol/l). This 
calculation compensates for fasting hyperglycaemia and generates an index for insulin 
sensitivity (Keskin et al., 2005). The index classification is presented below in Table 8.
50
Table 8: HOMA-I Classification for insulin sensitivity (Keskin et al., 2005).
HOMA INDEX
Normal insulin function (high sensitivity) < 2.0
Borderline (compromised insulin sensitivity) 2.1 - 2.5
Moderate (insulin resistance) 2.6 - 3.0
High (sever insulin resistance) >3.0
An example of HOMA-I application:
Fasting glucose: 5.2 mmol/l 
Fasting insulin: 12.2 yU/ml3
(5.2 x 12.2) /22 .5
= 2.82 (Moderate insulin resistance)
3.7 LIFESTYLE RISKS
3.7.1 DIET
Habitual diet, and in particular, an unhealthy habitual diet, remains one of the strongest 
predictors of cardiovascular disease risk factors such as obesity, hypertension, and 
type II diabetes (Bouyateb, 2006; Steyn and Nel, 2006). Various techniques exist for 
the assessment of habitual diet, the most common of which being food frequency 
questionnaires, a 24-hour dietary recall, and a three-day dietary recall (Nel and Steyn, 
2002). The primary difference between these methods is that the food frequency 
questionnaires require participants to recall and foods and beverages consumed over
3 pU/ml = pIU/ml = mIU/L
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a longer period of time (days, weeks, or months), whereas the 24-hour dietary recall 
and the three-day dietary recall method (as the names suggest), requires consumption 
to be recalled over a shorter period, either 24 hours or 72 consecutive hours.
Despite the inherent limitation of only recording consumption over a 24-hour to 72- 
hour period, these methods are beneficial when compared to food frequency 
questionnaires in that they are quick, simply, and an easy for participants to adhere to 
(De Keyzer et al., 2015). For the purpose of this study, a three-day (72-hour) dietary 
recall was used as it was more likely to provide an accurate representation of habitual 
diet than a once-off 24-hour dietary recall. These recalls were administered so that 
participants include two weekdays and one weekend day in order to get as accurate 
a representation of a normal full week as possible.
Studies have also shown that the three-day dietary recall method to compare well with 
the results of food frequency questionnaires, particularly when repeated measures are 
used, and was therefore chosen as an appropriate alternative for this study (De Keyzer 
et al., 2015; Thompson et al., 2015). Due to logistical and time constraints, repeated 
measures were not possible for this study, however, in addition to carrying out a 24- 
hour food recall, additional questions regarding the habitual intake of various foods 
and beverages will be carried out. These questions are validated and based on similar 
questions in the Adult Health Questionnaire used in the 2003 Demographic Health 
Survey (DHS, 2003). This is added to strengthen the reliability of the dietary intake 
data so to ensure that dietary recollection is as accurate as possible.
3.7.2 PHYSICAL ACTIVITY
The association between physical activity and cardiovascular risk is well established, 
and the lack thereof is an ever-increasing global concern (Blair, 2009; WHO, 2010; 
Walter and Durandt, 2011) The regular participation in physical activity, recommended 
at 30 minutes of moderate intensity exercise, five days a week, is associated with a 
substantial reduction in cardiovascular disease risk (Whitt-Glover et al., 2012). In 
contrast, individuals who take part in little to no physical activity have increased 
cardiovascular disease risk (Kohl et al., 2012).
There are various methods pertaining to the measurement of physical activity, both 
objective and subjective. Previously, exercise was more strictly defined as ‘planned,
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structured exercise sessions’ (such as sports or jogging) with the specific aim of 
improving physical health (Lambert et al., 2007). Thus, objective measures such as 
calorimetry, the Double Labelled Water (DLW) technique, pedometers, and 
accelerometers were typically used to assess energy expenditure during these 
activities (Lambert et al., 2007). More recently however, it has been recognized that 
physical activity is not exclusive to structured exercise; it occurs in many other 
domains of life such as work and travel. Thus, self-reported measures of time spent 
engaging in these activities have become useful in the assessment of total physical 
activity levels (Lambert et al., 2007). Physical activity questionnaires have therefore 
become increasingly popular tools to use, as they have the added advantages of being 
inexpensive, and easy to apply and administer within a field-based setting (Pitta et al., 
2006).
Various validated physical activity questionnaires have been developed, such as the 
Minnesota Leisure Time Physical Activity Questionnaire (MLTPAQ); the Zutphen 
Physical Activity Questionnaire (ZPAC); the Stanford Seven-Day Physical Activity 
Questionnaire; the International Physical Activity Questionnaire (IPAQ); the Global 
Physical Activity Questionnaire (QPAQ), and more. Of these, the GPAQ was 
developed by the World Health Organization as an instrument to assess physical 
activity patterns in developing countries, and was used as part of a larger project aimed 
at monitoring risks for chronic diseases in developing countries (Armstrong and Bull, 
2006). Research was carried out testing the reliability and validity of the GPAQ in a 
large number of countries, particular those with low levels of education (including 
South Africa). From this, the final GPAQ version 2 instrument (GPAQv2) was 
developed and was deemed a suitable physical activity surveillance instrument in 
developing countries (Armstrong and Bull, 2006). The GPAQv2 has since been 
incorporated within the WHO STEP-wise approach model and was thus chosen as an 
acceptable method for this study.
The GPAQv2 comprises of 16 questions grouped to capture physical activity 
undertaken in different behavioural domains namely work, transport, and leisure 
(Singh and Purohit, 2011). The main outcome variables from GPAQv2 analysis are a 
categorical variable of total physical activity (low, moderate, or high); and a continuous 
variable of total physical activity within each domain (reported as median 
METmins.week-1) (Armstrong and Bull, 2006).
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3.7.3 ALCOHOL CONSUMPTION
Alcohol abuse is widely accepted as a contributing risk factor to the development of 
cardiovascular disease (Chopra et al., 2002; Schneider et al., 2007). For this reason, 
it is imperative to assess alcohol consumption in order to compare and relate 
consumption to cardiovascular disease risk factors. The WHO STEP-wise 
questionnaire is a comprehensive and appropriate tool for the assessment of habitual 
alcohol intake, and encompasses the frequency of alcohol use as well as past and 
present consumption practises (Bonita et al., 2001). Moreover, the alcohol 
consumption in the latest National Demographic and Health Survey (2003) was 
assessed using questions based on the WHO STEP-wise questionnaire, thus 
validating the applicability of this test on a South African population (DHS, 2003).
3.7.4 TOBACCO USE
As with alcohol consumption, the habitual use of tobacco is linked to a high risk of 
cardiovascular disease and therefore requires assessment (Bonow et al., 2002; DHS, 
2003; Myer et al., 2004; WHO, 2011).
In 1998, the first Demographic and Health Survey was carried out in South Africa and 
this provided a platform for the assessment of tobacco use within different population 
groups and within different provinces (DHS, 1998). The tobacco-related questions in 
this survey were based on and derived from the WHO guidelines for controlling and 
monitoring of the tobacco epidemic (Bradshaw and Steyn, 2001; Swart and Panday, 
2010). In the 2003 Demographic Health Survey however, these initial questions were 
adapted to form a more rigorous assessment based on the WHO STEP-wise 
programme. To date, the tobacco-use questionnaire within the STEP-wise approach 
is still commonly used and widely accepted for assessing chronic disease risk and was 
thus chosen for this study.
3.8 SOCIO-ECONOMIC STATUS
Defined as a measure of an individual’s social position in society based on education, 
income, and occupation, socio-economic status is well documented factor affecting 
cardiovascular disease risk (Winkleby et al., 1992; Stringhini et al., 2013; Kivimaki et 
al., 2014). More specifically, poor socio-economic status has been linked to increased 
risk of cardiovascular disease, and this is attributed in large to lack of education
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surrounding health lifestyle choices, and financial constraints limiting access to 
adequate health care (Stringhini et al., 2013; Kivimaki et al., 2014).This is of particular 
relevance to a South African context where socio-economic disparity is so high 
(evidenced, in part, by a Gini Coefficient of 63.4 in 2015), and where the majority of 
those from poor socio-economic backgrounds are Black African populations (The 
World Bank, 2016). It is therefore essential to assess the influence of socio-economic 
status on health in Black South African populations as it is such central feature to their 
demographic.
The WHO STEP-wise programme contains a section pertaining to the demographic 
information of individuals, and includes socio-economic questions based on 
employment, income level, and education level. As this programme is a widely 
accepted and used tool for developing countries, it was therefore used in study.
3.9 EXPERIMENTAL PROCUDRES: EQUIPMENT AND MEASURMENTS
Due to factors not within the control of the primary researcher, glucose and insulin 
measures, as well as body fat distribution measures were not able to be done in the 
study as initially planned. Subsequently, methods pertaining to these measures were 
removed from the procedures section of this chapter below. These limitations are 
addressed in further detail under ‘Limitations to the study’, pg. 63).
3.9.1 ANTHROPOMETRIC AND MORPHOLOGICAL RISK
3.9.1.1 Stature
Stature was be measured to the nearest millimetre (mm) using a stadiometer 
(Harpenden Stadiometer, Chasmors Ltd, London). Before measurement commences, 
participants were required to remove their shoes and stand upright facing forwards 
while allowing three points of their body to be in contact with the back of the 
stadiometer, namely the back of the head, gluteus maximus, and calcaneus. The 
measurement was taken from the floor to the vertex in the mid-sagittal plane.
3.9.1.2 Body Mass
Body mass was measured to the nearest 0.1 kg using a calibrated electronic scale 
(Toledo® Trek Scale Co, Model 1842, Cleveland). Participants were required to
55
remove their shoes and any heavy clothing or jackets in order to obtain accurate 
results.
3.9.1.3 Body Mass Index (BMI)
BMI (kg.m2) was calculated from stature and body mass values using the following 
formula: body mass (kg) / stature (m) 2
3.9.1.4 Waist Circumference (WC)
Iliac waist circumference was measured using a standard dressmaker’s tape measure 
and was recorded to the nearest millimetre (mm). This measurement was performed 
with the participant standing upright, at the end of normal expiration, and after having 
removed any heavy outer garments (Janssen et al., 2004).
3.9.1.5 Waist-to-stature Ratio (WSR)
The waist-to-stature ratio was calculated by dividing waist circumference (cm) by 
stature (cm). This calculation elicited a ratio which was then used as a classification 
system for cardiovascular disease risk, based on the Ashwell Shape Chart© (Ashwell, 
2011).
Table 9: Waist-to-stature ratio.
INDEX VALUE CLASSIFICATION COLOUR REGION
<0.4 Low (‘take care’) Brown
0.4 -  0.49 Normal (‘ok’) Green
0.5 -  0.59 Moderate (‘take care’) Yellow
>0.6 High (‘action’) Red
The data above is taken from the Ashwell Shape Chart (Figure 3), demonstrating the 
cut-offs visually.
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Figure 3: The Ashwell Shape Chart based on waist-to-stature ratio.
3.9.2 CARDIOVASCULAR RISK
3.9.2.1 Blood Pressure
Blood pressure (mm Hg) was measured in triplicate by the principle researcher using 
a manual sphygmomanometer (Baumanometer® Sphygmomanometer, W.A. Baum 
Co., Inc., New York) with two minutes separating the three measurements. 
Participants were required to rest quietly in a seated position for five minutes prior to 
the measurement. The blood pressure measurements were taken according to the 
auscultatory method (Chobanian et al., 2003), by applying a sphygmomanometer cuff 
of appropriate size to the left brachial artery. Systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) were recorded at the first and fifth Korotkoff sounds 
and the two closest readings will be averaged and recorded.
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3.9.2.2 Medical Conditions Questionnaire
In addition to the physical measurement of blood pressure, glucose and insulin levels, 
self-reported hypertension and insulin resistance or type II diabetes were also 
recorded. This was done by means of structured questions in which the individuals 
were asked if they have ever been told by a health professional that they were 
hypertensive/had high blood pressure, and/or if they have ever been told they have 
insulin resistance or type II diabetes.
3.9.3 LIFESTYLE RELATED RISKS
3.9.3.1 Diet
3.9.3.1.1 Three-day food recall
A three-day food recall was used in order to assess the habitual dietary habits of the 
participants over a consecutive 72-hour period. This method required participants to 
record everything they consumed (food and liquid) over a period of 72 hours, which 
was filled in on a blank template provided (Appendix 9). Thereafter, an interview was 
carried out during which the participants were required to verbally confirm specific 
quantities and types of foods consumed. Visual aids of various portion-size references 
were also included to assist with understanding, explanation, and accuracy of food 
quantities recorded (Appendix 11).
3.9.3.1.2 Dietary Intake Questionnaire
Individuals will also be asked various additional questions regarding the type of food 
stuffs typically consumed, and how often these food stuffs are consumed. These 
question are included to gain a deeper understanding of the types of foodstuffs 
habitually consume, and thus serves to strengthen the accuracy of dietary 
assessment. The dietary intake questionnaire is taken from the WHO STEP-wise 
programme.
3.9.3.1.3 Food Finder
Dietary intake and macronutrient composition for each participant as analysed using 
the Medical Research Council (MRC) FoodFinder 3™ software programme for 
Windows® (Microsoft Corporation). This contains a South African Food Composition
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Database (SAFOODS) which is the official database on the nutrient composition of 
foods eaten in South Africa.
3.9.3.2 Physical Activity
3.9.3.2.1 Global Physical Activity Questionnaire version 2 (GPAQv2)
Individuals were asked various questions on their habitual physical activity levels using 
the GPAQv2. This questionnaire included questions related to activity at work, activity 
involved in getting to and from places, and activity related to recreational activities. 
This therefore aimed to provide an overall indication of physical activity, taking into 
account the different lifestyle domains, as well as duration and intensity of physical 
activity.
Physical activity levels were also categorised according to a scoring system in the 
volume of activity is computed by weighting each type of activity by its energy 
requirements. This was computed using METs (multiples of the resting metabolic rate), 
to derive a score in MET-minutes: calculated by multiplying a MET score by minutes 
performed. 1 MET-minute represent 3.5 ml of oxygen per kg of body weight per minute 
(GPAQv2). Data was therefore collected as a continuous measure and reported as 
median MET-minutes for walking (W); moderate-intensity activities (M); and vigorous- 
intensity activities (V), within each domain (work, transport, and leisure). Physical 
activity was calculated using the following MET values:
Table 10: Domain-specific MET classification (GPAQv2).
DOMAIN MET VALUE
Work Moderate MET value = 4.0
Vigorous MET value = 8.0
Transport Walking MET value = 4.0
Leisure Moderate MET value = 4.0
Vigorous MET value = 8.0
Physical activity levels were defined according to the definition proposed by the 
International Physical Activity Questionnaire (IPAQ) Scoring Committee, which 
defines overall reported physical activity levels as follows:
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Table 11: Classification of levels of physical activity (adapted from IPAQ 
classification of physical activity).
CATEGORY CRITERIA
1. Low/inactive or insufficiently active < 600 MET-minutes/week
2. Moderate/Minimally active 600- 3000 MET-minutes/week
3. High/Sufficiently active > 3000 MET-minutes/week
3.9.3.3 Tobacco use
3.9.3.3.1 STEP-wise questionnaire
The WHO STEP-wise questionnaire contains questions pertaining to past and current 
smoking habits, as well as exposure to environmental tobacco smoke at home and at 
work, and exposure to dust and fumes. Participants were asked these questions in an 
interview format and the primary research and/or research assistants filled in their 
answers.
Smokers were classified as individuals who report that they currently smoke either 
occasionally or daily, and were further classified as light smokers (1 -  14 tobacco 
equivalents per day) or heavy smokers (> 15 tobacco equivalents per day) where 
applicable (Bradshaw and Steyn, 2001). One tobacco equivalent is defined as one 
manufactured cigarette; one hand-rolled cigarette; one pipe; one cigar; one cheroot; 
or one cigarillo (Bradshaw and Steyn, 2001).
3.9.3.4 Alcohol consumption
3.9.3.4.1 Adapted questions for the assessment of alcohol use (WHO STEP-wise)
Alcohol use was assessed by means of a set of questions based on those used in the 
DHS (2003), and adapted from the WHO STEP-wise programme. Through the use of 
these questions, information was obtained regarding the frequency of consumption, 
as well as the quantities of alcohol consumed each day during a typical week. 
Individuals were considered ‘risky drinkers’ if the consumed over three drinks per day 
(in the case of females) (Schneider et al., 2007).
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3.10 EXPERIMENTAL PROCEDURES
3.10.1 PHASE 1
As the central aim of this project was to assess cardiovascular risk in Black and 
Caucasian females within the Eastern Cape, the priority was to find enough 
participants residing in the greater urban area of Grahamstown who were both willing 
and able to participate in the study. As this was a comparative-descriptive study 
design which was non-repeated, the aim was get as many participants as possible. 
Looking at similar studies conducted in South Africa, the majority of these are large 
scale studies involving 900 to 5000 + participants (Vorster et al., 2002; Steyn et al., 
2005; Motala et al., 2008; Motala et al., 2011; Murphey et al., 2014). However, three 
studies have included 200 to 300 participants in total, with no fewer than 100 
participants per comparative group (Schutte and Olckers, 2007; Jennings et al., 2008; 
Jackson et al., 2010). The nature of this study was such that the sample group would 
be on a smaller scale, therefore guidelines from smaller scale studies were used. A 
sample size of 200 to 300 participants, with approximately equal numbers of Black 
and Caucasian women, was therefore chosen for this study. This was to ensure that 
the study was statistically viable, while also practically achievable with respect to 
availability of eligible participants, and time.
Therefore, in order to gather as many participants as possible, the initial stage of this 
study involved contacting local businesses and institutions within the Grahamstown 
area. Where possible, meetings were set up with managers and supervisors where 
the aims of the project, the requirements for participation, as well as the benefits of 
participating were communicated (Appendix 4). A mother-tongue Xhosa speaking 
individual who assisted in the data-collection phase of this study was present at the 
meetings in order to provide translation if necessary. Here, any questions that the 
supervisors had were answered and clarified. The supervisors were then be asked to 
distribute the project information to their employees.
The second stage involved an information session with interested employees (as 
gathered by the supervisors) where the research project aims and procedures were 
explained in detail by the primary researcher, as well as by the isiXhosa translator 
where necessary. Participants were also told that if they wished, they would be allowed 
to bring some food and drink with them to the testing session which they could
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consume directly after the physical measurements have been taken. This was to 
optimize their comfort, as they would have fasted for 10 hours prior. Participants were 
then recruited on a voluntary basis, and were required to sign a consent form after 
thoroughly reading the information letter and completing the pre-screening 
questionnaire. Where necessary, follow-up meetings were held where logistics with 
regards to when testing commencement were discussed.
Once all interested participants had signed-up and have selected a day and time slot 
for testing, this marked the transition into phase 2.
3.10.2 PHASE 2
On arrival, each participant was introduced to the researcher, research assistants, 
nursing sister, and translator, and were then assigned their participant code. 
Thereafter, participants were verbally reminded of the purpose of the study, as well as 
the testing procedures they were about to undergo. They were also assured that if at 
any point they wished to pull out from the study, they were welcome to do so. As all 
participants were female, only female research assistants were conducting the 
measurements to ensure that the participants felt as comfortable as possible. 
Furthermore, each participant was measured in a different area of the department to 
ensure their privacy.
Once the participants felt ready to begin, the researcher and/or research assistants 
began with the physical measurements. While the physical measures were being 
taken, the participants were given verbal feedback about the values they obtained, 
and any questions they had about these values were answered. After the physical 
measures were taken, the participants were given a few minutes to relax before 
commencing the questionnaire portion of the study.
The questionnaires on self-reported CVD risk, tobacco use and alcohol consumption, 
socio-economic status, dietary habits, and physical activity habits were then 
administered and completed. Although there was only one translator present, the 
translator was called when/if needed by the research assistants and could therefore 
assist with more than one individual’s testing session when necessary. Once the 
questionnaires were completed, the participants were thanked for their time and 
reminded of their participant codes, which would be used for feedback purposes.
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3.11 DATA ANALYSES
Statistical analyses were conducted using STATISTICA version 13 (Statistica©, 
Statsoft Inc). Descriptive statistics were carried out initially in order to obtain mean and 
standard deviation responses for all variables. Independent T-tests were then 
conducted on all variables to determine any significant differences between Black and 
Caucasian females. Cohen’s d formula was then used to determine the effect size of 
all variables. Correlational analyses were also carried out to assess for any significant 
relationships between different variables. All statistical hypothesis tests were set at a 
5% level of significance.
3.12 LIMITATIONS TO THE STUDY
Various limitations of this research project reduce the accuracy and applicability of the 
data obtained. The following factors should be taken into consideration:
Due to time and financial constraints, testing a large number of individuals was not 
possible. The sample size in the current study was relatively small, and was therefore 
not encompassing and entirely representative of the Makana district of the Eastern 
Cape. Therefore, conclusions drawn from this sample specifically may not be 
indicative of trends for the whole province, or country as a whole.
Due to the small geographical size of the Makana region, selecting a narrow age range 
would have substantially reduced the number of participants viable for participation. 
Therefore, a broader age range encompassing women of adult reproductive age (18­
50 years) was chosen. However, due to the notable effect of age on cardiovascular 
disease risk, this was a limitation as the age effect was not accounted for.
The use of self-reporting questionnaires required participants to answer as honestly 
as possible. Every effort was made to emphasize the need for honesty and accurate 
reporting, and participants were reminded that their responses would remain 
confidential, however, this could not have been objectively controlled. Thus, it is 
possible that this may have affected the accuracy of the data. Despite this limitation 
however, it is accepted that physical activity questionnaires and other self-report 
instruments such as food recall diaries remain the most practical when assessing 
larger samples in epidemiological studies (Richardson et al., 2001).
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Of the 166 participants in the study, only 95 participants returned completed food recall 
diaries (46 Caucasian and 49 Black). This greatly reduced the accuracy of the dietary 
results, particularly with respect to correlations between dietary data and other factors. 
As a result, correlations with dietary data were excluded from analyses.
Language barriers between the researcher and participants may have hindered the 
accuracy of the results obtained. The primary researcher and research assistants were 
English mother tongue speakers, while the Black participants were all Xhosa mother 
tongue speakers. Despite ensuring that all participants were able to read and 
understand basic English, the extent of English language proficiency was not 
ascertained, therefore likely impacting the accuracy of data obtained. Nevertheless, 
the use of a Xhosa-speaking interpreter was made, who was present and assisted 
during all testing sessions. Questionnaires were also translated into Xhosa in an 
attempt to overcome language barriers.
Due to financial constraints, glucose and insulin concentrations were not able to be 
assessed in this study. Thus, insight into insulin resistance and type II diabetes 
prevalence in this study was not ascertained.
Due to equipment malfunction, it was not possible to conduct Bioelectrical Impedance 
on participants in this study. Therefore body fat percentage was not measured.
64
CHAPTER IV -  RESULTS
Risk factors have been grouped into three categories: 1) obesity, classified as 
‘morphological risk’; 2) hypertension classified as ‘cardiovascular (CV) risk’; and 3) 
diet, physical activity, smoking and alcohol use, classified under ‘lifestyle-related risks’.
4.1 DEMOGRAPHIC INFORMATION
Table 12: General demographic and socioeconomic characteristics of participants.
Caucasian Black
Age (years) 33.88 (± 12.19) 39.67 (± 11.79)
Gross monthly income (ZAR) R17242.31 (± 10834.93)** R4710.61 (± 2671.84)**
Education (years) 17.05 (± 2.80)** 11.66 (± 2.10)**
(**) denotes significant difference (p < 0.01)
In addition to being urban working individuals, participants were age-matched with no 
significant difference (p>0.05) between groups (Table 12). However, there were 
significant differences (p< 0.01) with both education levels and gross monthly income 
between groups. Caucasian women in this sample reported a gross monthly income 
3.66 times higher than the Black women (d=1.69). Despite this, as well as a larger 
standard deviation within the Caucasian cohort however, coefficients of variation 
(62.84% and 56.72% respectively) indicate that the disparity in earnings within both 
groups is similar.
Caucasian women in this sample are also significantly (p<0.01) more educated than 
the Black females, having spent an average of 17.05 (± 2.80) years in formal education 
as compared to 11.66 years (± 2.10) (d=2.21) (Table 12).
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Figure 4: Levels of completed education (%).
Of the Caucasian females, 92% completed tertiary education with the average number 
of years spent in formal education being 17.05 years (± 2.80). This equates to 
approximately 12 years of schooling and five years of Tertiary education, with no 
participant having completed less than 12 years of formalized schooling. Black 
women, on the other hand, spent an average of 11.66 (± 2.10) years at school, with 
only 65% completing 12 years of formalized schooling. Of this 65%, only 10% went on 
to study at University. The remaining 36% did not complete high school.
4.2 MORPHOLOGICAL RISK
4.2.1 OBESITY
4.2.1.1 Stature, mass, Body Mass Index (BMI)
With the exception of stature, Black women demonstrated significantly (p<0.01) higher 
values for Mass, BMI, waist circumference, and waist-to-stature ratio than Caucasian 
females (Table 13).
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Table 13: Mean (±SD) anthropometric and morphological characteristics of 
participants.
Black Caucasian
Stature (cm) 156.74 (± 6.18) 164.55 (± 6.36)**
Mass (kg) 84.16 (± 21.62) 70.15 (± 13.44)**
BMI (kg.m2) 34.19 (± 8.07) 25.90 (± 4.67)**
WC (cm) 95.34 (± 16.77) 79.84 (± 10.81)**
WSR 0.61 (± 0.10) 0.48 (± 0.09)**
(**) denotes significant difference (p < 0.01)
Black women were significantly (p<0.01) heavier than their Caucasian counterparts 
(d=0.95) and subsequently had significantly higher BMI values (d=1.35). The BMI 
classification categorizes the Caucasian women as ‘overweight’ while the Black 
women are classified as ‘Obese class I (Figure 5).
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Figure 5: Mean (±SD) BMI classification.
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Noteworthy is that both groups lie close to the extremes of their respective BMI 
classification brackets. Black women, with a mean BMI of 34.19 kg.m2, fall just short 
of the ‘Obese II’ classification which begins at 35.00 kg.m2. Similarly the Caucasian 
women, with a mean BMI of 25.90 kg.m2, are just short of the ‘normal’ category which 
ends at 24.99 kg.m2.
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Figure 6: Percentage of participants falling within different BMI classifications.
Figure 6 represents the distribution of participants falling within the six different BMI 
classification categories. In the Caucasian group, the majority of participants fell within 
the ‘normal’ category, followed by ‘overweight’ and ‘obese I’. The Black group, 
however, had the majority of participants fall within the ‘obese III’ category, followed 
by ‘obese I’, and ‘obese II’. This highlights the inherent limitations of relying on mean 
data when individuals vary so greatly.
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4.2.1.2 Waist circumference (WC) and waist-to-stature ratio (WSR)
Black women had significantly (p<0.01) larger waist circumferences than the 
Caucasian women, with a mean of 95.34 cm (± 16.77) compared to 79.84 cm (±10.81) 
(d=1.09).
Figure 7: Mean (±SD) waist circumference of both groups.
With respect to waist circumference (WC) ‘cut-offs’, the Caucasian group are 
categorized as ‘not at risk’ while the Black women are classified as being at ‘high’ risk 
for cardiovascular disease. As with the relationship between weight and BMI, this 
measure similarly contributes to the significantly (p<0.05) higher WSR in the Black 
South African group (0.61) as compared to the Caucasian group (0.48). The 
Caucasian women are classified as ‘healthy’ (0.42 -  0.48) while the Black women are 
classified as being at ‘high risk’ for cardiovascular disease.
Both waist circumference and waist-to-stature results indicate that the majority of 
weight is centrally distributed in the Black group.
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4.3 CARDIOVASCULAR RISK
4.3.1 BLOOD PRESSURE
Systolic (SBP), Diastolic (DBP) and Mean Arterial Blood pressure (MAP) measures 
were significantly (p<0.05) higher in the Black compared to the Caucasian group (d = 
0.40; d = 0.50; d = 0.41, respectively). Nevertheless, with respect to blood pressure 
classifications, both groups presented with measures within the ‘normal’ range (Table 
14).
Table 14: Mean (±SD) blood pressure measures.
Black Caucasian
(n = 88) (n = 79)
SBP (mm Hg) 122 (± 18)* 116 (± 12)*
DBP (mm Hg) 77 (± 16)* 70 (± 11)*
MAP (mm Hg) 92 (± 16)* 86 (± 11 )*
(*) denotes significant difference (p < 0.05)
When isolating cases of ‘known hypertension’, 18% of the Black women reported 
previously known hypertension diagnoses, compared to 6% in the Caucasian cohort. 
Of these, all reported taking blood pressure lowering medication during the duration 
of this study. As a result, total mean blood pressure measures must be considered in 
this context.
The effect of participants taking hypertension medication during this study is 
noticeable, and not surprising as the efficacy of hypertension medication is well 
documented (Gu et al., 2012).
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Table 15: Mean (±SD) blood pressure measures.
Black ALL 
(n = 88)
Black (B-WHD) 
(n = 72)
Caucasian 
ALL (n = 
79)
Caucasian 
(C-WHD) 
(n = 74)
SBP (mm Hg) 122 (± 18)* 130 (± 15)** 116 (± 12)* 115 (± 12)**
DBP (mm Hg) 77 (± 16)* 83 (± 14)* 70 (± 11)* 69 (± 11)
MAP (mm Hg) 92 (± 16)* 98 (±14)* 86 (± 11 )* 85 (± 11)
(**) denotes significant difference (p < 0.01); (*) denotes significant difference (p<0.05); WHD = without hypertension diagnosis
Table 15 shows that among participants without hypertension diagnoses (WHD), the 
Black group again present with significantly (p<0.01) higher measures compared to 
the Caucasian group. In addition, the B-WHD group also present with significantly 
(p<0.05) higher measures compared to the entire (n = 88) Black group, placing this 
sub-sample at increased cardiovascular disease risk (SBP d=0.92; DBP d=1.21; MAP 
d=1.08). The Caucasian group, however, show no significant difference when 
comparing the entire groups’ data to the reduced sample (C- WHD) (Figure 7). 
According to established South African norms, the B-WHD group classifies as ‘pre­
hypertensive’ while the C-WHD group remain ‘normal’.
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Figure 8: Mean (±SD) blood pressure of participants with and without previous 
hypertension diagnoses.
4.4 LIFESTYLE-RELATED CHARACTERISTICS
Black females presented with significantly higher (p<0.05) self-reported physical 
activity levels and total energy intake per day (KJ) compared to the Caucasian sample. 
Caucasian females however, presented with significantly higher (p<0.05) self-reported 
cases of alcohol use and smoking (Table 16).
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Table 16: Self-reported lifestyle-related risks
Measure Caucasian Females Black Females
Active MET- 1828.27 ± 2238.10 2688.86 ± 1486.56*
minutes/week
Diet: Total energy intake 6401.19 ± 1796.47 7243.60 ± 1977.44*
(KJ/day)
Alcohol consumption 10.42 ± 19.21 0.92 ± 3.90**
(g/day)
Current smokers (%) 14 3*
(*) denotes significant difference (p < 0.05); (**) denotes significant difference (p<0.01); kJ = kilojoules
4.4.1 PHYSICAL ACTIVITY
4.4.1.1 Total active MET-minutes/week
Black females were significantly (p<0.05) more active than the Caucasian females, 
taking part in a mean total of 2688.86 (±1486.56) MET-minutes of activity per week as 
compared to the Caucasian mean total of 1828.27 (±2238.10) MET-minutes per week 
(d=0.46). However the high standard deviations, particularly in the Caucasian group, 
indicate large variation in baseline physical activity levels between groups.
According to the GPAQ physical activity classifications, ‘sufficient’ physical activity is 
defined as expending >3000 MET-minutes/week. Within the Black group, 45% 
reported being sufficiently active, while only 23% of the Caucasian group met this 
criterion. In contrast, 41% of the Black group reported being ‘minimally’ active (600 -  
<3000 MET-minutes/week), while 47% of Caucasian women reported being minimally 
active. Insufficient physical activity, classified as <600 MET-minutes/week, was higher 
in the Caucasian cohort (29% versus 13%) (Figure 8).
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Figure 8: Percentage of participants falling in GPAQ categories
Figure 8 represents the distribution of participants falling within the GPAQ activity 
classification categories. In the Caucasian group, the majority of participants fell within 
the ‘minimally active’ group, while in the Black group, the majority fell within the 
‘sufficiently active’ group, closely followed by the ‘minimally active’ group’. Between 
groups, there was a significantly (p<0.05) greater percentage of ‘sufficiently active’ 
participants in the Black group (45%) compared to the Caucasian group (23%). 
Similarly, there was a significantly (p<0.05) greater percentage of ‘insufficiently active’ 
participants in the Caucasian group (29%) compared to the Black group (13%). There 
was no significant difference found between the percentages of ‘minimally active’ 
participants in both groups.
4.4.1.2 Transport-related physical activity
Of the total mean active MET-minutes/week, the Black group reported a significantly 
(p < 0.01) higher percentage attributed to walking to and from work compared to the 
Caucasian group (d=0.69). In the Black group, 15% of total activity was attributed to
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walking to and from work (415.68 ± 588.21) while only 5% was attributed to walking to 
and from work in the Caucasian group (95.13 ± 271.28).
Within the Black group, 45% of participants reported walking for more than 10 minutes 
continuously to get to and from work every day, while 55% reported using motorized 
transport. In the Caucasian group, 15% reported walking to and from work every day 
while 85% reported driving to and from work (Figure 9).
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Figure 9: Adoption of transport modes.
Despite the preference for motorised transport in both groups, a significantly (p<0.01) 
larger percentage of total active MET-minutes/week were attributed to walking in the 
Black group compared to the Caucasian group (45% and 15%, respectively).
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4.4.1.3 Seated MET-minutes
Figure 10: Mean total seated MET-minutes/week.
Caucasian females spent significantly (p<0.05) more time sitting than the Black 
females, reporting a mean total of 3384.05 (±1264.12) seated MET-minutes/week 
versus 1952.05 (±1286.73) seated MET-minutes/week (d=1.12) (Figure 10). Large 
standard deviations however, indicate variance within both samples.
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4.5 DIET
Black females consumed significantly (p<0.05) more kilojoules (7243.60 ± 1977.44) 
per day than the Caucasian females (6401.19 ± 1796.47) (d=0.45) (Figure 9).
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Figure 11: Mean (±SD) total energy intake (kJ) per day.
Figure 11 shows the significant difference in mean kJ intake between groups per 
day. Both groups reported consuming less than the standard recommendation for 
females of 8,700kJ (or 2000cal) per day.
When analysing macronutrient composition, carbohydrates (CHO) were shown to 
contribute the bulk of total dietary intake in both groups (Figure 12).
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Figure 12: Macronutrient composition.
Figure 12 shows that for both groups, over half of the daily macronutrient intake was 
composed of carbohydrates. However in the Black group, the carbohydrate intake 
approximates two-thirds of total intake, while in the Caucasian group it approximates 
half of total intake (64% and 52%, respectively). The remaining intake was divided 
almost equally between protein and fat in the case of both cohorts.
In addition to consuming significantly more total kilojoules and carbohydrates 
(d=1.05), Black females consumed significantly (p<0.05) more polyunsaturated fat 
(d=0.70) and total sugar (d=0.55), while Caucasian females consumed significantly 
(p<0.05) more total protein (d=0.46) and trans fats (d=0.52) (Table 17).
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Table 17: Mean (±SD) daily consumption of selected dietary components.
Caucasian Black
TOTAL PROTEIN (g) 69.42 ± 29.65 58.45 ± 17.30*
CARBOHYDRATES (CHO) (g) 141.82 ± 55.60 214.93 ± 80.32**
TOTAL FAT (g) 64.26 ± 22.65 61.73 ± 21.24
Saturated fat (g) 22.23 ± 9.03 18.44 ± 8.10
Monounsaturated fat (g) 21.38 ± 9.48 19.08 ± 7.11
Polyunsaturated fat (g) 12.35 ± 6.75 17.49 ± 7.95*
Trans fat (g) 1.61 ± 1.28 1.06 ± 0.80*
TOTAL SUGAR (g) 35.02 ± 15.00 46.72 ± 24.14*
(*) denotes significant difference (p<0.05); (**) denotes significant difference (p<0.01).
These differences in polyunsaturated and saturated fat consumption between groups 
is likely associated with the types of cooking fats predominantly used within each 
group (Figure 13).
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Figure 13: Cooking fat preferences.
Figure 13 shows that the majority of the Black females reported using vegetable oil as 
their primary cooking fat (85%). This is followed by 8% who reported using margarine 
and 6% who reported using butter. In the Caucasian sample however, more of a 
distribution is evident. The majority of participants in this group reported using olive oil 
as their primary cooking fat (35%), and this is closely followed by the use of vegetable 
oil (30%). The remaining participants reported using butter (20%), coconut oil (11%), 
and only 4% used margarine.
Table 18: Classification of cooking fats according to chemical structure.
Polyunsaturated fats Monounsaturated
fats
Saturated fats
Vegetable oil Margarine Olive oil Butter and ghee Coconut oil
Caucasian 34% 35% 31%
Black 93% 0% 7%
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When classifying these five household cooking fats as ‘monounsaturated fats’, 
‘polyunsaturated fats’, and ‘saturated fats’, it is evident that Black women used 
polyunsaturated fats almost exclusively (93%), while the Caucasian women did not 
show such a distinct tendency (Table 18).
4.6 SMOKING AND ALCOHOL CONSUMPTION 
4.6.1 SMOKING
Figure 14: Percentage of participants in both groups who currently smoke.
Significantly (p<0.05) more Caucasian females reported being smokers (14%) than 
Black females (3%). Nevertheless, the majority of the participants in this study were 
non-smokers.
81
100
o'
CDO)
CO
CD
CL
90
80
70
60
50
40
30
20
10
0
Currently smoke Smoke daily
I
Used to smoke Do not smoke
■ Black
■ Caucasian
Figure 15: Past and current smoking habits.
Figure 15 shows that while there were more current and past smokers in the 
Caucasian group, the majority of both groups reported being non-smokers. As a result, 
it is unlikely the smoking is a prevalent contributor cardiovascular disease risk in these 
sample groups.
4.6.2 ALCOHOL CONSUMPTION
Alcohol consumption was significantly (p<0.05) higher in the Caucasian sample 
(10.46g ± 19.21) compared to the Black sample (0.92g ± 3.90) (d=0.73). (Figure 16).
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Figure 16: Mean (±SD) alcohol consumption (g) per day.
Figure 16 shows that the Caucasian sample consumed significantly (p<0.05) more 
alcohol (g) per day, however the standard deviations indicate large variance within 
and between both samples.
In addition to consuming more alcohol per day, the majority (91%) of the Caucasian 
sample reported consuming alcohol within the last 12 months while surprisingly, in 
the Black sample, the majority (51%) reported having never consumed any alcoholic 
beverage (Figure 17).
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Figure 17: Frequency of alcohol consumption over the past 12 months.
The majority of Caucasian women reported consuming alcohol within the last 12 
months (91%). Conversely, the majority of Black females reported never having 
consumed alcohol (51%).
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Figure 18: Frequency of alcohol consumption.
When assessing the alcohol consumption of those participants who had consumed 
within the past 12 months, the majority of the Black women (57%) reported consuming 
alcohol ‘less than once a month’ while the Caucasian women reported mostly 
consuming between ‘1-3 days a month’ (35%) and ‘1-4 days a week’ (33%) (Figure
18).
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4.7 CO RRELATIONS
4.7.1 SOCIOECONOMIC FACTORS
The strength of relationships was determined using the correlation coefficient (r): r < 
.40 = weak; r .40 - .60 = moderate; r > .60 = strong.
Table 19: Correlations between socio-economic variables and CVD risk conditions.
Body mass BMI WC W SR MAP Total active 
MET-m inutes
C B C B C B C B C B C B
Education
(years)
r= -0.15 
r2= 0.02
r= -0.13 
r2= 0.17
r= -0.17 
r2= 0.29
r= -0.18 
r2= 0.32 o
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CO r= -0.20 
r2= 0.04 o
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CO r= -0.24 
r2= 0.58
r = -0.08 
r2= 0.01
r = -0.24 
r2= 0.58
r = -0.07 
r2= 0.01
r = -0.35 
r2= 0.12
Income
(R/month)
r= -0.13 
r2= 0.17
r= -0.09 
r2= 0.01
r= -0.16 
r2= 0.03
r= -0.08 
r2= 0.01 o
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r2= 0.01 o
 
o
 
o
 
o
 
o
 -»
■ r= -0.01 
r2= 0.00
r= 0.03 
r2= 0.00
Red indicates significance (p<0.05); C = Caucasian; B = Black; BMI = Body Mass Index; WC = Waist
Circumference; WSR = waist-to-stature ratio; MAP = mean arterial pressure.
Negative relationships were found between education level and each of the risk 
conditions outlined in Table 19. However, these relationships are weak with the only 
significances being with education and WSR, MAP, and total active MET-minutes in 
the Black group. In addition, low r2 values indicate that the predictability of one variable 
from another were poor. Weak negative relationships were also found between 
monthly income and risk conditions, however none were significant.
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4.7.2 PHYSICAL MEASURES
Table 20: Correlations between cardiovascular risk conditions (Caucasian; Black).
Mass BMI WC WSR MAP
Mass r=0.91 r2=0.83 r=0.85 r2=0.72 r=0.63 r2=0.40 r=0.41 r2=0.17
BMI r=0.95 r2=0.90 r=0.85 r2=0.72 r=0.87 r2=0.76 r=0.36 r2=0.13
WC r=0.91 r2=0.83 r=0.92 r2=0.85 r=0.96 r2=0.92 r=0.39 r2=0.15
WSR r=0.84 r2=0.71 r=0.92 r2=0.85 r=0.97 r2=0.94 r=0.22 r2=0.05
MAP r=0.43 r2=0.18 r=0.44 r2=0.19 r=0.43 r2=0.18 r=0.42 r2=0.18
(*) denotes significance (p<0.05); BMI = Body Mass Index; WC = Waist Circumference; WSR = Waist-to-stature ratio; MAP = 
Mean Arterial Blood Pressure
Table 20 shows significant positive correlations between all risk conditions except for 
WSR and MAP in the Caucasian group. In addition, the relationship between all risk 
conditions except for MAP, were strong (r>0.6). This supports the evidence 
highlighting the prevalence of co-occurring risk conditions, leading to increased risk of 
metabolic syndrome.
4.7.3 LIFESTYLE
4.7.3.1 Physical Activity
Table 21: Correlations between physical activity variables and CVD risk conditions.
Body mass BMI WC WSR MAP
C B C B C B C B C B
Total active 
MET- 
minutes
r= -0.17 
r2= 0.03
r= -0.03 
r2= 0.00
r= -0.12 
r2= 0.01
r= -0.01 
r2= 0.00
r= -0.24 
r2= 0.58
r= 0.02 
r2= 0.00
r= -0.19 
r2= 0.04
r= 0.04 
r2= 0.00
r = -0.11 
r2= 0.01
r = 0.29 
r2= 0.08
Seated
MET-
minutes
r= -0.03 
r2= 0.00
r= -0.12 
r2= 0.01
r= -0.05 
r2= 0.00
r= -0.15 
r2= 0.01
r= -0.05 
r2= 0.00
r= -0.16 
r2= 0.03
r= -0.01 
r2= 0.00
r= -0.18 
r2= 0.03
r= -0.20 
r2= 0.04
r= -0.38 
r2= 0.14
Red indicates significance (p<0.05); C = Caucasian; B = Black; BMI = Body Mass Index; WC = waist circumference; WSR = 
waist-to-stature ratio; MAP = mean arterial pressure.
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No strong relationships were evident between physical activity variables and CVD risk 
conditions, despite significance in some (Table 21). In the Black group, significance 
was found between total active MET-minutes and MAP, as well as seated MET- 
minutes and MAP. This was not mirrored in the Caucasian group where there was no 
significance.
4.7.3.2 Diet
Due to the limitations with respect to dietary data recall, correlations using dietary 
variables were excluded from analysis.
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CHAPTER V - DISCUSSION
Following the format of Chapter IV, this Chapter discusses the results according to the 
following three categories: 1) obesity, classified as ‘morphological risk’; 2) 
hypertension classified as ‘cardiovascular (CV) risk’; and 3) diet, physical activity, 
smoking and alcohol consumption classified as ‘lifestyle-related risks’. Owing to the 
interlinking of various risk factors and the need for combined discussion, however, the 
order changes in some instances to allow for an integrated and coherent 
understanding of the results.
5.1 SOCIOECONOMIC STATUS
Socio-economic results pertaining to education levels and gross monthly income 
showed large disparities between groups; Black women were significantly less 
educated, and earned less (Table 12). These findings were supported by the effects 
sizes, indicating the large difference between groups (d=1.69 and d=2.21, 
respectively). With respect to education, this is a largely expected finding as the 
prevailing lack of funding and resources allocated to public education in the Eastern 
Cape disproportionately affects the poorest populations (DHS, 2003; WHO, 2016).
Looking at disparities in income, this is largely attributed to the type of work the 
participants did. Within the Black sample, most individuals were domestic workers, 
kitchen assistants, or cleaners working as Rhodes University. This type of work is 
classified as ‘basic skills’ work which does not require any specific training or 
education after school, and subsequently yields low income (DHS, 2003). This 
coincides with the simultaneous low education levels of this group. In the Caucasian 
group the type of work was more varied, however the majority of women held graduate 
jobs in the business sector. Due to the education levels required to attain these types 
of jobs, they typically yielded a higher income.
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5.2 M O RPHO LO G ICAL RISK
5.1.2 OBESITY
5.1.2.1 Mass and Body Mass Index (BMI)
Black women were significantly (p<0.01) heavier than the Caucasian women resulting 
in significantly (p<0.01) higher BMI values classifying them as obese (34.19 kg/m2 and 
25.90 kg/m2. Similarly, effect sizes showed a large difference between groups for both 
measures (d=0.95 and d=1.35 respectively). This finding is supported by Goedecke et 
al. (2009) and van der Merwe and Pepper (2006) who similarly found that Black South 
African females were significantly heavier and had higher BMIs than their Caucasian 
counterparts. In addition, extensive research suggests that Black South African 
women are the most obese population in South African- a finding attributed to both 
low socio-economic status and sociocultural beliefs surrounding the perceived 
desirableness of excess body fat (van der Merwe & Pepper, 2006; Goedecke et al., 
2009; Tibazarwa et al., 2009; Jackson et al., 2010; Walter & Durandt, 2011 Goedecke 
et al., 2015; South African Heart and Stroke Foundation, 2016).
Literature from 2006 found that 31 -34% of Black South African women and 18-24% of 
Caucasian women were obese countrywide (BMI>25.00 kg/m2) (van der Merwe & 
Pepper, 2006). The current study, however, found that 69% of Black women and only 
16% of Caucasian women were obese. This discrepancy is likely owing to the fact that 
the current study was localized to the Makana region of the Eastern Cape, while the 
former study was conducted across all provinces.
This is evidenced, in part, by region-specific data from the 2003 Demographic Health 
Survey (DHS) indicate that obesity rates vary considerably between provinces (Table 
22).
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Table 22: Provinces ranked according to obesity prevalence in adult South African 
women (DHS, 2003).
Provinces Obesity Prevalence
Eastern Cape 31.9%
Western Cape 30.3%
Gauteng 30.1%
Mpumalanga 28.0%
Free State 26.2%
Kwazulu Natal 24.5%
North West 24.4%
Northern Cape 24.2%
Limpopo 21.8%
Table 22 shows that the Eastern Cape had the highest percentage of obese women, 
followed closely by the Western Cape and Gauteng. In-line with previous findings, the 
2003 DHS also indicated that Black women accounted for the majority of obese 
women across all provinces (55.0%).
As highlighted in Table 22, obesity prevalence in Black women in the Eastern Cape 
was approximately 31.9% in 2003. More recent data, however, shows a much higher 
percentage: a study conducted on Black males and females in the Makana region of 
the Eastern Cape found that 81% of the female population were obese (Jackson et 
al., 2010) while the current study found that 69% of females in the same region were 
obese. However, these studies focused on a small sub-sample of the Eastern Cape 
population, thus the findings are likely not representative across the entire province. 
Nevertheless, both studies show an obesity prevalence markedly higher than 
provincial data, suggesting that this specific sub-sample of Black females are more 
obese than the rest of the province. In part, this may be attributed to socioeconomic 
factors as it is well documented that a negative relationship between socioeconomic 
status and obesity levels exists (Vorster et al., 2002; Kruger et al., 2005; DHS, 2003; 
WHO, 2016). However, the current study showed no significance in the relationships 
between socioeconomic factors and obesity markers, despite the relationships being 
negative (Table 19). A further consideration is that the majority of Black females in
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both studies were employed by an institution which provided meals for their 
employees. Although the nutrient composition of these meals was not evaluated, it is 
possible that these meals were high in energy and low in nutritional value, leading to 
overconsumption and subsequent weight gain in this group. A deeper look into diet as 
well as other contributing lifestyle factors will be addressed later on in this chapter.
To the author’s knowledge, limited research on obesity prevalence in South African 
Caucasian women exits. Nationwide data from 2003, however, showed that the mean 
BMI of Caucasian South African women was 25.00 kg/m2, and 14% were obese (DHS, 
2003). Conversely, one regional study in the North West province found that the mean 
BMI of Caucasian women was 28.50 kg/m2, and 30.4% were obese (Schutte & Olkers, 
2006). The current study, however, mirrored the results of the 2003 DHS study where 
mean BMI was 25.90 kg/m2 and 16% of Caucasian women were obese. As Caucasian 
female populations in South African typically do not present with high obesity 
prevalence, this may account for the lack of research in this area.
5.2.1.2 Waist Circumference and Waist-to-Stature ratio
Black women had significantly (p<0.01) larger waist circumferences than Caucasian 
women (95.34 cm and 79.84 cm), with a large between-group effect size (d=1.09).This 
is indicative of central obesity (WC > 80 cm) and a ‘high’ risk classification for 
cardiovascular disease (WC > 88 cm) in the Black women (Figure 7). The Caucasian 
women, however, presented with no central obesity and a ‘low’ risk classification for 
cardiovascular disease.
As with body mass and BMI results, this finding is supported by data from 2003 
showing that Black South African women had larger waist circumferences than 
Caucasian South African women countrywide (84.6 cm and 80.2 cm, respectively) 
(DHS, 2003). DHS data also showed that 34.7% of women in the Eastern Cape 
exceeded the 88 cm cut-off for ‘high’ CVD risk, and that Black women accounted for 
two thirds of this percentage (66.3%).
The current findings, nevertheless, appear to be in direct conflict with studies by 
Weinsier et al. (2001) and Jennings et al. (2008) who found that Caucasian women 
had higher levels of visceral (central) adiposity compared to Black women. The 
Weinsier et al. (2001) study, however, was conducted on 46 America participants (23
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of Black African descent and 23 Caucasian).It is, thus, not directly comparable to the 
current study. In addition, contrary follow-on research by Goedecke et al. (2015) found 
that Black South African women had significantly (p<0.05) larger waist circumferences 
than Caucasian females. Upon further analysis, however, body fat distribution results 
showed that the Black women had less visceral adipose tissue and more 
subcutaneous adipose tissue than Caucasian females (Goedecke et al., 2015). This, 
therefore, placed the Caucasian women at higher CVD risk despite their lower relative 
waist circumference measures. Thus, although the current findings appear to be 
contradictory at first glance, the waist circumference findings are similar albeit the 
different interpretation of associated risk. The Goedecke et al. (2015) study 
subsequently concluded that waist circumference measures alone, while useful 
surrogates, were not accurate in determining fat mass distribution and thus should be 
interpreted with caution.
Waist-to-stature ratio (WSR) was used in this study in addition to waist circumference 
measures. This was due to the proposed limitations associated with waist 
circumference measures alone, particularly when comparing populations with varying 
statures. As with waist circumference, waist-to-stature results showed that Black 
women were classified as at ‘high risk’ for cardiovascular disease (0.61) while the 
Caucasian women were classified as ‘normal’ or healthy’ (0.48). These ratios were 
calculated according to the Ashwell Shape Chart® outlined in Chapter 3, pp. 57. 
Despite the limitations associated with waist circumference measures alone, in this 
study, both the waist circumference and waist-to-stature results indicated high 
cardiovascular disease risk in the Black women compared to the Caucasian women.
5.3 CARDIOVASCULAR RISK
5.3.1 BLOOD PRESSURE
Black women presented with significantly (p<0.05) higher systolic, diastolic, and mean 
arterial blood pressure than the Caucasian women. Both groups, nevertheless, 
presented with ‘normal’ mean blood pressure readings (Black women: 122/77 mm Hg 
and Caucasian women: 116/70 mm Hg). In addition, the effect size was moderate 
(d=0.40; d=0.50; d=0.41, respectively). This finding supports nationwide data from 
2003 where Black South African women had a mean blood pressure of 121/75 mm Hg 
and Caucasian South African women, 120/75 mm Hg (DHS, 2003). The current
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findings are, however, contradictory to the bulk of previous literature highlighting the 
disproportionately high prevalence of hypertension in Black females (Cappuccio, 
1997; Forrester, 2004; Kearney et al., 2005; Norman et al., 2007; Walter & Durandt, 
2011; Crymble et al., 2014; South African Heart and Stroke Foundation, 2014).
A more in-depth analysis into the current study revealed a likely explanation. Isolating 
the cases of ‘known hypertension’ revealed that 18% of Black women reported 
previously known hypertension diagnoses, compared to 6% in the Caucasian group. 
More importantly, 100% of all previously diagnosed participants, Black and Caucasian, 
reported taking blood pressure lowering medication for the duration of the study. 
Consequently, the results showed that Black women without previous hypertension 
diagnosis presented with a mean blood pressure of 130/83 mm Hg, placing them 
within the ‘pre-hypertensive’ classification category (Table 4; Figure 5). This was a 
significantly (p<0.05) higher result compared to the total mean finding of 122/77 mm 
Hg in this group, and highlights the increased risk within this sub-sample. This finding 
is supported by a large between-group effect size (d=1.086). Unlike the Black women 
however, the Caucasian women showed no significant difference between the total 
group (116/70 mm Hg) and the sub-group of participants without previously diagnosed 
hypertension (115/69 mm Hg).
This finding highlights the importance of conducting health research within the context 
of existing health conditions and diseases. The 2003 nationwide DHS findings stating 
that both Black and Caucasian South African females had ‘normal’ blood pressures 
did not account for those who were already diagnosed and on medication. Results 
from the DHS study, therefore, likely represented an inaccurate picture of hypertension 
risk. Jackson et al. (2010) similarly found that Black females were classified as ‘pre­
hypertensive’ after accounting for those who were previously diagnosed, which 
supports the findings of the current study.
Previous literature suggests that obesity is a powerful contributor to hypertension in 
Black women, thus, it is postulated that raised obesity levels within the current Black 
female sample may account for increased hypertension risk (Schutte et al., 2006; 
Norman et al., 2007; Tibazarwa et al., 2009; WHO, 2011). The relationship between 
obesity and hypertension in this study will be addressed in more detail below.
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5.4 CORRELATIONS BETWEEN CVD RISK CONDITIONS
All five measured CVD risk conditions (Mass, BMI, WC, WSR, and MAP) showed a 
significant positive correlation in both groups, except for WSR and MAP in the 
Caucasian group (Table 20). This supports the evidence surrounding the clustering of 
conditions evident in the development of the metabolic syndrome or ‘syndrome X’ 
(Reaven, 2005). The most recent diagnostic criteria, however, for metabolic syndrome 
include the presentation of three or more of the following five conditions: central 
obesity (WC > 88 cm), Hypertension (BP > 130/85 mm Hg), high triglycerides (>1.7 
mmol.l-1), low HDL cholesterol (< 1.29 mmol.l-1) and fasting hyperglycaemia (fasting 
plasma glucose >5.6 mmol.l-1). The current study only included obesity and 
hypertension measures, thus, the prevalence of metabolic syndrome is not possible 
to ascertain in the population studied.
Positive significant relationships, nevertheless, are evident between obesity 
surrogates (Mass, WC, and WSR), and MAP in both groups, highlighting the link 
between obesity and hypertension (Black: r2=0.18, r2=0.18, r2=0.17, and Caucasian: 
r2=0.16, r2=0.15, r2=0.05) (Table 9, pp x). In addition, both groups expressed strong, 
positive and significant relationships between waist circumference and waist-to- 
stature ratios (Black, r2=0.94, Caucasian, r2=0.92), suggesting that the two measures 
are intrinsically linked despite the proposed limitations of such surrogates. Body fat 
distribution was, however, not measured in this study. The validity of these surrogates 
as obesity markers was, therefore, not ascertained.
5.5 LIFESTYLE
5.5.1 PHYSICAL ACTIVITY
Black women were significantly (p<0.05) more active than the Caucasian females, 
taking part in 2688.86 MET-minutes/week compared to 1828.27 MET-minutes/week 
However, the effect size was only moderate (d=0.46). Both groups, however, were 
equally classified as ‘minimally active’, which is defined as taking part in 600-3000 
M ET-minutes/week.
In comparison to national data, however, both Black and Caucasian women in this 
study appeared to be notably more active (DHS, 2003). In 2003, 66.0% of Black 
females and 66.8% of Caucasian females were inactive, while only 12.4% of Black
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females and 10.8% of Caucasian females were sufficiently active. Conversely in the 
current study, 13% of Black females and 29% of Caucasian females were inactive, 
while 45% of Black females and 23% of Caucasian females were sufficiently active. 
The DHS (2003) further reported that physical inactivity was higher in urban 
individuals, and linked this to increased risk of CVD within Black South African 
females.
The current data do not appear to match this trend, however, it is noteworthy that 
urban national data encompasses individuals from both the business sector as well as 
the informal sector. The inclusion of office-bound individuals within the ‘urban black’ 
cohort may have impacted on physical activity scores as the majority of participants in 
this study were involved in more active jobs (cleaning or kitchen assistance). This is 
supported by a study conducted on Black males and females in the Makana region of 
the Eastern Cape where 42.4% of the Black females were sufficiently active, and 
14.4% were inactive (Jackson et al., 2010); findings nearly identical to those in the 
current study (45% active, 13% inactive). Within the Caucasian cohort, however, 
females in the current study were found to be more active than average national 
scores, despite the fact that they were mostly office workers.
Nevertheless, it is noteworthy that exercise intensity; a key factor in determining the 
health benefits associated with regular exercise, was not measured in this study. It is 
well documented that in order to benefit from the effects of physical activity, a certain 
threshold or intensity of regular exercise is required (Blair et al., 2004; WHO, 2010; 
Garber et al., 2011). Despite some variations, it is generally accepted that adults 
should accumulate 30 minutes of moderate-intensity cardiorespiratory exercise on 
most, but preferably all days or the week to reap the health benefits associated with 
regular exercise (Blair et al., 2004; Garber et al., 2011). The current study however 
used MET-minutes as the unit for expenditure; a measure encompassing the product 
of intensity and time. Thus when comparing total MET-minutes between groups, it is 
possible that the Black women engaged in low physical activity levels spanning a great 
amount of time, which could result in a high number of total active MET-minutes. This 
low intensity exercise might therefore not have met the recommended exercise 
intensity guidelines despite being maintained over a long period of time. Subsequently, 
this could place the group as insufficiently active. Conversely, the Caucasian women 
may have engaged in higher exercise intensities in short bursts, leading to lower total
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MET-minutes, but nevertheless meeting the recommended guidelines categorizing 
them as sufficiently active. Therefore the findings of this study may have inaccurately 
reported on physical activity levels due to the absence of exercise intensity measures, 
and should thus be interpreted with caution.
When comparing domains of exercise, findings from this study are once again 
inconsistent with national findings. Although work and leisure-related physical activity 
were not differentiated between in this study, transport-related physical activity was 
found to be significantly higher in the Black females compared to Caucasian females 
(15% and 5%, respectively) with a moderate effect size (d=0.70). National data from 
2003, however, showed that both Black and Caucasian females attributed 
approximately 30% for their weekly physical activity expenditure to transport (30.6% 
and 29.0% respectively). However, this discrepancy is likely due to the fact that the 
current study was conducted in Grahamstown; a geographically small town spanning
65.1 km2 (Google maps). In comparison to larger cities in South Africa (Johannesburg, 
334.81 km2), it is expected that travel time will be substantially lower in smaller towns 
such as Grahamstown.
With respect to seated MET-minutes/week, Caucasian females spent significantly 
more time sitting (3384.05 MET-minutes/week and 1952.05 MET-minutes/week, 
respectively) and the between-group effect size was large (d=1.12).This was an 
expected finding as the majority of Caucasian women were office workers. 
Nevertheless, Caucasian women in this study were significantly more active than 
reports from 2003 (DHS, 2003), suggesting that leisure time physical activity was likely 
high in this sample. Additionally, this supports the postulation that Caucasian women 
may have exercised at a higher intensity to their Black counterparts.
5.5.2 PHYSICAL ACTIVITY AND SOCIOECONOMIC STATUS
Throughout literature, it is well documented that a positive relationship between 
socioeconomic status and physical activity levels exists (DHS, 2003; McVeigh et al., 
2004; Wilson et al., 2004; Walter & Durandt, 2011; WHO, 2016). This is typically 
attributed to 1) the financial costs associated with many types of sports or activities 
such as membership fees, equipment, and gear, and 2) the lack of education 
surrounding the health benefits of regular physical activity (DHS, 2003). Therefore, in 
accordance with the large disparities in socioeconomic status between groups in this
97
study, it was expected that the Caucasian women would be more physically active 
than the Black women. This, however, was not the case, and the opposite was found: 
within the Black group, a weak but significant negative relationship between education 
level and total MET-minutes/week was found (r2=0.12) and no relationship was evident 
in the Caucasian sample (Table 19, pp. 86). This confounding finding, however, could 
be explained by the fact that physical activity levels may have been inaccurately 
measured within this study. Further studies should incorporate measures of exercise 
intensity as this will highlight whether or not participants are meeting the 
recommended dosage necessary to obtain the health benefits of exercise.
5.5.3 PHYSICAL ACTIVITY AND CVD RISK CONDITIONS
No strong relationships were evident between physical activity variables and CVD risk 
conditions, despite significance in some (Table 21). In particular, no reduction in CVD 
risk conditions was evident in the Black group, who were classified as more physically 
active.
This supports the postulation that physical activity may have been inaccurately 
represented in this study, such that Black women may have been engaging in exercise 
at an intensity too low to from which to receive the health benefits. Alternatively, these 
findings may suggest that other external or lifestyle factors may be negating the 
positive effects of physical activity in this group.
5.4 DIET
Due to the limited number of completed food dairies recalled, dietary analyses were 
done on a smaller sub-sample of participants. This subsequently led to the exclusion 
of correlational analyses with dietary data, as relationships were not able to be 
assessed.
It is widely accepted that the average recommended daily energy intake for females 
is approximately 8700KJ (or 2000kcal) per day (FBDG-SA, 2013). According to this 
criteria however, both Black and Caucasian females consumed notably less than the 
recommended daily amount (Figure 11). In fact, Black females consumed nearly 
1500KJ less (1457KJ) and Caucasian women, nearly 2500KJ less (2299KJ). 
Nevertheless, the between-group effect size was moderate (d=0.45). This was a 
surprising result, particularly due to the high prevalence of obesity the Black sample.
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However, literature suggests that such inconsistencies may be due to inaccurate and 
under-reporting of energy intake, as this is known to pose challenges in dietary-related 
research (Mendez et al., 2004; Jackson et al., 2010). Such under-reporting is often 
attributed to two main factors: 1) people are typically not used to recording everything 
they consume and thus can be inaccurate, and 2) many people feel ashamed or 
insecure about their dietary choices and thus tend to over report the healthier foods, 
and underreport unhealthy foods (Mendez et al., 2004). In this study, it is likely that 
both of these factors played a part; however inaccurate reporting due to unfamiliarity 
is postulated to have been more of a factor in the Black group than the Caucasian 
group. This is because many of the Caucasian females expressed having done some 
form of food recall before, which is a common component of many formalized weight 
management programmes (www.myfitnesspal.com; www.fatsecret.co.za). 
Conversely, within the Black group, the majority of women had no previous experience 
in food recalls. Thus it is likely that this unfamiliarity may have led to inaccurate 
reporting. In addition to this, the language barriers would also have likely impacted the 
accuracy for the food recalls, as discussed in ‘Limitations to the Study’ pp. 63.
In addition, previous research shows that obese individuals are more likely to under­
report than overweight or normal weight individuals, although the exact reason why 
was not explored (Charlton et al., 2001; Vorster et al., 2002; Mendez et al., 2004; 
Jackson et al., 2010). One study conducted in the North West province found that 
obese Black women tended to under-report to the greatest extent (Vorster et al., 
2002). This was to such an extent that when under-reporters where were excluded 
from analyses, the power of the positive relationships between BMI and total energy 
intake increased (Vorster et al., 2002). This highlights the importance of assessing 
dietary data within the context of the limitations of self-reported data.
Macronutrient breakdown showed that Black women consumed significantly (p<0.05) 
more carbohydrates per day than Caucasian women (214.93 g/day and 141.82 g/day 
respectively) and the effect size was large (d=1.05). This accounted for 64% of total 
intake in the Black group, and 53% in the Caucasian group. Owing to the lower 
socioeconomic status of the Black females, this was an expected finding as 
carbohydrates are typically cheaper than foods high in protein or fat (FBDG-SA, 2013). 
Conversely, the higher protein intake in the Caucasian group (25% and 17%
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respectively) is attributed to the same reason, as protein-rich foods are typically the 
most expensive foods (FBDG-SA, 2013).
Second to carbohydrate intake, the biggest difference between groups was the total 
grams of added sugar consumed on a daily basis. Black South African women 
consumed an average of 46.72 g of sugar per day; nearly two times the recommended 
daily allowance of 25 g (FBDG-SA, 2013; American Heart Association, 2016). 
Caucasian women also consumed more sugar than the recommended daily 
allowance, although it was significantly (p<0.05) less than the Black females (35.02 
g/day). Nevertheless, the between-group effect size was moderate (d=0.578). 
Extensive research highlights the relationship between excessive sugar intake and 
obesity, thus it postulated that was a likely contributor to the high prevalence of obesity 
in Blacks females in this study (Puoane et al., 2006; Wolmarans & Danster, 2008; 
Jackson et al., 2010; FBDS-SA, 2013; South African Heart and Stroke Foundation, 
2016; WHO, 2016). As with carbohydrate intake, it is also postulated that increased 
sugar consumption is related to lower socioeconomic status, as sugar is a cheap and 
high source of energy which is readily available to those with lower income (Puoane 
et al., 2006; FBDG-SA, 2013; Wentzel-Viljoen et al., 2013). Additionally, lower 
education levels are also likely to be related as this results in less exposure to the 
dangers of excess sugar consumption from a young age (DHS, 2003; FBDG-SA, 
2013). Due to the limited number of food diaries recalled in the current study however, 
these direct correlations were not able to be obtained.
Nevertheless, these socioeconomic factors do not account for the high levels of sugar 
consumption in Caucasian females. It is therefore further postulated that within both 
groups, sugar intake may have exceeded the recommended daily allowance through 
the consumption of processed and packaged foods; a common constituent of the 
Westernized diet. It is well documented that sugar is added to many processed foods 
to extend the shelf-life, and this often results in people unintentionally consuming 
excess sugars (Taubes, 2008; Wentzel-Viljoen et al., 2013). The Food-Based Dietary 
Guidelines of South Africa (2013) state that ‘foods containing excess sugars and salts 
should be consumed sparingly’ (pp 1). While this advocates the reduced consumption 
of added sugars, it lacks sufficient detail pertaining to how much dietary sugar is in 
fact ‘too much’, and how much sugar in in certain common foods. This therefore
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highlights the need for education surrounding the dangers of consuming processed 
foods, as well as the need for detailed national dietary guidelines pertaining to this.
With respect to fat consumption, total fat intake was relatively similar between groups, 
despite the higher prevalence of obesity in Black females. Nevertheless, Black 
females consumed significantly more polyunsaturated fat than Caucasian females 
(17.49 g/day and 12.35 g/day) yet the effect size was only moderate (d=0.69). 
Furthermore, there was no significant difference between saturated fat intakes 
between groups (Table 17). These findings challenge the notion that saturated fat 
intake is the primary cause of obesity, as well as the notion that polyunsaturated fats 
are favourable (Krauss et al., 2000; Vorster et al., 2002; Taubes, 2008; American 
Heart Foundation, 2016). Due to exclusion of correlational dietary analyses however, 
this relationship was unfortunately not explored in this study.
5.5 SMOKING AND ALCOHOL CONSUMPTION
Significantly more Caucasian women reported being smokers than Black women, 
however percentage prevalence in both groups was small. National findings from 2003 
indicated that 5.1% of Black women and 26.7% of Caucasian women smoked, while 
this study found that only 3% of Black females and 14% of Caucasian females. This 
is in accordance with evidence highlighting the decline in smoking as a result of 
effective legislation aimed at reducing its desirability (DHS, 2003). Nevertheless, 
smoking prevalence in Black female populations particularly is consistently low 
throughout literature, thus it was an expected finding in the current study. In part, this 
is supported by an Eastern Cape based study conducted in 2010 similarly found that 
only 3% of Black females reported being smokers (Jackson et al., 2010). Additionally, 
smoking prevalence among women in the Eastern Cape was ranked third lowest in 
2003, thus it was expected that the current study would find a low prevalence in this 
Eastern Cape sample. Therefore, it is unlikely that smoking played an integral role in 
cardiovascular disease risk in these sample groups. Nevertheless, it is acknowledged 
that the data were self-reported, thus the accuracy of the results was not able to be 
tested. Due to the inherent limitations associated with self-reported data, as well as 
the tendency for under-reporting, the findings need to be interpreted with caution.
With respect to alcohol consumption, Caucasian females consumed significantly 
(p<0.05) more alcohol per day than Black females (10.46g and 0.92g, respectively)
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with only moderate between-group effect size (d=0.70). However, large standard 
deviations highlight pronounced inter-individual variance, suggesting that mean values 
may not give an accurate representation of alcohol consumption behaviours in these 
samples.
In part, this is evidence by differences in frequency of alcohol consumption within and 
between groups. The majority of Caucasian females reported consuming alcohol 
within the last 12 months (91%), and typically consumed alcohol weekly. Conversely, 
51% of Black females reported having never consumed alcohol before, and of those 
who had consumed in the past 12 months, average consumption was 1 to 3 times per 
month. This was an expected finding as previous literature indicates that abstinence 
is prominent in Black African females (Martinez et al., 2011). Nevertheless, it is 
acknowledged that these findings are drawn from self-reported data thus they may not 
be accurate.
In addition, the current study didn’t measure alcohol dependence. This is a limitation 
as the difference between the beneficial effects of moderate alcohol consumption 
versus the damaging effects of alcohol dependence were not differentiated between. 
Therefore the results need to be interpreted within this context.
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CHAPTER VI - SUMMARY, CONCLUSIONS AND RECOMMENDATIONS
6.1 MAIN FINDINGS AND CONCLUSIONS
The current findings confirm and emphasize the severity of obesity in Black women of 
the Eastern Cape. This is evidenced by the high percentage of Black females 
classified as obese, particularly severely obese. In addition, the high mean waist 
circumference and waist-to-stature ratios highlight the prevalence of central adiposity 
within this population group. Despite the limitations attributed to obesity surrogates 
such as BMI and waist circumference, in this sample, they provided a good indication 
of obesity prevalence. This is evidenced by the significant and strong correlations 
between BMI, weight, waist circumference, and waist-to-stature ratio in both groups.
Blood pressure findings showed that of those without previous hypertension 
diagnoses, Black females were classified as ‘pre-hypertensive’, while Caucasian 
females presented with normal blood pressures. In addition, a greater percentage of 
the Black females reported being previously diagnosed as hypertensive compared to 
the Caucasian females, thereby highlighting the high prevalence of hypertension in 
Black females.
Despite the fact that Caucasian females reported consuming more alcohol and 
smoking more than Black females, neither groups did so excessively. Thus the 
majority of cardiovascular disease risk in both groups was attributed to other factors 
perhaps including physical activity, diet, and socioeconomic status. Black females 
reported being more physical activity than Caucasian females, and attributed a greater 
proportion of their daily physical activity to transport. Conversely, Caucasian females 
reported spending significantly more time sitting than Black females. Nevertheless, 
lack of exercise intensity measures limited the interpretation of these findings and 
subsequent inferences thereof.
Dietary data also showed significant differences between groups, particularly with 
respect to carbohydrate, sugar, and fat consumption. Specifically, Black females 
consumed significantly more Kilojoules, carbohydrates, polyunsaturated fats, and 
added sugars than Caucasian females. Caucasian females, on the other hand, 
consumed significantly more protein and monounsaturated fats. However, due to
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postulated under-reporting, as well as a reduced number of food recall diaries that 
were recalled, inferences with respect to dietary data are similarly limited.
Socioeconomic status showed to be a notable predictor of cardiovascular disease risk 
in this study, as those of low socioeconomic status presented with the greatest risk of 
cardiovascular disease. However, the exact mechanisms behind this relationship were 
not fully explored.
6.2 SUMMARY OF THE STATISTICAL HYPOTHESES 
Hypothesis 1:
Significant differences were found between groups with respect to all morphological 
characteristics except body composition which was not measured. Therefore the null 
hypothesis is rejected for measures a), b), c), and d) and neither accepted not rejected 
for measure e).
Hypothesis 2:
A significant difference was found between groups with respect to systolic, diastolic, 
and mean arterial blood pressure measures. However, glucose and insulin measures 
were not able to be conducted in this study. Therefore the null hypothesis is rejected 
for measure f), and neither accepted not rejected for measures g) and h).
Hypothesis 3:
Significant differences were found between groups with respect to all lifestyle 
characteristics. Therefore the null hypothesis is rejected for measures i), j), k) and l).
Hypothesis 4:
Significant differences were found between groups with respect to both education 
levels and income. Therefore the null hypothesis is rejected for measures m) and n).
6.3 RECOMMENDATIONS
Future studies assessing cardiovascular disease risk in South African populations 
should take the following recommendations into consideration:
Despite the practicalities of self-reported data in epidemiological research (Richardson 
et al., 2001), future studies should consider incorporating objective measures of
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physical activity, diet, smoking, and alcohol consumption where possible. This would 
negate inaccuracies and under-reporting, and would strengthen the findings of the 
research.
Due to some evidence highlighting the limitations of obesity surrogates in the absence 
of body fat distribution measures (Goedecke et al., 2009), future studies should 
consider measuring body fat distribution in conjunction with mass, BMI, waist 
circumference, and waist-to-stature ratio.
It is acknowledged that race-specific ‘cut-off’ norms were not used for this study as 
they do not exist for Black South African populations. Future studies should consider 
ascertaining the validity of these cut-off norms, and aim to generate modified ones for 
Black South African populations if necessary.
In addition, future studies should incorporate measures of exercise intensity. This 
would enable researchers to assess whether exercise or physical activity is at an 
intensity high enough from which to derive health benefits.
Furthermore, future studies should consider assessing full lipid profiles as well as 
glucose and insulin. This would elicit a complete picture of cardiometabolic risk in a 
population, in addition to cardiovascular risk.
Due to the established relationship between age and cardiovascular disease risk 
(Dubnov et al., 2003; Bray & Champagne, 2005), future studies should consider 
assessing a population within a small age range. Alternatively, future research should 
compare cardiovascular disease risk between age ranges.
Future studies should also consider assessing alcohol dependency behaviours in 
addition to total alcohol habitually consumed. This would allow for the differentiation 
between beneficial levels of alcohol consumption, versus problematic and damaging 
levels of consumption.
Lastly, future studies should aim to explore the exact mechanisms behind why low 
socioeconomic status lends itself to increased cardiovascular risk. Factors such as 
poor education, lack of access to health care, financial strain, and socioeconomic 
stress could be assessed in greater detail within each at risk population group.
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APPENDIX 2
CARDIOVASCULAR DISEASE RISK IN BLACK AFRICAN FEMALES: AN
EASTERN CAPE SAMPLE
Letter to participants
Dear Participant
Thank-you for expressing interest in the study.
The aim of this study is to assess the prevalence of cardiovascular disease within 
women in the Eastern Cape- an area of research which has received very little 
attention in the past. Information gained from this study will therefore be invaluable in 
not only creating awareness of cardiovascular disease risk within Eastern Cape 
women, but will also help you to understand your health status better.
Participation in this project will require you to initially have some physical 
measurements taken, and then to be interviewed about questions pertaining to your 
lifestyle. This will all be done at the Human Kinetics and Ergonomics department at 
Rhodes University, in a once-off testing session.
Before any of the physical measurements are taken, you will be required to fast the 
night before. This means not having anything to eat or drink (even water) for 10 hours 
prior to your testing session. This is for accuracy purposes, particularly for your body 
composition measures and for fasting glucose and insulin levels, which requires you 
to be in a ‘fasted’ state. This may cause a little discomfort, but every effort will be made 
to minimize this as much as possible, and testing sessions will be scheduled for early 
morning wherever possible so that the 10-hour fast is done the night before. You will 
then be allowed to eat and drink as you please as soon as your physical measures 
have been taken.
Once you have arrived at the department (at a previously agreed upon time which you 
choose), the measurements taken will include the following: your stature (height); your 
mass (how much you weigh), your waist circumference (taken using a measuring tape 
around your waist), and your body composition using Bioelectrical Impedance Analysis
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(BIA). BIA is a method whereby a small current (which you cannot feel) is passed 
through your body. What this will measure is the time take for this current to go through 
your body as this is used as an indirect indicator of percent body fat. This is based on 
the understanding that the more body fat, the slower the current passes through your 
body. This measure will require you to take off your shoes and socks and lie down, 
while the researcher places electrodes on your hands and feet. This entire procedure 
is painless and takes a couple of minutes.
After this, you will need to have your blood pressure taken three times (for accuracy 
purposes). This will be done by the primary research using a sphygmomanometer. 
You will be required to rest quietly for five minutes before the cuff is placed on your 
arm and the measurement is taken. Three measurements will be taken and each 
measurement will be separated by three minutes.
This type of manual assessment of blood pressure usually leads to a small level of 
discomfort, however this shouldn’t be too much too handle. In the event that it is too 
uncomfortable or causes any pain, you may decide not to take this measure.
The last physical measurement will be a blood withdrawal which is needed so that 
your fasting glucose and fasting insulin levels can be measured (a measure done for 
determining type II diabetes risk). This will be done by an accredited nursing sister 
from AMPATH laboratories in Peppergrove mall and will be done in the Human 
Kinetics and Ergonomics department. It is a simple once-off blood withdrawal that will 
be taken from your left forearm vein, and every effort will be made to ensure that this 
is as painless as possible.
Once all of these measurements are taken, you will be given some time to relax before 
we begin the interview stage. Here, you will be asked various questions regarding your 
lifestyle- the kind of work you do, the kinds of activities you are involved in, and the 
kinds of foods you eat. Please answer these questions as honestly as possible- there 
is not ‘right’ or ‘wrong’ answer; the questionnaires simple allow the researcher to get 
to know you and understand your typical day-to-day lifestyle habits better. The more 
accurate and honest the responses, the better the researcher can assess your 
cardiovascular disease risk.
Although this interview will be carried out in English, a copy of the questions will be 
available in isiXhosa, and an interpreter will be present to ensure that you understand
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the questions fully. Feel free to ask either myself (the primary researcher), any 
research assistants, or the translator any questions at any point during the testing and 
interview stages.
Please note that all information received from you will be treated confidentially, and 
will be coded for use. At no point in time will your name be used, and your information 
will not be released to any other individual. The data will be used for academic 
purposes such as for publications, presentations, and thesis work, however will remain 
anonymous and coded. Once the information has been analysed, it will be 
communicated to you. This will include detailed information in the form of a written 
report on your cardiovascular health, as well as lifestyle habits which may be 
improved, and how to do so. We trust that you will find this information helpful and 
educational, and that it will help you to head a healthy and low-risk lifestyle going 
forward!
Participation in this study is purely voluntary, and you need not provide any justification 
should you choose not to participate. If you would like to participate however, please 
indicate this to anyone on the research team so that you can begin to read and sign 
your consent form.
Thank-you very much for your interest thus far, and feel free to ask any questions.
Sandra Remsing
Primary researcher (student)
076 898 4678
Email: sandraremsing@gmail.com
Dr. Candice Christie 
Supervisor
046 603 8470
Email: c.christie@ru.ac.za
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APPENDIX 3
SAMPLE DETAILS
Due to the nature of the study, a strictly homogeneous sample group is not required. 
Therefore, the inclusion and exclusion criteria are minimal to ensure that the sample 
group is as closely representative of the naturally existing wider populations as 
possible. Nevertheless, a number of restrictions have been chosen where necessary 
in order to ensure the safety of participants.
Inclusion criteria
Black African and Caucasian women: All chosen participants will be either Black 
African females or Caucasian females. Participants will be exposed to the same 
protocol and experimental conditions, thereby forming one large sample group. Once 
the data are recorded, the data will then be analysed in two separate groups with 
respect to race for comparative purposes.
Urban, working population: As the health implications of rapid urbanization are the 
central area of focus in this study, participants will be chosen from an urban, working 
population. This will be determined by the presence of up-to-date full-time or part-time 
employment contracts from established institutions, business, or companies. 
Participants will be required to work a minimum of three days a week to ensure that 
all participants work for the majority of the week. This will be determined in the pre­
screening questionnaire, and through above mentioned documentation.
Females of reproductive age: All women chosen will be of adult reproductive age (18­
49 years). This is to ensure that the hormone-imbalances associated with menopause, 
and the subsequent hormonal changes and health implications of post-menopause do 
not influence the individuals’ health status (see exclusion criteria ‘menopause’). This 
will be determined through the pre-screening questionnaire (Appendix 8).
Exclusion criteria
Peri-menopausal and post-menopausal: Menopause is characterised by a reduction 
in female sex-hormones which typically leads to changes in morphology and increased 
cardiovascular disease risk (Dubnov et al., 2000). Consequently, the biological profile
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of a peri- or post-menopausal female is considerably different to that of a female or 
reproductive age. (Dubnov et al., 2000). Nevertheless, women of reproductive age 
still exhibit risk of developing cardiovascular disease, particularly if lifestyle factors 
such as physical inactivity and unhealthy eating habits are present (Goedecke et al., 
2008). Therefore, in order to ensure the sample group are at similar baseline levels of 
cardiovascular disease risk, women who are peri-menopausal or post-menopausal will 
not qualify for participation. This will be determined in the pre-screening questionnaire 
as presence of menstruation within the last 30 days.
Pregnant or lactating: Pregnancy and lactation both lead to morphological and 
anthropometric changes in the body; thus measurement of individuals in these states 
would likely lead to an inaccurate representation of cardiovascular disease risk 
(Rychick, 2010). Additionally, it may be unsafe to subject pregnant woman to an over­
night fast in order to determine fasting glucose and insulin levels. Therefore women 
who are currently pregnant or lactating upon commencement of the study will be 
excluded from participation. This will be determined through the pre-screening 
questionnaire.
Physical disabilities/ injury: The measurement and assessment of habitual physical 
activity levels are central to this study. Therefore, participants who are disabled or 
injured to the point that they are physically incapable of participating in regular 
activities of daily living (ADL) will be excluded from participation, as this will influence 
normal metabolic expenditure (Motl and McAuley, 2010). This includes disabilities 
such as being wheelchair bound, or immobilized in any way such that ADLs are 
compromised. However, if a disability doesn’t impact on the person’s ability to 
participate in ADLs, they will not be excluded from participation. This will be 
determined by self-reporting in the pre-screening questionnaire.
English proficiency: Basic English literacy is required for participation to ensure that 
the participants are able to read, understand, and communicate autonomously with 
the researcher and research assistants as far as possible. Any participants who do not 
understand basic spoken English will be excluded from participation. This will be 
determined in the pre-screening form. To ensure that participants understand the 
study requirements and protocol, medical terminology that is not a part of 
everyday/basic English while be translated in writing into isiXhosa wherever possible.
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A first language Xhosa-speaking translator will also be present at the information and 
testing sessions should any terminology without direct Xhosa translation requires 
explanation. In addition, if any Xhosa-speaking participant doesn’t fully understand 
what they are reading or what they are being told, they may ask the translator to 
translate for them.
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APPENDIX 4
RISKS AND BENEFITS
RISKS
Anthropometric and morphological measures
The majority of the anthropometric and morphological measurements are minimally 
invasive. These include: stature, mass, waist circumference, and bioelectrical 
impedance analysis. To minimize any potential embarrassment or feelings of 
uneasiness, all women will be measured by a female researcher in a private area. 
Before each measure is taken, the process will be thoroughly explained to the 
participants and any questions they have will be answered. A female translator who is 
proficient in English and Xhosa will be present in order to explain the procedure to any 
participants who are not proficient in English, while the primary researcher will explain 
to all participants who are proficient in English. This translator will be thoroughly 
briefed before testing commences to ensure that they are well prepared to adequately 
answer any questions that may arise. Effort will be made to ensure that participants 
are as comfortable as possible at all times, and their measurements will be kept 
confidential. In the rare event that any participant feels too compromised or 
embarrassed to participate, they will be reminded that they may withdraw from the 
study without any justification or adverse consequences, and will be fully supported by 
the researchers should they decide to do so.
The more invasive and discomfort-inducing measurements include the measuring of 
blood pressure, and blood withdrawals (which is accompanied by period of fasting 
prior to the blood withdrawal). The levels of discomfort will be managed as follows:
Blood Pressure
The act of taking blood pressure may cause mild to moderate discomfort. This method 
involves placing an inflatable cuff around the forearm, and pumping it up with air to 
create pressure on the brachial artery. Once the air pressure build around the arm, 
this usually leads to some mild discomfort, and rarely to moderate or severe 
discomfort. Every effort will be made to ensure that the discomfort is minimized by 
pumping up the cuff no higher than 200 mm Hg, and by ensuring the researcher and 
research assistants are well practised in taking the measure before the
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commencement of study. However, risk of some discomfort cannot be avoided entirely 
and is a standard consequence of the procedure. Most importantly, the discomfort is 
temporary, and is alleviated as soon as the cuff is released (usually within 30 seconds).
In the rare even that any participant finds this too uncomfortable or painful, they may 
alert the researcher and they will be excluded from this measure, but may continue 
participating in the study.
Fasting
In order to determine fasting insulin concentrations, the patient is required to fast for 
10 hours prior to having their blood taken. This is solely to ensure that the blood insulin 
levels are not affected be recent ingestion of food or drink, and that the measure is an 
accurate representation of the body’s typical insulin function. Although fasting may 
lead to discomfort and irritability in some participants, it is not possible to achieve an 
accurate representation of insulin function without it. In order to minimize the 
discomfort, effort will be made to commence the blood withdrawal early in the morning 
so that the majority of the fasting is done during the previous night while sleeping.
Some participants may experience nausea or light headedness due to having not 
eaten or drunk in 10 hours. In order to manage this, participants will be allowed to sit 
or lie down whilst waiting for their blood to be taken, and effort will be made to ensure 
that the blood withdrawal is done as quickly and as efficiently as possible. Participants 
will also be given a small amount of water to sip if the nausea and/or feeling of 
faintness persist. If any participant is unable to manage the feelings of nausea or 
faintness, they are permitted to abstain from the blood withdrawal and ingest food or 
drink as they please. An on call doctor may also be contacted should any participant 
need medical attention.
Despite the discomfort associated with taking a fasting insulin measure, it is a regular 
and accepted test to monitor insulin function, and it is common procedure to go for 
blood tests following a 10 hour fast.
Blood test
Blood will be taken by a qualified nursing sister to ensure that the procedure is done 
effectively and safely with minimal pain and discomfort. As some participants may 
have a phobia of needles or may not want to have blood taken, participants will be
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informed about this step in the consent form and will need to agree to this before 
participating. If any participants would not like to have blood taken, they may choose 
not to participate in the study.
In the unlikely event that there be any health problems or injuries as a result of the 
testing, and the on-call Doctor will be immediately contacted. There will also be a first 
aid kit available and well stocked, and a researcher with experience in First-Aid will be 
contacted.
Completion of questionnaires
The completion of the questionnaires can be considered invasive in that it requires the 
participants to provide private and personal information. However, all information 
provided will remain private and confidential, and the participants will all be reminded 
of this verbally (it is also stipulated in the information letter and the consent form). 
Participants will also be reminded why the questionnaire information is required: that 
it is a necessary aspect for the study so that the impact of lifestyle factors on 
cardiovascular disease can be assessed. Nevertheless, if any participant feels too 
uncomfortable to complete parts of, or entire questionnaires, they will not need to do 
so.
BENEFITS
After participating in this study, participants will have received:
Information on cardiovascular disease
During the introductory meeting, participants will have been informed about the 
dangers of cardiovascular disease and how it manifests in the body. Participants will 
also be informed about common risk factors for cardiovascular disease, as well as the 
dangers of not diagnosing/managing cardiovascular disease risk factors 
(hypertension, high glucose levels, and central obesity).
Free cardiovascular health screening
By virtue of participating in this study, participants will receive free and confidential 
cardiovascular health screening. Herein, participants will be measured for the main 
cardiovascular risk factors including central obesity, hypertension, and insulin 
resistance, but not including blood lipid profiles. It will be communicated to participants
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that should they desire a full cardiovascular health screening, that they may consider 
further assessing their lipid profiles with their doctors, in addition to the measures they 
receive from the study. Participants’ results will be communicated to them personally, 
and should any of the results be cause for concern, participant’s will be notified as well 
as the on-call doctor, Dr. Jameson. Thereafter, appropriate protocol will be followed 
by the doctor regarding diagnosing the participant, and providing them with treatment 
option if necessary.
Education surrounding dangers of unhealthy eating habits and physical 
inactivity
As the main focus of the study is on modifiable risk behaviours, participants will be 
informed about the dangers of unhealthy habits (particularly consuming processed 
foods and foods high in sugar) as well as the dangers of being physically inactive, with 
the emphasis being how these habits can greatly increase a person’s chance of 
developing cardiovascular disease. Participants will also be provided with a list of 
dietary and activity adjustments for them to make after they study should they wish to. 
This will act as a tool that the participants can use to make small improvements in their 
lifestyles, and will be based on each individual’s circumstance.
A copy of personal measures
After participating in this study, each participant will have received a copy of their own 
personal cardiovascular risk measures as a reference point for any further testing.
145
APPENDIX 5
RHODES UNIVERSITY
Grahamstown* 6 i4 0  *Soutb Africa
Human Kinetics and Ergonomics Department 
INFORMED CONSENT AND INDEMNITY 
For research involving human participants *I
(a) I, .............................................................  .................................. have been fully
informed of the research project entitled “Cardiovascular disease risk in Black and 
white South African women: an Eastern Cape sample”
I have read the information sheet and understand the testing procedure that will take 
place. All testing procedures, associated risks and the benefits from partaking in this 
study have been verbally explained to me as well as in writing [letter of information 
appended to this document]. I have had ample opportunity to ask questions and to 
clarify any concerns or misunderstandings. I am satisfied that these have been 
answered satisfactorily. I understand that all data collected for publication purposes 
will be kept anonymous and all information gained in this regard will be treated 
confidentially. Furthermore, I consent to photographs, knowing that these will be 
altered to ensure my anonymity. I understand that I am able to withdraw from the study 
at any point and without any negative consequences, irrespective of external 
influences placed on me by the researcher.
In agreeing to participate in this research study I waive any legal recourse against the 
researchers from the Department of Human Kinetics and Ergonomics (HKE), Rhodes 
University, from claims resulting from personal injuries sustained whilst participating
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in the above mentioned research. I am aware and fully understand that the Department 
of Human Kinetics and Ergonomics is not responsible for any injuries due to my 
personal negligence and non-compliance with instructions. This waiver shall be 
binding upon my heirs and personal representatives.
I have read and understood the above information, as well as the information provided 
in the letter accompanying this form. I therefore consent to voluntarily participate in this 
research project.
PARTICIPANT PROVIDING CONSENT:
(Print Name) (Signed) (Date)
WITNESS:
(Print Name) 
(Date)
(Signed)
PRINCIPAL RESEARCHER:
(Print Name) (Signed) (Date)
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APPENDIX 6
PRIVACY, ANONYMITY AND CONFIDENTIALITY ISSUES
To ensure anonymity of participants, each will be assigned an individual code which 
will be used to record their results. Their individual codes will be a combination of 
letters and numbers and will be assigned to them at random using a computer 
program. Only the primary researcher will have access to the information linking the 
participants’ name to the code. When results are presented in the final thesis, only the 
individual codes will be used to differentiate between participants if necessary, but not 
their names.
To ensure privacy, all anthropometric and physiological measurements will be taken 
by the primary researcher and will be done in a closed off room that no other persons 
may enter during measuring except another female post-graduate assistant who will 
help with the measurements.
If any photos are taken, prior permission will be required from the participant in writing 
(consent form, Appendix 5). Participants will be assured verbally assured that they are 
not obligated to agree to this, and that if they do agree, their faces will be blocked out 
from any photos that are used in the thesis. Photos will also remain secured on the 
primary researcher’s camera and will not be accessed by any other persons. Photos 
may also be used in electronic presentation or during lectures, however the identity of 
individuals will remain anonymous by blocking out the faces.
All measurements and results will be stored on the computer of the primary researcher 
and will not be sent out to other persons. At the end of the study, results will be 
archived on the Human Kinetics and Ergonomics results data base for security 
purposes; however individual participants’ results will be labelled using their randomly 
assigned code. Stored data will only be available for re-use by the primary researcher 
or by supervisor Dr. Candice Christie, however participants’ anonymity will still be 
secured if so.
The blood work results will also be archived at AMPATH laboratory but these results 
will remain secured and confidential; results will also be coded.
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The primary researcher is aware that they are collecting sensitive personal and 
medical information and will retain this confidentiality by not discussing results with 
any persons apart from the participants whose information it is directly, or with 
supervisor Dr. Candice Christie if necessary.
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APPENDIX 8
All medical terminology, as far as possible, is presented in English and isiXhosa. The 
remainder of the questionnaires are in English, and a translator will be present during 
the testing sessions should you require any assistance.
Participant screening questionnaire
1. Please indicate your SEX (male or 
female)
2. Please circle your race White; Black; Coloured; Indian; Other
3. Please give your AGE in years and 
months
4. Are you able to read and understand 
basic ENGLISH?
5. Have you experienced menstruation 
/ ‘exesheni’ within the last 30 days?
6. If you answered ‘NO’ to question 5, 
please indicate with a tick whether
a)
you are a) pregnant / ‘khulelue’ b) 
pre-menopausal or menopausal /
b)
‘kwixesha’ or c) unknown/other 
reason
c)
7. Have you ever been told that you 
have DIABETES / ‘isifo seswekile’ 
by a medical health professional?
8. Have you ever been told that you 
are HYPERTENSIVE / ‘ukunyuka
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kwegazi’ by a medical health 
professional?
9. If you have answered ‘YES’ to a)
questions 7 or 8, please indicate
with a tick if a) you are on any b)
medications / ‘amayeza’ for these
conditions, b) what medication, and c)
c) how long you have been on the
medication for.
If you answered ‘NO’ to questions 7
or 8, leave this question blank.
10. Do you take any other chronic
medication ‘amayeza’ (medication
you take every day)
11. Have you had any MAJOR
SURGERY / ‘uqhaqho’ in the last 6
months?
12. Are you a full-time employee of an
institution, corporation, or business?
13. Do you currently have any physical
disability(s) / ‘ukukhubazeka’ ?
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I [full nam e]________________________________________________declare that the
information provided above is truthful and accurate.
BASED ON THE INFORMATION PROVIDED, I UNDERSTAND THAT THERE IS A 
POSSIBILITY THAT I MAY NOT BE ALLOWED TO CONTINUE IF I DO NOT MEET 
THE CRITERIA, OR IF IT IS UNSAFE FOR ME TO PARTICIPATE. SHOULD I BE 
EXCLUDED FROM PARTICIPATION, I AM OF THE UNDERSTANDING THAT THE 
RESEARCH WILL COMMUNICATE THE REASONING BEHIND THIS TO ME.
Signed by participant Date
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APPENDIX 9
T IM E T yp e  o f  fo od  a n d /o r d rin k . ( If  a n y  in g re d ien ts  
w e re  ad d ed  to  th e  p rep ara tio n  p ro ces s , p lease  
add  it as w e ll i.e. o il, s u g ar, sa lt).
Q u a n tity E aten  a t h o m e  
(H ) o r  a t (W )
BREAKFAST
MID-MORNING: Between breakfast and lunch
LUNCH
MID-AFTERNOON: Between lunch and dinner
DINNER
AFTER DINNER
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Participant cod e :..........................
Day of the w e e k :..........................
Is this a typical day? (Yes or no):
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APPENDIX 10
DEPARTMENT OF HUMAN KINETICS AND ERGONOMICS
RHODES UNIVERSITY, GRAHAMSTOWN
[This research has been cleared by the Ethics Committee for research involving 
human subjects through the Department of Human Kinetics and Ergonomics]
ARE YOU INTERESTED IN:
• HEALTH AND WELLBEING?
• RECEIVING FREE HEALTH SCREENING? 
• HEALTHY LIFESTYLE HABITS?
• WAYS TO IMPROVE YOUR HEALTH?
This study is focussed on assessing the cardiovascular health / ‘Iso fo  
s e n tliz iy o ’ of Black and White South African women residing in the Eastern
Cape!
Some of the measures taken will include:
• Weight ‘u b u n z im a ’
•  Blood Pressure ‘u ku n yu ka  k w e g a z i’
•  Blood glucose and Insulin ‘isifo seswekile’
• Lifestyle habits such as diet, physical activity, smoking, and alcohol use
• AND MORE.....!
FOR MORE INFORMATION, DON’T HESITATE TO CONTACT Sandra Remsing 
on 0768984678 or g10r0007@campus.ru.ac.za
LOOKING FORWARD TO HEARING FROM YOU ©
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APPENDIX 11
The size of your fist refers to a medium sized fruit or vegetable 
(Le. apple, orange, potato)
The size of your fmgertjp refers to one teaspoon
(i.e. sugar, butter on bread)
The size of your thumb refers to one tablespoon
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The palm of your hand refers to a medium portion of cooked meat
poultry or fish
Small Medium L a  - g e Mug Cup
Y our cupped hand refers to approx im ate ly  45 g
(i.e. a cupped hand of chopped vegetables or rice)
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APPENDIX 12
Statistical analyses
Variable
T-tests: Grouping: Participants (Basic data start point sta) 
Group 1: W 
Group 2: B
Mean
W
Mean
B
t-value df P Valid N 
W
Valid N 
B
Std.Dev.
W
Std.Dev.
B
F-ratio
Variances
P
Variances
Age 38 8846 39.6705 -0.42180 164 0 673720 78 88 12.19323 11.78809 1 069918 0.757189
Height 164.5513' 156.7318 8.02776 164 0.000000 78 88 6.35844 6.17826 1.059178 0.792032
weight 70.1538 84.1648 -4.93886 164 0.000002 78 88 13.43655 21.62198 2.589495 0 000031
BMI 25.3365 34.1893 -7.96726 164 0 000000 78 88 4.66984 8.07128 2.987319 0.000002
Ponderal index 15.7694 21.8417 -9.13922 164 0.000000 78 88 2.97019 5.15762 3.015294 0.000002
WC 79.8462 95.3352 -6.97278 164 0.000000 78 88 10.81074 16.76849 2.405897 0.000115
WSR 0.4794 0.E085 -8.60070 164 0.000000 78 88 0.08611 0.10487 1.482925 0.078732
BP systolic 116.2179 122.2159 -2 50564 164 0.013198 78 88 11.93559 17.90425 2.250215 0 000353
BP diastolic 70 4103 77.1250 -3.11767 164 0002153 78 88 11.32568 15.74934 1.933731 0.003484
MAP 85.6795 92.1553 -3.01071 164 0 003019 78 88 10 89057 15 98890 2.155440 0 000701
Variable
T-tests: Grouping: Groups (Spreadsheet79) 
Group 1: W 
Group 2: B
Mean
W
Mean
B
t-value df P Valid N 
W
Valid N
B
Std.Dev
W
Std.Dev
B
F-ratio
Variances
P
Variances
KJ 6401 192 7243 596 -2.16873 93 0.032654 46 49 1796473 1977.444 1.21162 0 518074
Kcal 1530.963 1731 262 -2.15339 93 0 033875 46 49 431.251 472.621 1.20106 0.537381
Protein (q) 69.420 53.446 2.22008 93 0.028843 46 49 29.649 17.296 2.93858 0.000326
Total fat (q) 64.262 61.729 0.56250 93 0.575127 46 49 22.652 21.240 1.13738 0 660198
Saturated fat (g) 22.233 18.440 2.15781 93 0 033519 46 49 9.031 8.099 1.24350 0 458103
Monounsaturated fat (q) 21.348 19.075 1.32779 93 0187496 46 49 9.475 7.113 1 77465 0 052352
Polyunsaturated fat (q) 12.345 17.492 -3.39294 93 0.001017 46 49 6.745 7.947 1.38827 0.269427
Trans fat (g) 1.608 1.058 2.53486 93 0 012919 46 49 1.276 0.800 2.54307 0 001764
Carbohydrate (g) 141 815 214.933 -5.12671 93 0 000002 46 49 55.605 80.325 2 08678 0 014139
Alcohol (g) 10.425 0.922 3.39084 93 0 001024 46 49 19208 3.899 24.27211 0 000000
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Variable
T-tests; Grouping: Group (Spreadsheetl (Recovered)) 
Group 1: W 
Group 2: B
Mean
W
Mean
B
t-value df P Valid N 
W
Valid N
B
Std Dev 
W
Std Dev
B
F-ratio
Variances
P
Variances
KJ 6401 192 7243 596 -2.16873 93 0 032654 46 49 1796.473 1977.444 1.21162 0.518074
kcal 1530 963 1731 262 -2 15339 93 0 033875 46 49 431.251 472 621 1.20106 0 537381
Protein (g) 69 420 58.446 2 22008 93 0 028843 46 49 29.649 17.296 2.93858 0 000326
Total fat (q) 64.262 61.729 0 56250 93 0 575127 46 49 22.652 21 240 1.13738 0.660198
Sfat(g) ’ 22.233 18 440 2.15781 93 0 033519 46 49 9.031 8.099 1.24350 0.458103
Mono fat (g) 21.348 19 075 1 32779 93 0 187496 46 49 9.475 7.113 1.77465 0 062352
Poly fat (g) 12.345 17.492 -3.39294 93 0 001017 46 49 6.745 7.947 1.38827 0.269427
Trans fat (g) 1.608 1.058 2 53486 93 0 012919 46 49 1.276 0.800 2.54307 0 001764
CHO (g) 141 815 214.933 -5.12671 93 0 000002 46 49 55 605 80.325 2.08678 0 014139
Total sugar (g) 35 016 46.721 -2 77036 91 0 006788 44 49 15.004 24.142 2.58908 0 001947
Alcohol (g) 10.425 0.922 3 39084 93 0 001024 46 49 19 208 3.899 24.27211 0 000000
T-tests; Grouping: Group (Spreadsheet83) 
Group 1; W
Group 2: B ________________________
Variable
Mean
W
Mean
B
t-value df P Valid N 
W
Valid N
B
Std.Dev.
W
Std.Dev.
B
F-ratio
Variances
P
Variances
Total Active METminutes 1828 2691 2688.864 -2.94786 164 0.003667 78 88 2238.104 1486.558 2.266713 0.000241
Transport METminutes 95.128 415.682 4.41379 164 0.000018 78
C
O
C
O 271.278 588.209 4.701496 0.000000
Seated METminutes 3384 051 1952.045 7.21560 164 0 000000 78 88 1264 118 1286.734 1 036103 0.876643
Group=W
Correlations (Basic data start point.sta)
Marked correlations are significant at p < .05000 
N=78 (Casewise deletion of missing data)
Variable Means Std.Dev. BMI MAP
BMI 25 396501 4.66984 1 000000 0.355707
MAP 85.67949* 10.89057 0.355707 1 000000
Group=B
Correlations (Basic data start point.sta)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data)
Variable Means Std.Dev. BMI MAP
BMI 34.189331 8.07128 1 000000 0.442757
MAP 92.15530 15.98890 0.442757 1 000000
Variable
GrGup=W
Correlations (Basic data start point.sta)
Marked correlations are significant at p < .05000 
N=73 (Casewise deletion of missing data)
Means Std.Dev. WC BMI
WC 79.846151 10 81074 1.000000 0 353895
BMI 25.89650 4.66984 0.853895 1 000000
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Variable
Group=B
Correlations (Basic data start point.sta}
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data}
Means Std.Dev. WC BMI
WC 95.33523 . 15.76849 1.000000 0 917697
BMI 34.18933J 8 07128 0.917697 1 000000
Group=W
Correlations (Basic data start point.sta}
Marked correlations are significant at p < .05000 
N=78 (Casewise deletion of missing data)
Variable Means Std.Dev. WC MAP
WC 79.846151 10.81074 1.000000 0.386331
MAP 85.67949" 10.89057 0.386331 1 000000
Variable
Group=B
Correlations (Basic data start point.sta}
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data}
Means Std.Dev. WC MAP
WC 95.335231 16.76849 1 000000 0 433420
MAP 92.15530 15.98890 0.433420 1 000000
Group=W
Correlations (Basic data start point.sta}
Marked correlations are significant at p < .05000 
N=78 (Casewise deletion of missing data)
Variable Means Std.Dev. WSR MAP
WSR 0 479401 0.08611 1 000000 0.219670
MAP 85.67949" 10 89057 0.219670 1 000000
Group=B
Correlations (Basic data start point.sta)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data)
Variable Means Std.Dev. WSR MAP
WSR 0.60850 0.10487 1.000000 0.423231
MAP 92.15530 ' 15.98890 0.423231 1 000000
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Group=W
Correlations [Basic data start point.sta}
Marked correlations are significant at p < .05000 
N=78 [Casewise deletion of missing data}_____
Variable Means Std.Dev. weight WSR
weight 70.15385 13.43655 1 000000 0.627126
WSR 0 4 794 o'' 0.08611 0.627126 1.000000
Variable
Group=B
Correlations [Basic data start point.sta}
Marked correlations are significant at p < .05000 
N=88 [Casewise deletion of missing data)
Means Std.Dev. weight WSR
weight 84.164771 21.62198 1.000000 0 844448
WSR 0.60850 0 10487 0.844448 1 000000
Group=W
Correlations (Basic data start point.sta}
Marked correlations are significant at p < .05000 
N=78 [Casewise deletion of missing data)
Variable Means Std.Dev. weight MAP
weight 70.15385 13.43655 1 000000 0.407174
MAP 85.67949 ' 10 89057 0.407174 1.000000
Variable
Group=B
Correlations [Basic data start point.sta)
Marked correlations are significant at p < .05000 
N=88 [Casewise deletion of missing data)
Means Std.Dev. weight MAP
weight 84.164771 21.62198 1.000000 0 433879
MAP 92.15530 15.98890 0.433879 1 000000
Groups =W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=46 [Casewise deletion of missing data)
Variable Means Std.Dev. Carbohydrate (g) WC fern)
Carbohydrate (g) 141.81461 55.60481 1.000000 -0.528202
WC [cm) 80.4891* 10.00472 -0.528202 1.000000
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Variable
Groups =B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 (Casewise deletion of missing data)
Means Std.Dev. Carbohydrate (g) WC fern)
Carbohydrate (g) 214 9329 I 80.32505| 1.000000 -0.204805|
WC [cm} 95.2551 16.67150 -0.204805 1.000000
Groups=W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=46 (Casewise deletion of missing data)
Variable Means Std.Dev. Seated METminutes Weight (kg)
Seated METminutes 3360.2171 1305.313 1.000000 -0.067929
Weight (kg) 70 576* 12.813 -0.067929 1.000000
Groups =B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 (Casewise deletion of missing data)
Variable Means Std.Dev. Seated METminutes Weight (kg)
Seated METminutes 1821.4291 1109.054 1.000000 -0.130853
Weight (kg) 83.980* 21.685 -0.130853 1 000000
Variable
Groups=W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
NN46 (Casewise deletion of missing data)
Means Std.Dev. Carbohydrate (g) MAP (mmHg)
Carbohydrate (g) 141.8146 I 55.60481| 1.000000 -0.1070181
MAP (mmHg) 84.1884 10 57492 -0.107018 1 000000
Variable
Groups =B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 (Casewise deletion of missing data)
Means Std.Dev. Carbohydrate (g) MAP [mmHg)
Carbohydrate (g) 214 9329 I 80.32505| 1.000000 -0.296565
MAP (mmHg) 93.9116 16.00546 -0.296565 1 000000
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Grcnjps=W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=46 [Casewise deletion of missing data)
Variable Means Std.Dev. Carbohydrate fg) Weiqht (kg)
Carbohydrate (g) 141.81451 55.60481 1.000000 -0.395700
Weiqht (kg) 70.576l" 12.81317 -0.395700 1 000000
Groups=B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 [Casewise deletion of missing data)
Variable Means Std.Dev. Carbohydrate (g) Weiqht (kg)
Carbohydrate (g) 214 9329 80.32505 1.000000 -0.245744
Weight (kg) 83.979G1' 21.68548 -0.245744 1 000000
Groups=W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=46 [Casewise deletion of missing data)
Variable Means Std.Dev. Carbohydrate fg) BMI [kg.m2)
Carbohydrate (g) 141.81451 55.60481 1.000000 -0.443535
BMI [kg.m2) 25.9001" 4.72463 -0.443535 1 000000
Groups=B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 [Casewise deletion of missing data)
Variable Means Std.Dev. Carbohydrate fg) BMI [kg.m2)
Carbohydrate (g) 214 9329 80.32505 1.000000 -0.242707
BMI [kg.m2) 34.49161' 7.98631 -0.242707 1 000000
Variable
Groups=W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=46 [Casewise deletion of missing data)
Means Std.Dev. Carbohydrate fg) BP systolic [mmHg)
Carbohydrate (g) 141 8146 . 55.604811 1.000000 -0.0064311
BP systolic [mmHg) 114.2609 11.69888 -0.006431 1.000000
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Groups=B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 [Casewise deletion of missing data)
Variable Means Std.Dev. Carbohydrate (g) BP systolic fmmHg)
Carbohydrate (g) 214.93291 80.32505 1.000000 -0.262611
BP systolic [mmHg) 124.5102 19.04285 -0.262611 1.000000
Groups =W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=46 [Casewise deletion of missing data)
Variable Means Std.Dev. Carbohydrate (g) BP diastolic [mmHg)
Carbohydrate (g) 141.81451 55.60481 1.000000 -0.152379
BP diastolic [mmHg) 69.1522" 10 99892 -0.152379 1.000000
Variable
Groups =B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 [Casewise deletion of missing data)
Means Std.Dev. Carbohydrate (g) BP diastolic fmmHg)
Carbohydrate (g) 214.93291 80.32505| 1.000000 -0.302049
BP diastolic [mmHg) 78.6122 15.29408 -0.302049 1.000000
Groups =W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=46 [Casewise deletion of missing data)________
Variable Means Std.Dev. Total fat fg) Weiqht (kg)
Total fat (g) 64.262391 22.65185 1 000000 -0.360705
Weiqht fkg) 70.57609 ' 12.81317 -0.360705 1 000000
Variable
Groups=B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 [Casewise deletion of missing data)
Means Std.Dev. Total fat fg) Weiqht [kg)
Total fat fg) 61.72939 . 21.239811 1 0000001 -0.184857|
Weight [kg) 83.97959 21.68548 -0.184857 1.000000
Groups =W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=46 [Casewise deletion of missing data)
Variable Means Std.Dev. Saturated fat fg) Weiqht fkg)
Saturated fat (g) 22.233261 9.03085 1 000000 -0.209816
Weiqht fkg) 70.57609 12.81317 -0.209816 1 000000
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Variable
Groups =6
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 (Casewise deletion of missing data)
Means Std.Dev. Saturated fat fg) Weight (kg)
Saturated fat [g] 18 44020I 8.09852| 1.0000001 -0.109B1B|
Weight (kg) 83 97959 21.68548 -0.109818 1 000000
Groups =W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=46 (Casewise deletion of missing data)
Variable Means Std.Dev. Polyunsaturated fat (g) Weight (kg)
Polyunsaturated fat (g) 12.34457 6.74510 1 000000 -0.275195
Weight [kg) 70.57609 ' 12.81317 -0.275195 1 000000
Groups =B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 (Casewise deletion of missing data)
Variable Means Std.Dev. Polyunsaturated fat (g) Weight (kg)
Polyunsaturated fat (g) 17.49224 7.94740 1 000000 -0.184708
Weight (kg) 83.97959 ' 21.68548 -0.184708 1 000000
Groups=W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=46 (Casewise deletion of missing data)
Variable Means Std.Dev. Monounsaturated fat fg) Weight (kg)
Monounsaturated fat (g) 21.34848 [ 9.47518 1.000000 -0.258049
Weight [kg) 70.57609 ' 12.81317 -0.258049 1 000000
Groups=B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 [Casewise deletion of missing data)________
Variable Means Std.Dev. Monounsaturated fat (g) Weight (kg)
Monounsaturated fat (g) 19.075101 7.11265 1.000000 -0 15283m
Weight (kg) 83.97959 ' 21.68548 -0.152835" 1 000000
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Groups =W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N^46 [Casewise deletion of missing data)________
Variable Means Std.Dev. Weiqht (kg) Active METminutes
W eight (kg) 70 5701 12.813 1 000000 -0.089665
Active METminutes 1774.783 2219.375 -0.089GG5 1.000000
Variable
Groups =B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 (Casewise deletion of missing data)
Means Std.Dev. Weiqht (kq> Active METminutes
W eight (kg) 83.9801 21.685| 1.0000001 0.012723|
Active METminutes 3005.714 1507.586 0.012723 1.000000
Groups=W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=46 (Casewise deletion of missing data)
Variable Means Std.Dev. KJ Weiqht (kg)
KJ 6401.1921 1796.473 1.000000 -0.438902
Weight [kg) 70 57&" 12.813 -0.433902 1 000000
Variable
Groups=B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 (Casewise deletion of missing data)
Means Std.Dev. KJ Weiqht (kg)
KJ 7243.5961 1977.4441 1 0000001 -0.258549
Weight (kg) 83.980 21.685 -0.258549 1 000000
Variable
Groups=W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
l\M 6  (Casewise deletion of missing data)
Means Std.Dev. KJ BMI (kg.m2)
KJ 6401.192 I 1796.473| 1.000000 -0.453435|
BMI [kg.m2) 25.900 4.725 -0.453435 1 000000
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Groups=B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 [Casewise deletion of missing data)
Variable Means Std.Dev. KJ BMI fkg.m2)
KJ 7243.596 [ 1977.444 1.000000 -0.283125
BMI [kg.m2) 34.492' 7.986 -0.288125 1 000000
Variable
Groups=W
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=46 [Casewise deletion of missing data)
Means Std.Dev. KJ WC fern)
KJ 6401.1921 1796.473 1.000000 -0.431134
WC [cm) 80 489" 10.005 -0.431134 1.000000
Variable
Groups=B
Correlations [Compilation of all correlation data.sta) 
Marked correlations are significant at p < .05000 
N=49 [Casewise deletion of missing data)
Means Std.Dev. KJ WC fern)
KJ 7243.5961 1977.444 1.000000 -0.230645
WC [cm) 95.255" 16.671 -0.230645 1.000000
T-tests: Grouping: Group (Spreadsheet231) 
Group 1: W
Group 2: B__________________________
Variable
Mean
W
Mean
B
t-value df P Valid N
w
Valid N
B
Std Dev 
W
Std Dev
B
F-ratio
Variances
P
Variances
Gross monthly income (R) 17242 311 4710 614 10.49943 164 0 000000 78 88 10834.93 2671.844 16.44486 0 000000
Years of completed education 17.05* 11.653 14.15858 164 0 000000 78 88 2.80 2.095 1.78103 0 009258
T-tests: Grouping: Group (Spreadsheet241) 
Group 1: W
Group 2: B____________________________
Variable
Mean
W
Mean
B
t-value df P Valid N
w
Valid N
B
Std.Dev
W
Std.Dev
B
F-ratio
Variances
P
Variances
SBP (mmHg) 115.2297 129.6620 -6.64133 143 0.000000 74 71 11.50765 14.54151 1.596783 0.049154
DBP (mmHq) 69.4865 82.9014 -6.45302 143 0 000000 74 71 11.23868 13.71772 1.489817 0 093408
MAP (mmHg) 84.7342 98.4883 -6.83445 143 0.000000 74 71 10.67123 13.45478 1.589734 0.051319
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T-tests: Grouping: Group (Spreadsheet243)
Group 1: B Without Diagnosis
Group 2: B All________ _________ _ ___
Variable
Mean
B Without Diagnosis
Mean 
B All
t-value df P Valid N
B Without Diagnosis
Valid N 
B All
Std.Dev.
B Without Diaqnosis
Std.Dev. 
B All
F-ratio
Variances
P
Variances
SBP (mmHg) 129 6620 1222159 2 830619 157 0.005254 71 88 14.54151 17.90425 1.515979 0 072112
DBP (mmHq) 82 9014 77.1250 2.433830 157 0 016062 71 88 13.71772 15.74934 1.318138 0 231501
MAP (mmHg) 98 4883 92 1553 2 662154 167 0 008572 71 88 13 45478 15 98890 1 412159 0 135210
T-tests; Grouping: Group (Spreadsheet245) 
Group 1: W Without known hypertension 
Group 2: WAII______________________
Variable
Mean
W Without known 
hypertension
Mean
WAII
t-value df P Valid N
W Without known 
hypertension
Valid N 
WAII
Std Dev
W Without known 
hypertension
Std.Dev
WAII
F-ratio
Variances
P
Variances
SBP (mmHg) 115 2297 116.0127 -0.411398 151 0 681364 74 79 11.50765 11.99839 1.087108 0 719821
DBP (mmHq) 69.4865' 70 1519 -0.361867 151 0.717957 74 79 11.23868 11.48476 1.044270 0 853328
MAP (mmHg) 84.7342 85.4388 -0.401113 151 0.688904 74 79 10.67123 11.02994 1.068360 0 776795
Variable
Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=78 (Casewise deletion of missing data)
Means Std.Dev. Weight (kq) Seated MET-minutes
Weight (kg) 70 1541 13.437 1.0000001 0.034425
Seated MET-minutes 3334.051" 1264.118 0.03442:5 1.000000
Group=B
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=38 (Casewise deletion of missing data)_____
Variable Means Std.Dev. Weight (kg) Seated MET-minutes
W eight (kg) 84 1651 21.622 1 000000 -0.117367
Seated MET-minutes 1952.045 1286.734 -0.117367 1.000000
Variable
Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < 
N=78 (Casewise deletion of missing data
.05000
Means Std.Dev. BMI (kq/m2) Seated MET-minutes
BMI (kg/m2) 25.3971 4.670| 1.000000 -0.054347
Seated MET-minutes 3384.051 1264.118 -0.054347 1.000000
Variable
Grcup=B
Correlations (Spreadsheets)
Marked correlations are significant at p < 
N=88 (Casewise deletion of missing data
.05000
Means Std.Dev. BMI (kq/m2) Seated MET-minutes
BMI (kg/m2) 34.189 . 8.071| 1.000000 -0.152167
Seated MET-minutes 1952.045 1236.734 -0.152167 1.000000
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Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000
Variable Means Std.Dev. Weiqht (kq) Total active MET-minutes
W eight (kg) 70 1541 13.437 1 000000 -0.173719
Total active MET-minutes 1828.269 2238.104 -0.173719 1.000000
lGrouD=B
Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000
Variable Means Std.Dev. DBP (mmHq) Total active MET-minutes
DBP (mmHg) 70.4101 11.3261 1.000000 -0.053030|
Total active MET-minutes 1828.269J 2238.104 -0.053030 1.000000
Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=7S [Casewise deletion of missing data)_____
Variable Means Std.Dev. Total active MET-minutes MAP (mmHq)
Total active MET-minutes 1828.2691 2238.104 1.000000 -0.107748
MAP (mmHg) 85.679 ' 10.891 -0.107748 1 000000
Group=B
Correlations (Spreadsheets)
Marked correlations are significant at p < 
N=88 (Casewise deletion of missing data)
05000
Variable Means Std.Dev. Total active MET-minutes MAP fmmHa)
Group=B
Correlations (Spreadsheets)
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Group=B
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data) 8CT-nn
Variable Means Std.Dev. WC (cm) Total active MET-minutes
WC (cm) 95.3351 16.768 1 000000 0.017526
Total active MET-minutes 2688.864" 1486.558 0.017526 1.000000
N=bb [Casewise deletion ot missing data) __ I
Variable Means Std.Dev. DBP (mmHg) Total active MET-minutes '
DBP_[mmHg) 77.1251 15.749 1.000000 0.307708
Total active MET-minutes 2688.864 1486.558 0.307708 1.000000
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Variable
Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=7B (Casewise deletion of missing data)
Means Std.Dev. WC (cm) Total active MET-minutes
WC (cm) 79.846 . 10.3111 1.000000 -0.242304
Total active MET-minutes 1328.269 2238.104 -0.242304 1.000000
Variable
Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=73 (Casewise deletion of missing data)
Means Std.Dev. WSR Total active MET-minutes
WSR 0 486 I 0.066| 1 000000 -0.193350|
Total active MET-minutes 1323.269 2233.104 -0 193350 1.000000
Group=B
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=38 (Casewise deletion of missing data)_____
Variable Means Std.Dev. WSR Total active MET-minutes
WSR 0 608 [ 0.105 1 000000 0.036671
Total active MET-minutes 2638.864 ' 1486.558 0.036671 1.000000
Variable
Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=78 (Casewise deletion of missing data)
Means Std.Dev. WC (cm) Seated MET-minutes
WC (cm) 79.3461 10 311 1.000000 0.053131
Seated MET-minutes 3334.051" 1264.118 0.053181 1 000000
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Variable
Group=B
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data)
Means Std.Dev. WC (cm) Seated MET-minutes
WC (cm) 95.3351 15.768 1.000000 -0.159832
Seated MET-minutes 1952.045" 1286.734 -0.159832 1.000000
Variable
Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=78 (Casewise deletion of missing data)
Means Std.Dev. MAP (mmHg) Seated MET-minutes
MAP (mmHg) 85.679 . 10.891| 1 0000001 -0.204477
Seated MET-minutes 3334.051 1264.113 -0.204477 1.000000
Variable
Group=B
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data)
Means Std.Dev. MAP (mmHg) Seated MET-minutes
MAP (mmHg) 92.1551 15.989| 1 000000| -D.380804|
Seated MET-minutes 1952.045 1286.734 -0.380804 1.000000
Variable
Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=78 (Casewise deletion of missing data)
Means Std.Dev. SBP (mmHg) Seated MET-minutes
SBP (mmHg) 116.2131 11.936| 1 000000 -0.1919931
Seated MET-minutes 3334.051 1264.113 -0.191993 1.000000
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Variable
Group=B
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data)
Means Std.Dev. SBP (mmHq) Seated MET-minutes
SBP (mmHg) 122.216 I 17.904| 1.0000001 -0.359231
Seated MET-minutes 1952.045 1286.734 -0.359231 1.000000
Variable
Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=78 (Casewise deletion of missing data)
Means Std.Dev. DBP (mmHq) Seated MET-minutes
DBP (mmHg) 70.4101 11.326| 1 OOOOOOl -0.193766
Seated MET-minutes 3384.051 1264.118 -0.193766 1.000000
Variable
Group=B
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data)
Means Std.Dev. DBP (mmHq) Seated MET-minutes
DBP (mmHg) 77.125 . 15.749__  1.000000 -0.375703
Seated MET-minutes 1952.045 1286.734 -0.375703 1.000000
Variable
Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < 
N=78 (Casewise deletion of missing data
.05000
Means Std.Dev. BMI (kq/m2) Total active MET-minutes
BMI (kg/m2) 25.897 . 4.6701 1.000000 -0.117243
Total active MET-minutes 1828.269 2238.104 -0.117243 1.000000
Variable
Group=B
Correlations (Spreadsheets)
Marked correlations are significant at p < 
N=88 (Casewise deletion of missing data
.05000
Means Std.Dev. BMI (kq/m2) Total active MET-minutes
BMI (kg/m2) 34.1851 8.071| 1.000000 -0.000467
Total active MET-minutes 2688.864 1486.558 -0.000467 1.000000
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variable
Mann-Whitney U Test (w/ continuity correction) (Spreadsheet101) 
By variable Group
Marked tests are significant at p <.05000
Rank Sum 
group W
Rank Sum 
group B
U Z p-value Z
adjusted
p-value Valid N 
group W
Valid N 
group B
Smoke daily 6278 000 7583.000 3197 000 -0.758729 0448015 -1.76102 0 078236 78 88
Mann-Whitney U Test (w/ continuity correction) (Spreadsheet101) 
By variable Group
variable
Mann-Whitney U Test (w/ continuity correction) (Spreadsheet101) 
By variable Group
Marked tests are significant at p < 05000
Rank Sum 
group W
Rank Sum 
group B
U Z p-value Z
adjusted
p-value Valid N 
group W
Valid N 
group B
Used to smoke 5848.000 8013.000 2767.000 -2.15000 0.031556 -4 09412 0 000042 78 88
variable
Mann-Whitney U Test (w/ continuity correction) (Spreadsheet101) 
By variable Group
Marked tests are significant at p < 05000
Rank Sum 
group W
Rank Sum 
group B
U Z p-value Z
adjusted
p-value Valid N 
group W
Valid N 
group B
Do not smoke 6880.000 6981.000 3065 000 1 185817 0.235695 2.463607 0.013755 78 88
variable
Mann-Whitney U Test (w/ continuity correction) (SpreadsheetHO) 
By variable Group
Marked tests are significant at p < 05000
Rank Sum Rank Sum 
W B
U Z p-value Z
adjusted
p-value Valid N 
W
Valid N 
B
Sufficiently Active 7320 0001 6541.000 2625.000 2.609445 0.009069 3.147529 0.001647 78 88
Mann-Whitney U Test (w/ continuity correction) (SpreadsheetHO) 
By variable Group
Marked tests are significant at p <.05000____________________
variable
Rank Sum 
W
Rank Sum 
B
u Z p-value z
adjusted
p-value Valid N 
W
Valid N
B
Insufficiently Active 5930 000 7931.000 2849.000 -1.88469 0 059473 -2.69620 0.007014 78 88
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variable
Mann-Whitney U Test (w/ continuity correction) (SpreadsheetHO)
By variable Activity levels
Marked tests are significant at p < 05000
Rank Sum
SA
Rank Sum 
MA
u Z p-value Z
adjusted
p-value Valid N 
SA
Valid N 
MA
Caucasian 6786 000 5460.000 2379 000 2.348184 0 018866 2.882402 0004205 78 78 J
173
variable
Mann-Whitney U Test (w/ continuity correction) (SpreadsheetHO)
By variable Activity Levels
Marked tests are significant at p <.05000
Rank Sum 
MA
Rank Sum
IA
U Z p-value Z
adjusted
p-value Valid N 
MA
Valid N
IA
Caucasian 5538 000 6708.000 2457.000 ■2.07172 0 038293 -2.46646 0 013646 78 78
Variable
Group=W
Correlations (Spreadsheet 142)
Marked correlations are significant at p < .05000 
N=78 (Casewise deletion of missing data)
Weiqht (kq) | BMI (kq/m2) WC WSR SBP DBP MAP Total Active MET-minutes
Income (R/month) -0.132026] -0.162174 -0.010022 -0.023844 0.123902 0.095000 0.111127 -0.001491
Group=W
Correlations (Spreadsheet142)
Marked correlations are significant at p < .05000 
N=78 (Casewise deletion of missing data)
Variable Weight (kq) BMI (kg/m2) WC WSR SBP DBP MAP Total Active MET-minutes
Years educated -0 1485331 -0.166473 -0.125426 -0.129970 -0.086744 -0.070402 -0.080499 0 0637991
Group=B
Correlations (Spreadsheet142)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data)
Variable Weight (kg) | BMI (kg/m2) | WC WSR SBP DBP MAP Total Active MET-minutes
Years educated -0.1299451 -0.181738 -0.206296 -0.238681 -0.280576 -0.200416 -0.236338 -0.3538071
variable
Mann-Whitney U Test (w/ continuity correction) (SpreadsheetHO)
By variable Activity Levels
Marked tests are significant at p < 05000
Rank Sum 
MA
Rank Sum 
IA
U Z p-value Z
adjusted
p-value Valid N 
MA
Valid N 
IA
Black South African 6688.000 8888.000 2772.000 -3.25324 0.QQ1141 ■4.24539 0.000022 88 88
variable
Mann-Whitney U Test (w/ continuity correction) (SpreadsheetHO)
By variable Activity Levels
Marked tests are significant at p <.05000
Rank Sum
SA
Rank Sum 
MA
U Z p-value Z
adjusted
p-value Valid N 
SA
Valid N 
MA
Black South African 7612 000 7964 000 3696 000 -0.519276 0 603568 -0.605253 0 545012 88 88
Group=B
Correlations (Spreadsheet142)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data)
Variable Weiqht (kq) BMI (kq/m2) | WC WSR SBP DBP MAP Total Active MET-minutes
Income (R/month) -00982291 -0.083705 -0 031224 -0.016002 -0.074349 0.031381 -0.007144 0.0338721
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Variable
GrGup=B
Correlations (Spreadsheets)
Marked correlations are significant at p < 
N=83 (Casewise deletion of missing data
.05000
Means Std.Dev. BMI (kg/m2) WSR
BMI (kg/m2) 34.189331 8.071284 1.000000 0.9207261
WSR 0.60350 0 104866 0.920726 1 000000
Variable
Group=W
Correlations (Spreadsheets)
Marked correlations are significant at p < 
N=78 (Casewise deletion of missing data
.05000
Means Std.Dev. BMI (kg/m2) WSR
BMI (kg/m2) 25.89650 I 4.669838I 1.000000 0.368217
WSR 0 48569 0.066275 0.868217 1 000000
Variable
Group=B
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data)
Means Std.Dev. WC WSR
WC 95.335231 16.76349 1.000000 0 973133
WSR 0.60850 0 10487 0.973133 1 000000
Variable
Group=W
Correlations (Spreadsheet 142)
Marked correlations are significant at p < .05000 
N=73 (Casewise deletion of missing data)
Means Std.Dev. WC WSR
WC 79.84615 . 10.81074 1.000000 0 953762
WSR 0 48569 0.06628 0.958762 1 000000
Variable
Group=B
Correlations (Spreadsheets)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data)
Means Std.Dev. Weight (kg) BMI (kg/m2)
W eight (kg) 84.164771 21.62198 1 000000 0 948494
BMI (kg/m2) 34.139331 8 07128 0.943494 1 000000
175
Variable
Group=W
Correlations (Spreadsheet 142)
Marked correlations are significant at p < .05000 
N=73 (Casewise deletion of missing data)
Means Std.Dev. Weiqht (kq) BMI (kq/m2)
Weight (kg) 70.153851 13.43655 1.000000 0.906017
BMI (kg/m2) 25.89650* 4.66984 0.906017 1 000000
Variable
Group=B
Correlations (Spreadsheet 142)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data)
Means Std.Dev. Weiqht (kq) WC
Weight (kg) 84 16477 . 21.62198 1 000000 0.914601
WC 95.33523 16.76849 0.914601 1 000000
Group=W
Correlations (Spreadsheet142)
Marked correlations are significant at p < .05000 
N=78 (Casewise deletion of missing data)
Variable Means Std.Dev. Weiqht (kq) WC
Weight (kg) 70.153851 13.43655 1 000000 0.350169
WC 79.84615* 10 81074 0.350169 1 000000
Variable
Group=B
Correlations (Spreadsheet 142)
Marked correlations are significant at p < .05000 
N=88 (Casewise deletion of missing data)
Means Std.Dev. WSR Seated MET-minutes
WSR 0 608 I 0.105| 1.000000 -0.177507|
Seated MET-minutes 1952.045 1286.734 -0.177507 1.000000
Variable
Group=W
Correlations (Spreadsheet 142)
Marked correlations are significant at p < .05000 
N=78 (Casewise deletion of missing data)
Means Std.Dev. WSR Seated MET-minutes
WSR 0.486 I 0.0G6| 1 OOOOOOl -0.007489
Seated MET-minutes 3334.051 1264.118 -0.007489 1.000000
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STEPS Instrument (V1.4)
• This is the generic template which countries use to develop their own Instrument. It contains 
the CORE (unshaded and in double lined boxes) and EXPANDED items (shaded and in single 
lined boxes) and response options for Step 1, Step 2 and Step 3.
• The introductory statements, questions and response options should be translated and adapted 
where necessary to suit local conditions. Italic typeface indicates where local examples should 
be inserted.
•  All CORE items should be included in the country-specific STEPS Instrument. Wording and 
response options for CORE questions should not be changed.
• Some countries may wish to expand the CORE questions. Recommendations for EXPANDED 
questions for the key risk factors are included in the shaded areas. These items may be modified 
but it is preferable to use them where possible.
•  Additional questions can be added as OPTIONAL items to meet local needs. For example 
questions asked in previous surveys could be added to link to previous data.
• The use of the coding column (as is used in this Instrument) facilitates easy, fast and accurate 
manual data entry. Using this approach does not replace the need for double data entry for 
maximum quality control (see data coding manual).
•  Relevant skip patterns are shown on the right hand side of the coding column. They should be 
carefully reviewed. Modifications to the skip patterns will be needed according to the final 
items included.
E X A M P LE - for a current smoker who eats 8 servings of fruit on a typical day
Response Coding
column
S 1a Do you currently smoke any tobacco 
products, such as cigarettes, cigars or 
pipes?
Yes 1 
No 2 
Don't know 7
c
D 1b How many servings of fruit 
do you eat on one of those days? 
USE SHOWCARD
Number of servings
Don't know 77 rnn
Skip
I f  N o , g o  to  
N e x t  S e c tio n
•  "Do not know", "Don’t remember", “Not applicable”, “Refuse” are all response options but 
should be used only as a last resort. In such cases, the first two categories and the last two 
categories are coded as "7", "77" or "777" and as "8", "88", or "888", respectively depending on 
the number o f numerals in the other response options. Missing responses should be entered as 
"9", "99" or "999" at time o f data entry. •
•  Interviewer training is essential to develop thorough knowledge of the instrument format, 
introductory statements, questions, skip patterns, response options, use of show cards and 
prompts (where needed). The STEPS Field Manual is a guide and resource for training sessions.
• Undertaking pilot work with the draft country-specific STEPS instrument is essential.
•  Each country will need to prepare a list o f the question numbers (e.g. D1a) and response code 
cross-referenced with the standard numbers and codes used in this generic template. This cross- 
referencing will facilitate communication and comparison.
This document is available electronically on the NCD Surveillance website: 
http://www.who.int/ncd surveillance
Other documents cross-referenced in above are available by contacting ncd_surveillance@who.int
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Respondent Identification Number
Identification Information:
This is a draft cover page. Each country will adapt this page to suit their local needs. The exact details 
to be collected in each country-specific STEPS instrument will vary depending on the survey design and 
implementation procedures. However, regardless o f how the interview is administered (e.g., household, 
clinic or other) a process by which the cover page containing personal identifying information is stored 
should be carefully designed and must meet recommended ethical standards. Clear instructions on 
handling and storage o f the cover sheets must be provided to the interviewers.
I 1 Country/district code □  □
I 2 Centre (Village name): □ □ □ □ □ □ □ □
I 3 Centre (Village code): (SEE NOTE BELOW) □  □ □
I 4 Interviewer code □  □ □
I 5 Date of completion of the questionnaire
□  □ / □ □ / □ □ □ □
Day Month Year
\ <=r\
Respondent Id Number □ □ □ □ □ □
Consent
I 6 Consent has been read out to respondent Yes 1
No 2 □__□ If NO, read consent
I 7 Consent has been obtained (verbal or written) Yes 1
No 2  □  If NO, END
I 8 Interview Language [ In s e r t  L a n g u a g e ]
English 1
[Add others] 2 □
I 9 Time of interview (24 hour clock) □  □ : □ □
I 1 0 Family Name
I 1 1 First Name
Additional Information that may be helpful
I 1 2 Contact phone number where possible
I 13 Specify whose phone Work 1 
Home 2 
Neighbour 3 
Other (specify) 4
□
Note: Identification information I6  to I13 should be stored separately from the questionnaire because it contains 
confidential information. Please note: village code (or household code) is required as part of main instrument for 
data analyses.
Date of interview is required to calculate age.
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Step 1 Core Demographic Information
Coding Column
C1 Sex (R ecord  M ale /  Fem ale as observed) Male 1 Female 2 □
C2 What is your date of birth?
I f  D o n ’t Know, See N o te * b e low  an d  Go to C3
Day □ □  Month □ □  Year □ □ □ □
C3 How old are you? Years □  □
C4 In total, how many years have you spent at school or in full-time study (excluding pre-school)? Years □  □
EXPANDED: Dem ographic Inform ation
C5 What is your [insert re levant ethnic group / rac ia l group  
/  cu ltu ra l subgroup / others] background?
[D e fined  acco rd ing  
to  lo c a l dem ograph ic  needs]
□  □
C6 What is the highest level of education you have 
completed?
[IN S E R T  C O U N TR Y -S P E C IF IC  C A TE G O R IE S ]
No formal schooling 0 1 
Less than primary school 0 2 
Primary school completed 0 3 
Secondary school completed 0 4 
High school completed 0 5 
College/University completed 0 6 
Post graduate degree 0 7
□  □
C7 Which of the following best describes your main work 
status over the last 1 2  months?
[IN S E R T  C O U N TR Y -S P E C IF IC  C A TE G O R IE S ] 
USE SHOWCARD
Government employee 0 1 
Non-government employee 0 2 
Self-employed 0 3 
Non-paid 0 4 
Student 0 5 
Homemaker 0 6 
Retired 0 7 
Unemployed (able to work) 0 8  
Unemployed (unable to 0 9 
work)
□  □
C8 How many people older than 18 years, including 
yourself, live in your household? Number of people □  □
C9 Taking the past year, can you tell me what the 
average earnings of the household have been?
per week n n n n n n  
or per month n n n n n n
or per year n n n n n n n
Go to N e x t Section
Refused 8 □
C10 If you don't know the amount, can you give an 
estimate of the annual household income if I read 
some options to you? Is it
[R E A D  O P TIO N S ]
[IN S E R T  Q U IN TILE  VALUES]
< Quintile (Q) 1 1 
More than Q 1, < Q 2 2 
More than Q 2, < Q 3 3 
More than Q 3, < Q 4 4 
More than Q 4 5
Refused 8
□
I f  R e fused  
Go to C10
’Note: Coding Rule: Code “Don't Know” 7 (or 77 or 777 as appropriate).
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Step 1 Core Behavioural Measures
CORE T obacco  Use (Section  S)
Now I am going to ask you some questions about various health behaviours. This includes things like smoking, drinking
alcohol, eating fruits and vegetables and physical activity. Let's start with smoking.
Response Coding Column
S 1a Do you currently smoke any tobacco products, Yes 1
□such as cigarettes, cigars or pipes? No 2
S 1b If Yes, Yes 1
□Do you currently smoke tobacco products daily? No 2
S 2a How old were you when you first started smoking 
daily?
Age (years) 
Don't remember 7 7 □  □
S 2b Do you remember how long ago it was? In Years Years □ □
OR in Months Months □ □
OR in Weeks Weeks □ □(CODE 77 FOR DON'T REMEMBER)
S 3 On average, how many of the following do you 
smoke each day? Manufactured cigarettes □  □
(R E C O R D  FO R  E A C H  TYPE)
Hand-rolled cigarettes □  □
Pipes full of tobacco □  □
(CODE 88 FOR NOT APPLICABLE)
Cigars, cheroots, cigarillos □  □
□ □ □ □ □ □ □ □ Other (please specify): □  □
I f  No, go  to  
N e x t S ec tion * 
I f  No, go  to  
N e x t S ec tion * 
I f  K now n, go  to  
S 3
EXPANDED: Tobacco Use
S 4 In the past, did you ever smoke daily? Yes 1 
No 2 □
S 5a If Yes,
How old were you when you stopped smoking 
daily?
Age (years)
Don't remember 7  7 □  □
S 5b How long ago did you stop smoking daily? Years ago 
OR Months ago 
OR Weeks ago
Years □ □  
Months □ □  
Weeks □ □
S 6 a Do you currently use any smokeless tobacco such 
as [snuff, che w in g  tobacco, be te l[ ?
Yes 1 
No 2 □
S 6 b If Yes,
Do you currently use smokeless tobacco products 
daily?
Yes 1 
No 2
□
I f  No, go  to S 6a
I f  Know n, go  to 
S 6a
I f  7 7, g o  to  S 5b
I f  No, go  to S 8 
I f  No, go  to S 8
Amend skip instructions if EXPANDED or OPTIONAL items are added to the Tobacco section
* Amend skip instructions if EXPANDED or OPTIONAL items are added to the Tobacco section
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S 7 On average, how many times a day do you use .... Snuff, by mouth □  □(R E C O R D  FO R  E A C H  TYPE)
Snuff, by nose □  □
Chewing tobacco □  □
Betel, quid □  □
□ □ □ □ □ □ □ □ Other (specify) □  □
S 8 In the past, did you ever use smokeless tobacco Yes 1
□such as [snuff, che w in g  tobacco, o r be tel\ daily? No 2
CORE A lc o h o l C onsum p tion  (Section  A)
The next questions ask about the consumption of alcohol.
Response Coding Column
A  1a Have you ever consumed a drink that contains 
alcohol such as beer, wine, spirit, fermented cider o r Yes 1
□[a d d  o th e r lo c a l exam ples\ ?
U S E  S H O W C A R D  o r S H O W  E XA M P LE S
No 2
A  1b Have you consumed alcohol within the past 12 Yes 1
□months? No 2
A  2 In the past 12 months, how frequently have you 5 or more days a week 1
had at least one drink? 1-4 days per week 2
□(R E A D  R E SP O N S ES ) 1-3 days a month 3
U S E  S H O W C A R D Less than once a month 4
A  3 When you drink alcohol, on average, how many Number
□  □drinks do you have during one day? Don't know 7 7
A  4 During each of the past 7 days, how many standard 
drinks of any alcoholic drink did you have each day? Monday □  □
(R E C O R D  FO R  E A C H  D A Y  
U SE S H O W C A R D )
Tuesday □  □
Wednesday □  □
Thursday □  □
Friday □  □
Saturday □  □
Sunday □  □
I f  No, Go to 
N ext S ec tion *
I f  No, Go to 
N e x t S ection*
EX PA N D ED  : A lcoho l
A  5 In the past 12 months, what was the largest number 
of drinks you had on a single occasion, counting all 
types of standard drinks together?
Largest number
□  □
A  6 a For men only:
In the past 12 months, on how many days did you 
have five or more standard drinks in a single day?
Number of days
□  □ □
A  6 b For women only;
In the past 12 months, on how many days did you 
have four or more standard drinks in a single day?
Number of days
□  □ □
* Amend skip instructions if EXPANDED or OPTIONAL items are added to the Alcohol section 
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CORE D ie t (Section  D)
The next questions ask about the fruits and vegetables that you usually eat. I have a nutrition card here that shows you 
some examples of local fruits and vegetables. Each picture represents the size of a serving. As you answer these 
questions please think of a typical week in the last year.
D 1a In a typical week, on how many days do you 
eat fruit?
U S E  S H O W C A R D
Number of days
□  □
D 1b How many servings of fruit do you eat on one 
of those days?
U S E  S H O W C A R D
Number of servings □  □
D 2a In a typical week, on how many days do you 
eat vegetables?
U S E  S H O W C A R D
Number of days □  □
D 2b How many servings of vegetables do you eat on 
one of those days?
U S E  S H O W C A R D
Number of servings □  □
EXPAN D ED : D iet
D 3 What type of oil or fat is most often used for meal 
preparation in your household?
U S E  SH O W C A R D  
S E L E C T  O N LY  O N E
□ □ □ □ □ □ □ □
Vegetable oil 0 1 
Lard or suet 0 2 
Butter or ghee 0 3 
Margarine 0 4 
Other 0 5 
None in particular 0 6 
None used 0 7
Don't know 7 7
□  □
I f  Ze ro  days, 
go  to  D  2a
If Zero days, go 
to Section P
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CORE Physical Activity (Section P)
Next I am going to ask you about the time you spend doing different types of physical activity. Please answer these 
questions even if you do not consider yourself to be an active person.
Think first about the time you spend doing work. Think of work as the things that you have to do such as paid or unpaid 
work, household chores, harvesting food, fishing or hunting for food, seeking employment. [ In s e r t  o th e r  e x a m p le s  if 
n e e d e d ]
P 1 Does your work involve mostly sitting or standing, 
with walking for no more than 1 0  minutes at a time?
Yes 1 
No 2 D
P 2 Does your work involve vigorous activity, like [heavy  
lifting, d igg ing  o r construction  work] for at least 10  
minutes at a time?
IN S E R T  E X A M P LE S  & U S E  S H O W C A R D
Yes 1 
No 2 D
P 3a In a typical week, on how many days do you do 
vigorous activities as part of your work?
Days a week d d
P 3b On a typical day on which you do vigorous activity, 
how much time do you spend doing such work? In hours and minutes hrs 1 . mins| l l 1 
OR in Minutes only or minutes D D D
P 4 Does your work involve moderate-intensity activity, 
like brisk walking [o r  ca rry ing  lig h t loads] for at least 
1 0  minutes at a time?
IN S E R T  E X A M P LE S  & U S E  S H O W C A R D
Yes 1 
No 2 D
P 5a In a typical week, on how many days do you do 
moderate-intensity activities as part of your work? Days a week D D
P 5b On a typical day on which you did moderate-intensity 
activities, how much time do you spend doing such 
work?
In hours and minutes hrs| I ^ J  . mins| l l 1 
OR in Minutes only or minutes D D D
P 6 How long is your typical work day? Number of hours hrs D D
Other than activities that you've already mentioned, I would like to ask you about the way you travel to and from places. 
For example to work, for shopping, to market, to place of worship. [ in s e r t  o th e r  e x a m p le s  i f  n e e d e d ]
P 7 Do you walk or use a bicycle (p eda l cycle) for at least 
1 0  minutes continuously to get to and from places?
Yes 1 
No 2 D
P 8a In a typical week, on how many days do you walk or 
bicycle for at least 1 0  minutes to get to and from 
places?
Days a week
D D
P 8b How much time would you spend walking or bicycling 
for travel on a typical day? In hours and minutes hrs 11^^ . mins| l l 1 
OR in Minutes only or minutes D D D
The next questions ask about activities you do in your leisure time. Think about activities you do for recreation, fitness or 
sports [ in s e r t  re le v a n t  te rm s ]. Do not include the physical activities you do at work or for travel mentioned already.
P 9 Does your [recreation, sp o rt o r  le isu re  tim e] involve 
mostly sitting, reclining, or standing, with no physical 
activity lasting more than 1 0  minutes at a time?
Yes 1 
No 2
D
P 10 In your [le isure time], do you do any vigorous 
activities like [ru nn ing  o r s trenuous sports, weight 
lifting ] for at least 1 0  minutes at a time?
IN S E R T  E X A M P LE S  & U S E  S H O W C A R D
Yes 1 
No 2 D
P 11a If Yes,
In a typical week, on how many days do you do 
vigorous activities as part of your [le isure  tim e]?
Days a week D D
P 11b How much time do you spend doing this on a typical 
day?
In hours and minutes
h r s ^ J ^ J  . m in s ^ J ^ J
OR in Minutes only
or minutes
I f  Yes, go  to  P 6
I f  No, go  to P4
I f  No, go  to P6
I f  No, go  to P9
I f  Yes, go  to  P 14
I f  No, go  to  P 12
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P 12 In your [le isure time], do you do any moderate- 
intensity activities like brisk w a lk ing ,[cyc ling  o r 
sw im m ing] for at least 1 0  minutes at a time?
IN S E R T  E X A M P LE S  & U S E  S H O W C A R D
Yes 1 
No 2 D
P 13a If Yes
In a typical week, on how many days do you do 
moderate-intensity activities as part of [le isure  tim e]?
Days a week
D D
P 13b How much time do you spend doing this on a typical 
day?
In hours and minutes I- 1 I- 1 . I- 1 I- 1 
h r s ^ J ^ J  . m in s ^ J ^ J
OR in Minutes only V~ 1 V~ 1 V~ 1 
or minutes l _ l  l _ l  l _ l
The following question is about sitting or reclining. Think back over the past 7 days, to time spent at work, at home, in 
[ le is u re ], including time spent sitting at a desk, visiting friends, reading, or watching television, but do not include time 
spent sleeping.
P 14 Over the past 7 days, how much time did you spend 
sitting or reclining on a typical day?
In hours and minutes 1 1 1 1 . 1 1 1 1 
h r s ^ J ^ J  . m in s ^ J ^ J
OR in Minutes only 1 1 1 1 1 1 
or minutes l _ l  l _ l  l _ l
I f  No, go  to P 14
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EXPANDED : History o f High Blood Pressure
H 1 When was your blood pressure last measured by a Within past 12 months 1
□health professional? 1-5 years ago 2
Not within past 5 yrs 3
H 2 During the past 12 months have you been told by a Yes 1
□doctor or other health worker that you have elevated 
blood pressure or hypertension?
No 2
H 3 Are you currently receiving any of the following treatments for high blood pressure prescribed by a doctor or other health
worker?
H 3a Drugs (medication) that you have taken in the last 2 Yes 1
□weeks No 2
H 3b Special prescribed diet Yes
No
1
2 □
H 3c Advice or treatment to lose weight Yes
No
1
2 □
H 3d Advice or treatment to stop smoking Yes
No
1
2 □
H 3e Advice to start or do more exercise Yes
No
1
2 □
H 4 During the past 12 months have you seen a Yes 1
□traditional healer for elevated blood pressure or 
hypertension
No 2
H 5 Are you currently taking any herbal or traditional Yes 1
□remedy for your high blood pressure? No 2
EXPANDED : History o f Diabetes
H 6 Have you had your blood sugar measured in the last 12 months? Yes 1 No 2 □
H 7 During the past 12 months, have you ever been told 
by a doctor or other health worker that you have 
diabetes?
Yes 1 
No 2
□
H 8 Are you currently receiving any of the following treatments for diabetes prescribed by a doctor or other health worker?
H 8a Insulin Yes 1 
No 2 □
H 8b Oral drug (medication that you have taken in the last 2 weeks
Yes 1 
No 2 □
H 8c Special prescribed diet Yes 1 
No 2 □
H 8d Advice or treatment to lose weight Yes 1 
No 2 □
H 8e Advice or treatment to stop smoking Yes 1 
No 2 □
H 8f Advice to start or do more exercise Yes 1 
No 2 □
H 9 During the past 12 months have you seen a 
traditional healer for diabetes?
Yes 1 
No 2 □
H 10 Are you currently taking any herbal or traditional 
remedy for your diabetes?
Yes 1 
No 2 □
I f  No, sk ip  to 
N ext Section
I f  No, sk ip  to 
N ext Section
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Step 2 Physical Measurements
Height and weight Coding Column
M 1 Technician ID Code
□ □ □
M 2a 
& 2b
Device IDs for height and weight
(2 a) height 1__I I __ 1 (2 b) weight I__ I I __ 1
M 3 Height
(in Centimetres) □  □ □ . □
M 4 Weight
I f  too la rge  fo r scale, code 666.6 (in Kilograms) □  □ □ . □
M 5 (F o r  w o m e n ) Are you pregnant? Yes 1 
No 2 □
W aist
M 6 Technician ID
□  □ □
M 7 Device ID for waist
□  □
M 8 Waist circumference
(in Centimetres) □  □ □ . □
I f  Yes, S kip  W aist
Blood pressure Coding Column
M 9 Technician ID
□ □ □
M 10 Device ID for blood pressure
□ □
M 11 Cuff size used Small 1 
Normal 2 
Large 3
□
M 12a 
M 12b
Reading 1 Systolic BP
Diastolic BP
Systolic mmHg 
Diastolic mmHg
□
 
□
 
□
 
□
 
□
 □
M 13a 
M 13b
Reading 2 Systolic BP
Diastolic BP
Systolic mmHg 
Diastolic mmHg
□
 
□
 
□
 □ 
□
 □
M 14a 
M 14b
Reading 3 Systolic BP
Diastolic BP
Systolic mmHg 
Diastolic mmHg
□ □ □
□ □ □
M 15 During the past two weeks, have you been treated 
for high blood pressure with drugs (medication) 
prescribed by a doctor or other health worker ?
Yes 1 
No 2 □
SELECTED EXPANDED ITEMS
M 16 Hip circumference (in Centimetres) □  □ □ . □
Heart Rate (Record if automatic blood pressure device is used)
M 17a Reading 1 Beats per minute: □  □ □
M 17b Reading 2 Beats per minute: □  □ □
M 17c Reading 3 Beats per minute: □  □ □
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Step 3 Biochemical Measurements
CORE Blood glucose Coding Column
B 1 During the last 12 hours have you had anything to 
eat or drink, other than water?
Yes 1 
No 2 □
B 2 Technician ID Code
□ □ □
B 3 Device ID code
□ □
B 4 Time of day blood specimen taken (24 hour clock)
hrs □ □  . m in s ^ J ^ J
B 5 Blood glucose
Low 1 
High 2 
Unable to assess 3
mmol/l □ □  ■ □  
□
CORE Blood Lipids
B 6 Technician ID Code
□  □ □
B 7 Device ID code
□  □
B 8 Total cholesterol
Low 1 
High 2 
Unable to assess 3
mmol/l □ □  ■ □ □  
□
SE LE C TE D  EX PA N D ED  ITEM S
B 9 Technician ID Code □  □ □
B 10 Device ID code □  □
B 11 Triglycerides
Low 1 
High 2 
Unable to assess 3
mmol/l □ □  ■ □ □  
□
B 12 Technician ID Code □  □ □
B 13 Device ID code □  □
B 14 HDL Cholesterol
Low 1 
High 2 
Unable to assess 3
mmol/l □  ■ □ □  
□
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